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Recently, the relationship of anxiety with asthma has been investigated in the 
psychological literature, revealing that individuals with asthma are more likely to develop 
panic disorder than are individuals without asthma (e.g., Carr, 1998). Two theories 
(dyspnedsuffocation fear theory and cognitive theory) have been used to explain how 
asthma symptoms are affected by panic attacks or panic disorder. The present study 
examines both theories, as well as a hypothesis developed by Carr (1 998) that suggests 
that the presence of panic disorder in individuals with asthma may lead to better lung 
functioning in response to stressful stimuli than for individuals with asthma alone. 
Sixty undergraduate females participated. They were divided into four groups 
based on history of asthma and panic disorder (Asthma only, Panic only, Asthma and 
Panic, Control). Participants completed questionnaires that assessed depressed mood, 
anxiety, anxiety sensitivity, self-focus on bodily sensations, fear of bodily sensations, and 
misinterpretation of bodily sensations. Each participant engaged in a 5 min baseline and 
three experimental tasks: breathing through a straw, turning one’s head from side to side, 
and relaxation. Following each task, spirometry measurements were taken, and 
participants completed measures of panic and asthma symptoms, panic attack related 
cognitions, and mood. 
Women with panic disorder (with or without asthma) reported more depressed 
mood, trait anxiety, self-focus on bodily sensations, fear of bodily sensations, and anxiety 
sensitivity (on one of two measures of anxiety sensitivity) than women with asthma only 
or controls. Women with both asthma and panic disorder reported higher levels of 
asthma-related symptoms than women with asthma only. Little support was found for the 
application of cognitive theory to asthma alone, however, cognitive theory continued to 
explain results for individuals in the panic groups. Likewise, dyspnedsuffocation fear 
theory was not supported by the present study, nor was Carr’s hypothesis. Implications 
of these results for the two theories and Carr’s hypothesis are discussed. In addition, 
suggestions for future research are made. 
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Asthma has long been viewed by both the medical and psychological community 
as a chronic respiratory illness that may be provoked or exacerbated by psychological 
factors. Knowledge of the relationship of asthma to psychological factors arose from an 
accumulation of case studies and anecdotes about the relation between emotional upset or 
exposure to benign objects and the exhibition of asthma symptoms (Dekker & Groen, 
1956; Dekker, Pelser, & Groen, 1957; French & Alexander, 1941; Rees, 1956). For 
example, MacKenzie (I  886) documented the case of a woman with asthma whose 
symptoms were precipitated by contact with roses. Interestingly, severe symptoms were 
also triggered by contact with an artificial rose. Over time, a variety of events (e.g., 
merely looking at dust, using an elevator, seeing a picture of a horse, or looking at a 
goldfish in a bowl) have been reported to lead to asthma symptoms (Dekker & Groen, 
1956). Because asthma symptoms appear at times to be evoked or worsened by an 
individual’s mental state, or by exposure to objects that should not physiologically lead to 
bronchoconstriction, psychological correlates of asthma continue to be widely researched. 
In the medical and psychological literature, there are opposing views about 
whether or not asthma is indeed caused or exacerbated by psychological factors (e.g., 
Benjamin, 1977; Ibor, 1956; Purcell & Weiss, 1970). In the 1950s, researchers suggested 
that emotional factors played a role in the etiology of asthma symptoms (Dekker & 
Groen, 1956; Dekker et al., 1957; French & Alexander, 1941). However, at the time, it 
was unclear how much emotional factors contributed and how they operated in creating 
symptoms (Rees, 1956). Unfortunately, over 40 years later, there has been little progress 
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toward a definitive resolution of either of these points. Researchers continue to disagree 
about the role played by psychological factors in the experience of asthma. 
A variety of contrasting views about the interaction between asthma and 
psychological factors have been presented. Psychosomatic models of asthma posit that 
the disease may be caused or exacerbated by intense emotions or particular personality 
types (e.g., dependent) or characteristics (e.g., emotional lability; Belloch et al., 1994; 
French & Alexander, 1941; Henry, Morera, Frugoni, & Gonzalez-Martin, 1993; Lyketsos 
et al., 1984). Some theorists suggest that asthma and specific psychological disorders 
(e.g., schizophrenia, agoraphobia, depression) are alternate manifestations of each other 
(Ibor, 1956; Kelly & Zeller, 1969). In contrast, other researchers propose that asthma is 
not caused by psychological phenomena at all, stating that the real task in studying 
asthma should be to examine the development of psychopathology as a consequence of 
having asthma (Maes & Schlosser, 1987). Conceivably, psychological disorders may 
occur as a result of living with a chronic illness, not vice versa (Plutchik, Williams, 
Jerrett, Karasu, & Kane, 1978). According to Maes and Schlosser (1 987), it may be more 
productive to direct research toward questions of psychomaintenance. This area of focus 
might include such issues as how particular disorders (e.g., anxiety, depression) or 
methods of coping with asthma affect the course and outcome of the disease (Deenen & 
Klip, 1993; Janson-Bjerklie, Ferketich, & Benner, 1993; Staudenmayer, Kinsman, & 
Jones, 1978). Research about the relation between asthma and psychological factors 
leads to conclusions that lie somewhere between these diverse views. Although it would 
be inaccurate to state that the etiology of asthma is entirely psychological, it would be a 
mistake to discontinue researching the role that psychological factors play in the 
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experience of the disease. It is important to continue to investigate antecedent, 
concomitant, and consequential psychological phenomena in the hopes of ultimately 
reducing the symptoms, suffering, and costs associated with asthma. 
Asthma: Relation to Symptoms and Theories of Panic Disorder 
Some of the symptoms of asthma are similar to those of panic disorder (e.g., 
shortness of breath, choking sensation, chest pain, fear). This similarity may have 
strengthened the view of asthma as an illness with both biological and psychological 
causes (Yellowlees & Kalucy, 1990; Zandbergen et al., 1991). In addition, high 
comorbidity rates and the applicability of theories of panic disorder to asthma research 
have fostered conjoint study of the two disorders. 
There is a particularly high rate of comorbidity between asthma and panic 
disorder. According to the Diagnostic and Statistical Manual of Mental Disorders-Fourth 
Edition (DSM-IV; American Psychological Association [APA], 1994), the 1 -year 
prevalence rate of panic disorder in the general population is 1 % - 2%. For individuals 
who have asthma, however, it is estimated to be between 6.5% and 24% (Shavitt, Gentil, 
& Mandetta, 1992; Yellowlees, Alpers, Bowden, Bryant, & Ruffin, 1987). This high rate 
of comorbidity has led to much speculation about the possibility of common etiological 
factors that could lead to both disorders. Because symptoms of asthma are similar to 
symptoms of panic disorder, two theories (i.e., dyspnea-suffocation fear theory, cognitive 
theory) that have proved useful for understanding panic disorder have been applied to 
asthma. 
The revised dyspnedsuffocation fear theory addresses the effects of the perception 
of difficulty in breathing on the production of panic symptoms (Ley, 1989). Dyspnea 
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refers to the sensation that breathing is impaired, whereas suffocation refers to a bodily 
condition that may lead to asphyxiation (Ley, 1994; 1998). Suffocation can occur with 
little or no discomfort or overt anxiety symptoms. This phenomenon has been observed 
in infants who suffer from Ondine’s curse, a disorder wherein an infant temporarily stops 
breathing when asleep (Klein, 1993). Oddly, a child with this disorder does not exhibit 
symptoms of discomfort or distress when breathing ceases. In contrast, the 
dyspnedsuffocation fear theory posits that it is the experience of severe dyspnea in a 
context in which an individual believes he or she has little control over the causes of the 
sensation (e.g., having one’s head forced under water; an uncued panic attack) that leads 
to the experience of panic. The theory’s connection to asthma is reflected in the 
experience of dyspnea, which may lead to increased anxiety and further difficulty in 
breathing (Dirks, Kinsman, Staudenmayer, & Klieger, 1979; Jones, Kinsman, Dirks, & 
Dahlem, 1979; Purcell & Weiss, 1970). 
Cognitive theory has been extensively discussed in relation to the understanding 
and treatment of panic disorder. Recently, cognitive theory has been applied to the 
experience of asthma (e.g., Can, 1998; Carr, Lehrer, & Hochron, 1995; Carr, Lehrer, 
Hochron, & Jackson, 1996). According to cognitive theory, panic disorder develops as a 
result of the experience of ambiguous sensations that occur in the body. These sensations 
are then misinterpreted by an individual as having catastrophic consequences (e.g., “I am 
dying”; Clark, 1986). Next, the catastrophic cognitions lead to increased anxiety and 
anxiety-related sensations, continuing the cycle (Figure 1.1). In relation to asthma, it has 
been hypothesized that misinterpreting or catastrophizing about ambiguous or asthma- 
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Figure 1.1 Representation of the sequence of events hypothesized to lead to panic attacks 
in Clark’s (1 986) cognitive theory of panic 
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related bodily symptoms may result in increased fear, that in turn may increase the 
severity of asthma symptoms (Dorhofer, Sigmon, & Boulard, 1998). 
Investigations of the utility of these two theories in explaining asthma symptoms 
(as well as the experience of panic) have produced mixed findings. There has been some 
support for the dyspnedsuffocation fear theory in relation to asthma (e.g., Carr, Lehrer, & 
Hochron, 1992; see Ley, 1994 for criticisms). Support for cognitive theory has been 
mixed (e.g., Can- et al., 1995; Carr et al., 1996; Dorhofer et al., 1998; see Carr, 1998 for 
opposing viewpoint). The utility of these theories may be in helping researchers better 
understand how symptoms of asthma can be triggered or exacerbated by cognitive 
interpretations of physiological sensations, or the sensations themselves. In turn, this 
understanding could lead to interventions that could possibly reduce asthma symptoms, 
suffering, and expense (Klingelhofer & Gershwin, 1988; Lehrer, Sargunaraj, & Hochron, 
1992; Rachelefsky, 1987). Thus, it may be important for the two theories to be tested 
together in an experimental paradigm in order to assess their applicability to the 
experience of asthma. These two theories are further discussed in a later section. 
Asthma: General Characteristics 
In order to discuss research pertinent to the psychological contributions to asthma 
symptoms, it is important to understand the basic characteristics of the disease. The 
physiological mechanisms and epidemiology of asthma have been studied for many years. 
It is now possible to understand trends in a number of epidemiological studies as well as 
the basic physiological changes that underlie an asthma attack. 
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Asthma Prevalence and DemoaraDhics 
Asthma represents one of three types of chronic obstructive pulmonary disease. 
Other types include chronic bronchitis and emphysema (Creer, 1979). Approximately 
0.3% - 7.9% of the population of the United States suffers from asthma (Bonner, 1984; 
Cookson, 1987; Rees, 1980). Between 1965 and 1983, hospitalization rates for adults 
with asthma increased by 50%, whereas in children, the rates increased by 200% (Evans 
et al., 1987). This dramatic increase in asthma rates continued in the period between 
1980 and 1987, when the prevalence of asthma in the United States increased by 29% 
(Expert Panel Report [EPR], 1991). In addition, asthma-related death rates increased by 
40% between 1982 and 1991 (Center for Disease Control [CDC], 1995). Researchers 
have yet to discover why the mortality rates have steadily increased. 
Approximately 63% of individuals with asthma experience symptom onset before 
the age of 15. In some studies, males appear to be slightly more prone to asthma (0.6% - 
4.7% for men, 0.6 - 1.5% for women; Evans et al., 1987; Rees, 1980). However, other 
estimates of gender differences in asthma rates indicate that age may be an important 
factor as well. In one community sample, no significant gender differences were found 
for individuals younger than age 30 (Dodge & Burrows, 1980). However, for individuals 
between 30 and 50, the rates of active asthma for women was nearly double those for men 
(although this difference was not statistically significant). Beyond age 50, the rates for 
men again exceeded those for women (Pearlman & Bierman, 1988). Asthma is, 
therefore, a relatively common disease that is increasing in prevalence. The necessity of 
identifying factors that can reduce asthma morbidity and mortality is clear. 
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It is particularly important to investigate correlates of asthma in a female 
population for several reasons. First, as described above, asthma rates may be higher for 
women in certain age groups (Dodge & Burrows, 1980). Second, approximately 75% of 
adults hospitalized for asthma are female (Skobeloff et al., 1996). Third, a larger increase 
in mortality rates was observed between 1982 and 1991 for women than men (59% for 
women, 34% for men; CDC, 1995). These differences in hospitalization and death rates 
indicate that there are additional factors beyond prevalence alone that account for gender 
differences in asthma severity and use of health care resources. 
Asthma remains a costly disorder. In 1976, total cost of asthma in the United 
States was estimated to be $1.3 billion dollars, By 1992, that figure, comprising inpatient 
hospital services and lost productivity, reached $6.2 billion (Weiss, Gergen, & Hodgson, 
1992). With medical costs increasing yearly for the treatment of asthma, the prevention 
or curtailing of symptoms and attacks may serve to decrease these overall costs (Dirks & 
Kinsman, 198 1 ; Kaptein, 1982). 
In summary, asthma rates, deaths due to the disease, and societal costs of the 
disorder have been on the rise according to research conducted over the past 30 years. 
Because of specific increases in hospitalization and death rates for women, it is important 
to examine factors in addition to gender that may lead to differential asthma severity. 
These factors include the role of stress and anxiety, which may operate differentially for 
males and females. 
Physical Alterations During an Asthma Attack 
Asthma represents a chronic disorder characterized by three major elements: 
airway obstruction that is reversible either spontaneously or in response to treatment, 
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airway inflammation, and hyperresponsivity of the airways (American Thoracic Society 
[ATS], 1962; 1987; Bailey, Higgins, Richards, & Richards, 1992; EPR, 199 1 ; Pearlman, 
1984). Asthma generally occurs in discrete episodes or “attacks,” that are reversible with 
or without medical intervention (Hogg, 1984). The severity and pattern of asthma attacks 
varies greatly from individual to individual (Purcell & Weiss, 1970). Some individuals 
with asthma may only need to utilize occasional medication in the presence of a specific 
trigger, whereas others may not need to use medication at all (Alexander, 198 1). More 
severe asthma may not be completely reversible or controllable through use of regular 
medication (Creer, 1982; Matts, 1984). In this case, the individual is never completely 
without some asthma-related symptoms (American Medical Association [AMA], 1996). 
When asthma symptoms are triggered by a particular stimulus (e.g., exercise, 
overbreathing, airway cooling, allergic irritation, emotional factors), a variety of 
physiological changes occur in the respiratory system (Matts, 1984). These changes 
include constriction of the smooth muscles in the airways and swelling or contraction of 
the bronchial walls, mucosal edema and secretion of thick mucus, and infiltration of the 
inflammatory cells (Creer, Reynolds, & Kotses, 1991; Hogg, 1984; Scanlon, 1984). 
When lung obstruction increases, the sternocleidomastoid muscles maximize chest 
expansion, leading to breathing at a level near total lung capacity (EPR, 199 1). 
Infiltration of the inflammatory cells involves the release of chemicals (e.g., 
histamine, prostaglandins) by mast cells into the mucosal, submucosal, and smooth 
muscle layers (McFadden, 1980a). This infiltration results in increased permeability of 
the capillaries, leading to inflammation. The inflammatory response results in the 
secretion of substances (e.g., mucus, proteins) that may occlude the smaller airways 
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(ATS, 1987; Cross, 1994). In addition, the mucus secreted becomes more viscous, and 
during an asthma attack, the speed at which it is cleared from the airways decreases 
(McFadden, 1980b). During a severe attack, mucus plugs may form in the airways, 
further reducing an individual’s ability to breathe (Nadel& Barnes, 1984). 
Although individuals’ symptom patterns may differ, the three major symptoms of 
hyperresponsivity, airway obstruction, and inflammation are generally observed across 
individuals with asthma. When symptoms are triggered, bronchial muscles constrict, the 
lungs may hyperinflate, and thick mucus may be secreted. Each of these physiological 
changes contributes to difficulty in breathing. 
Measures of Respiration 
Several different measures of bronchial change have been used in asthma 
research. To some extent, each of these measures is related to the effort exerted by an 
individual. When asthma symptoms are present, the narrowing of the bronchial tubes 
leads to the reduction of vital capacity, expiratory flow rate, and maximal voluntary 
ventilation, as well as increased airway resistance (ATS, 1962; see Table 1.1). These 
symptoms are measurable via apparatus designed for the monitoring of lung function. 
Frequently, a spirometer or a peak flow meter is used. This process involves having an 
individual take a deep inhalation and then exhale as rapidly and completely as possible 
into the apparatus (Hyatt, Scanlon, & Nakamura, 1997). Less frequently, the more 
invasive procedure of forced oscillation pneumography is used. 
Spirometry 
Spirometry assesses several different aspects of lung function, including forced 
vital capacity (FVC), forced expiratory volume, measurements during the middle of the 
11 
Table 1.1 
Measures of lung hc t ion ;  increase vs. decrease during an asthma attack 
Measures that Increase Measures that Decrease 
~ ~~ 
Total lung capacity Vital capacity 
Functional residual capacity Forced vital capacity 
Residual volume Forced expiratory volume at 1 second 
Total respiratory resistance Maximal voluntary ventilation 
Peak expiratory flow rate Forced expiratory volume at 1 second 
Forced vital capacity 
12 
exhalation, and total respiratory resistance. The overall purpose is to measure changes in 
the rate at which the lungs change volume during forced exhalations (Hyatt et al., 1997). 
As measured by a spirometer, FVC reflects the total amount of air exhaled 
forcefully after a complete inhalation. Vital capacity positively correlates with the level 
of lung hyperinflation that occurs during an asthma attack (EPR, 199 1). However, 
disagreement exists about the sensitivity of FVC as a measure. Some researchers report 
that FVC is very sensitive to narrowing of the airways during an asthma attack (Hyatt et 
al., 1997), whereas others contend that this measure alone may not be reliably affected by 
asthmatic symptoms (Carr et al., 1992). In addition, FVC is effort-dependent and may 
not be sensitive to changes in total respiration (Miller & Kotses, 1995). 
Forced expiratory volume at 1 sec (FEVl) represents the amount of air expelled in 
the first second after the start of exhalation. An estimation of the change in function of 
the large airways that narrow during an asthma attack is provided by this measure. FEVl 
is sensitive to the level of airway obstruction (which reduces the speed at which air is 
exhaled), as well as disease severity (Hyatt et al., 1997; Laszlo, 1994). A decrease greater 
than or equal to 20% is considered clinically significant (Isenberg, Lehrer, & Hochron, 
1992b). 
These two measures (i.e., FEVl and FVC) are frequently combined in a ratio 
format (FEVI/FVC) to provide an index of the percent of an individual’s full lung 
capacity expired after the first second. Generally, a normal adult is able to exhale 
between 75% - 85% of their total lung capacity after 1 sec, 94% after 2 sec, and 97% after 
3 sec (Creer, 1979). This ratio is important for two reasons. First, it provides the 
interpreter with the ability to identify individuals who have airway obstruction as well as 
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reduced FVC, indicated by a low ratio (Hyatt et al., 1997; Laszlo, 1994). Second, the 
ratio assists in the identification of the cause of low FEVI. If FEVl is low, but the ratio is 
normal, this finding may indicate that restriction is occurring. Alternatively, a decreased 
overall ratio indicates that obstruction is likely (Carr et al., 1992). 
Forced expiratory flow at 50% vital capacity (FEFso) represents the rates of air 
flow in the middle airways. It is much less effort dependent than FEVI. However, a 
larger range of values are considered to be normal, leading to difficulty in interpretation 
(Asmundson & Stein, 1994; Carr et al., 1992; Hyatt et al., 1997). FEF25-75 reflects the 
average rate of air flow during the middle half of the exhalation. This rate represents the 
state of both large and small airways. Generally, values are greater than 150 L/min for 
men and 100 L/min for women (Creer, 1979). 
Total respiratory resistance (R,) is a measure of the air flow resistance of the 
airways, lung tissue, and chest wall. When an individual experiences an asthma attack, 
constriction of the bronchioles leads to an increase in the measure of air flow resistance 
(Miller & Kotses, 1995). However, increased airway resistance may or may not be 
related to asthma symptoms. Normal individuals often exhibit temporary (less than 1 min 
in duration) responses to bronchoconstrictive suggestion (Isenberg, Lehrer, & Hochron, 
1992a). 
In summary, the use of spirometry in asthma research is reflected in several 
commonly used measures. Of these measures (e.g., FVC, FEVI, FEFso, Rt), the most 
frequently used and most informative appear to be FEVl and the ratio of FEVl/FVC (e.g., 
Aitken, Zealley, & Rosenthal, 1969; Carr et al., 1992; Carr, Lehrer, Rausch, & Hochron, 
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1994; Isenberg et al., 1992b). In the present study, these two measures will be utilized as 
an index of respiratory change in response to experimental tasks. 
Peak Air Flow 
Peak flow is measured by a simple apparatus that measures liters of air expelled 
per min, or an individual’s peak expiratory flow rate (PEFR). Many peak flow meters are 
made of plastic, with a spring device that bumps a marker up to the appropriate number 
(Chiaramonte & Prabhu, 1982). Peak air flow reflects a relatively rough estimate, and is 
quite effort-dependent (Hyatt et al., 1997). This measure is less sensitive to small airways 
obstruction, but does correlate strongly with measures obtained via spirometry (Creer, 
1979). PEFR also correlates with the level of lung hyperinflation (EPR, 1991). Overall, 
peak flow represents a simple measure of lung function, but it is highly effort-dependent, 
limiting its usefulness. 
Forced Oscillation Pnewnonraphy 
Forced oscillation pnewnography assesses the degree to which obstruction due to 
bronchoconstriction is occurring. Alternating multiple-frequency pressure oscillations are 
applied to the airways via a mouthpiece. This procedure results in a measure of total 
respiratory impedance (Rz; Franetzki, Prestele, & Korn, 1979; Lehrer et al., 1996). 
Measurement of lung function via the forced oscillation method is not effort-dependent, 
and does not require maximum exertion on the part of the participant. However, this 
equipment is not easily available to non-medically trained researchers (Sirota, 1982). 
Conclusions about Measurement 
Each of the above measures has documented strengths and weaknesses. 
Unfortunately, there has been no standardization of measurement within the asthma 
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literature. This lack of a common measurement standard, particularly in older articles, 
makes it difficult to compare results across studies. More recent studies examining the 
relationship between asthma and panic disorder have consistently utilized FVC, FEVl, 
FEFso, and the FEVl/FVC ratio (e.g., Carr et al., 1992; Carr et al., 1994; Isenberg et al., 
1992b). The consistent use of these measures in future asthma research should facilitate 
building a knowledge base and enhance communication among researchers in the field. 
Psychological Approaches to Asthma 
A large proportion of the published research in the psychological literature 
relating to asthma focuses on examining how, why, and when psychological events 
influence the elicitation of asthma symptoms. One line of research considers how airway 
changes may occur due to psychological manipulations. A second line of research 
involves measuring the respiratory effects of exposing an individual with asthma to a 
particular type of imaginal or real aversive stimuli (e.g., mental arithmetic, imagination of 
aversive scenes, viewing a graphic movie). A third line examines how suggestion can 
lead to bronchoconstriction or bronchodilation. These three areas are discussed next. 
Physiological Mechanisms 
If psychological stimuli produce airway changes in individuals with asthma, it is 
important to consider how these changes might occur physiologically (Masuda, Notske, & 
Holmes, 1966). The autonomic nervous system regulates and controls alterations in lung 
function, and an increase in arousal may lead to a large change in airway smooth muscle 
tone (Erskine-Milliss & Schonell, 198 1 ; McFadden, 1980a). Indeed, some researchers 
have conceptualized asthma as a malfunction of the autonomic nervous system 
(Holtzman, Sheller, Dimeo, Nadel, & Boushey, 1980; Nadel & Barnes, 1984). The 
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sympathetic and parasympathetic nervous systems appear to control different portions and 
functions of the airways. The sympathetic system controls the lower or small airways, 
whereas the parasympathetic system controls the upper or large airways (Nadel& Barnes, 
1984). Similarly, sympathetic nervous system activation leads to bronchodilation, 
whereas the parasympathetic nervous system produces bronchoconstriction (Erskine- 
Milliss & Schonell, 1981). 
The vagus nerve is one of the 12 cranial nerves, and represents a key component 
of the parasympathetic nervous system (Scanlon, 1984). Connecting the brain with the 
lungs, the vagus nerve may represent the specific pathway by which emotion may lead to 
asthma symptoms (Erskine-Milliss & Schonell, 198 1). When this nerve is directly 
stimulated, airway constriction results (Nadel, Cabezas, & Austin, 197 1 ; Widdicombe, 
1975). Constriction occurs due to the release of acetylcholine at the end of the vagus 
nerve, near the lungs (McFadden, 1980a). The released acetylcholine is then received by 
receptors in the bronchial smooth muscle tissue, forming cyclic guanosine 
monophosphate. When an overabundance of guanosine monophosphate occurs, an 
imbalance with cyclic adenosine monophosphate results. It is this imbalance that leads to 
airway smooth muscle constriction (Scanlon, 1984). Release of acetylcholine from 
postganglionic cholinergic fibers of the vagus nerve may also trigger contraction of 
bronchial smooth muscle as well as mucus secretion (Harries, Parkes, & Lessof, 198 1 ; 
Nadel & Barnes, 1984). Further evidence for the involvement of vagal activity is found 
in the cessation of bronchoconstriction by administration of substances that block the 
vagal efferent pathway (Mussel1 & Hartley, 1988; Widdicombe, 1975). Similarly, in 
animal research, cutting the vagus nerve results in bronchodilation (McFadden, 1980b). 
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Increases in vagal activity lead to more severe constriction of the upper airways 
than the lower airways (Nadel et al., 1971). Not all individuals with asthma exhibit 
alterations in lung function in response to psychological stimuli. Therefore, it has been 
suggested that those who do respond tend to experience more upper airway constriction 
(thus further implicating the parasympathetic nervous system; Lehrer, Isenberg, & 
Hochron, 1993). 
Evidence for parasympathetic system involvement in bronchoconstriction has 
been found in a variety of studies investigating the effects of stress and relaxation on 
bronchoconstriction. In a typical study, peak air flow is measured in controls who have 
been conditioned to tense or relax their facial muscles in response to a particular cue 
(Glaus & Kotses, 1983). As the face and throat muscles constrict (measured via 
electromyography), airway constriction results, leading to a decrease in peak air flow. 
Alternatively, when participants are asked to relax their facial muscles, bronchodilation 
results. Interestingly, other types of muscular tension and relaxation (e.g., limb muscle) 
do not produce alterations in lung function. One explanation for these findings is that 
sensory information from the facial muscles affects the vagus nerve via trigeminal 
pathways (Kotses & Miller, 1987). However, it is possible that the role of the facial 
muscles in producing bronchoconstriction is a facet of the more general diving reflex. 
This reflex occurs in humans and other animals when the face is immersed in cold water, 
or cold pressure is applied to the forehead. As a result, the body conserves oxygen by 




Further evidence implicating the vagus nerve in bronchoconstriction has been 
found in a study that used placebo bronchoconstrictor methodology. In this type of study, 
individuals with asthma are told that they will be inhaling a substance that provokes 
bronchoconstiction. In actuality, the substance is inert and should have no effect on lung 
hnction. Before the suggestion was given in this particular study, one group of 
participants was administered a substance known to block parasympathetic nervous 
system activity. By eliminating the action of the vagus nerve, the measurable effects of 
bronchoconstrictive suggestion were not observed (McFadden, Luparello, Lyons, & 
Bleecker, 1969). From these studies, evidence has accumulated suggesting that the vagus 
nerve and parasympathetic nervous system processes affect lung function. 
Parasympathetic nervous system involvement, specifically through stimulation of 
the vagus nerve, appears to be the conduit by which psychological stimuli lead to airways 
changes (e.g., Isenberg et al., 1992a, Lehrer et al., 1993). Increased arousal, possibly 
reflected in increased face and throat muscular tension, stimulates the vagus nerve. In 
turn, the vagus nerve sends chemicals to the lungs, which increase bronchoconstriction of 
the upper airways. Therefore, psychological stimuli appear to be capable of affecting the 
physiological mechanisms underlying asthma symptoms. Research exploring different 
psychological stimuli that have been utilized to produce asthma symptoms is summarized 
next. 
Imagined and In-Vivo Stressful Tasks 
The role of imaginal or in-vivo exposure to aversive or stressful events in the 
production of bronchoconstriction is well documented (e.g., Isenberg et al., 1992a; Kotses 
et al., 1987). Individuals with asthma may exhibit increased air flow resistance when 
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imagining symptoms of asthma, imagining the experience of a cough, or imagining 
emotions such as fear and anger (e.g., Creer et al., 1991). Similarly, the performance of 
particular types of aversive tasks in a laboratory setting have been shown to lead to 
increased air flow resistance in individuals with or without asthma (Isenberg et al., 
1992a). 
In a typical experimental paradigm, individuals with or without asthma would 
view three films that varied in emotional content (i.e., children with asthma in the 
hospital, an industrial accident, and a mother deciding whether or not to put her infant up 
for adoption). In comparison to controls, individuals with asthma tend to respond to each 
of the three films with increased Rt, particularly during extremely emotional scenes 
(Levenson, 1979). More recently, Dorhofer, Sigmon, and Boulard (1 997) found that 
women with asthma who listened to scenes depicting the experience of asthma and 
negative asthma-related situations (e.g., “You decide to go out with a friend. You go to a 
local bar, where most people are smoking. You feel your lungs tighten as you breathe in 
the smoky air.”) exhibited decreased peak air flow and higher levels of anxiety in 
comparison to controls. These studies demonstrate that exposing individuals with asthma 
to emotional or asthma-related stimuli consistently reduces lung function compared to 
controls. 
Other types of aversive cognitive tasks have been utilized in asthma research. In 
one study, male college controls were assigned to perform either an easy or difficult 
arithmetic task (Kotses, Westlund, & Creer, 1987). The group that performed the 
difficult calculations exhibited significantly higher Rt. It should be noted that controls 
exhibit transient increased lung resistance as well when engaging in arithmetic tasks. 
Therefore, it appears that physiological responses of individuals with asthma are not 
qualitatively different from that of individuals without asthma. This pattern of lung 
resistance effects indicates that asthma studies that do not include controls may simply be 
measuring normal human responses, not a particular response caused by the pathology of 
asthma (Kotses, Hindi-Alexander, & Creer, 1989). Individuals who have asthma do, 
however, exhibit greater and more consistent increases in Rt in response to a variety of 
stimuli than controls. According to some researchers, a quantitative (i.e., occurring along 
a continuum), rather than qualitative, difference in response may occur (Isenberg et al., 
1992a). 
The type of aversive task used may result in different types of lung response. In a 
study of individuals with and without asthma (Lehrer et al., 1996), the effects on lung 
function, measured via forced oscillation, of active (e.g., mental arithmetic and reaction 
time tasks) versus passive (e.g., watching 2 gory films) tasks were compared. 
Interestingly, when both groups engaged in active tasks, Rz decreased (resulting in better 
lung function) in comparison to the passive tasks. According to the researchers, active 
tasks may activate the sympathetic nervous system, which is responsible for the “fight or 
flight” response. Activation of this system may balance or override the effects of the 
parasympathetic system, leading to overall bronchodilation. In contrast, passive tasks 
may lead to increased parasympathetic activation that results in bronchoconstriction. 
Thus, the observed alterations in lung function may depend on the nature of the task 
utilized as a stressor. 
In general, it appears that a wide variety of aversive tasks lead to alterations in 
lung function. In many cases, these procedures lead to decreases in lung function, but in 
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some cases, an increase may be noted. Further research would be helpful in order to 
make more definitive statements about the conditions under which bronchoconstriction 
versus bronchodilation will occur. 
Placebo Bronchoconstrictor Studies 
The role that placebos (neutral substances that an individual believes will have a 
real effect) may play in the development of bronchoconstriction has been widely studied. 
It is well known in both the medical and psychological literature that placebos are 
frequently capable of creating measurable psychological or physical alterations in an 
individual (e.g., Edmeads, 1984). In the study of asthma, a specific type of research has 
evolved wherein bronchoconstriction is induced in response to a placebo. In a typical 
research protocol, participants inhale a substance that is presented as either a neutral 
substance (control condition) or as a strong bronchoconstrictor (e.g., Kotses et al., 1989; 
Luparello, Lyons, Bleecker, & McFadden, 1968; McFadden et al., 1969; Miller & Kotses, 
1990; Wigal, Kotses, Rawson, & Creer, 1988). In reality, the inhaled substance is inert 
(e.g., saline solution, distilled water, room air) in both conditions. At baseline and after 
the inhalation(s), airway function is measured via spirometry or peak flow. One early 
report indicated that full-blown asthma attacks were both induceable and reversible with 
the use of this methodology (Luparello et al., 1968). In this type of study, researchers 
hypothesize that the physiological mechanism responsible for the airway response is the 
vagus nerve, as the body responds to heightened arousal (Spector, Luparello, Kopetzky, 
Souhrada, & Kinsman, 1976). 
Subsequent studies, however, have not reported the occurrence of full-blown 
asthma attacks. More frequently, less severe but measurable alterations in lung function 
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occur. For example, a group of 29 individuals with asthma inhaled a saline solution on 
five occasions (Janson-Bjerklie, Boushey, Carrieri, & Lindsey, 1986). During the first 
(control) trial, participants were informed that they were inhaling an inert substance. 
During the second through fifth (suggestion) trials, participants were informed that they 
were inhaling a chemical in progressively increasing doses that would cause chest 
tightness and wheezing. Although no full-blown asthma attacks were noted, 34% of the 
participants responded to the suggestion with a clinically significant increase in airway 
resistance (i.e., greater than 20% above baseline). 
Similar studies have been conducted using variants of this basic methodology. 
Alterations in the focus of the experiments have led to the use of different types of inert 
substances (e.g., distilled water, saline) and different orders of control versus suggestion 
trials. Reviewing the use of saline as an inert substance, Isenberg et al. (1 992a) calculated 
that approximately 48% of participants responded to the suggestion trial with a clinically 
significant deterioration in lung function (20% decrease, e.g., Luparello et al., 1968; 
Luparello, Leist, Louie, & Sweet, 1970; McFadden et al., 1969; Philipp, Wilde, & Day, 
1972). In comparison, only 17% responded to the control condition. 
A large number of placebo bronchoconstrictor studies have been reported in the 
asthma literature. Most studies report that a proportion of the participants exhibit some 
bronchoconstriction in comparison to baseline (e.g., Butler & Steptoe, 1986; Janson- 
Bjerklie et al., 1986; McFadden et al., 1969). According to a review of studies that used 
bronchoconstrictive suggestion, approximately 30 to 40% of participants exhibit 
temporary decreases in lung function in response to the suggestion (Isenberg et al., 
1992a). However, these authors have suggested a more conservative average of 20% 
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participant response, taking into account serious methodological problems. This low rate 
of responsiveness to the experimental manipulation greatly reduces the value of data 
obtained with this type of methodology for drawing conclusions about the contribution of 
psychological factors to asthma. 
A related methodology involves using a substance that will cause actual 
bronchoconstriction or bronchodilation. These substances are inhaled with either 
suggestion of bronchoconstriction or bronchodilation (e.g., receive bronchoconstrictor but 
told it is a bronchodilator; Luparello et al., 1970; Strupp et al., 1974). One experiment of 
this type involved participants inhaling methacholine, a known bronchoconstrictor, during 
two trials. During the first trial, participants were told that they were inhaling either a 
bronchodilator or a bronchoconstrictor. During the second trial, participants were given 
the opposite suggestion. For example, one participant was given methacholine during 
two trials (Pastorello et al., 1987). During the first trial, he or she was told that the 
inhaled substance would produce difficulty in breathing. During the second trial, the 
participant was told that the inhaled substance would lead to easier breathing. Thus, 
individuals were given the same substance but were given two different suggestions about 
its possible effect. Airway responses to the trials were mixed. In comparison to baseline 
lung function, statistically significant changes did not occur after the trials. Normally, it 
would be expected that an individual would experience significant bronchoconstriction 
when inhaling methacholine. According to the authors, the absence of significant 
changes indicates that the suggestion prevents the expected bronchoconstriction. On the 
other hand, the lack of significant changes could be due to inconsistent physiological 
responses or heterogeneity within the sample. 
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Many studies that utilize bronchoconstrictive suggestion use small samples and 
have other serious methodological flaws that reduce the impact of the manipulation. For 
example, individuals with asthma have hyperreactive airways that are irritated by a wide 
variety of stimuli. The effects of a particular methodology may not be directly 
attributable to the experimental manipulation. In addition, simply taking a deep breath 
before exhaling into a spirometer or other apparatus can cause transient air flow 
obstruction in some individuals (Gayrard, Orehek, Grimaud, & Charpin, 1975; Gayrard, 
Orehek, Grimaud, & Charpin, 1979; Orehek, Gayrard, Grimaud, & Charpin, 1975). 
Therefore, it is important to consider the effects of these flaws or confounds on the results 
presented in this literature. 
Confounds from the type of substance inhaled are frequently observed in placebo 
bronchoconstrictor studies. The use of nebulized saline as a control substance raises 
particular difficulties. Inhalation of saline causes bronchoconstriction for some 
participants, confounding the results (Lewis, Lewis, & Tattersfield, 1983). In some cases, 
participants respond with bronchoconstriction to both control and suggestion conditions 
as a result of warm saline's effects on the lungs. Unfortunately, response to the control 
substance in some cases eliminates any measurable placebo effect (Pastorello et al., 
1987). Indeed, particular concentrations of saline have been suggested for use as a 
challenge task for measurement of airway hyperreactivity in individuals with asthma 
(Boulet, Legris, Thibault, & Turcotte, 1987; Schoeffel, Anderson, & Altounyan, 198 1). 
Cooling of the airways has also been shown to cause bronchoconstriction (Deal, 
McFadden, Ingram, Breslin, & Jaeger, 1980; Spector & Farr, 1974). Room temperature 
saline (20" C) and warm saline at 37" C produces different results. Bronchoconstriction 
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as a result of suggestion only occurs when saline is cool, not when it is at room 
temperature (Lewis et al., 1983). Thus, when the type of substance inhaled in a control 
condition causes bronchoconstriction, the level of airway change due to the experimental 
manipulation is difficult to estimate. 
Another flaw commonly found in placebo bronchoconstrictor studies reflects the 
lack of estimates of the clinical significance of the reduction in airway function. A 
reduction of approximately 20% of peak air flow is considered to be indicative of 
impairment, and a reduction of 50% or more is likely to require emergency medical 
intervention (Isenberg et al., 1992a). However, few studies use these guidelines in 
assessing the degree to which participants responded. 
Control groups are rarely used in placebo bronchoconstrictor studies (e.g., Butler 
& Steptoe, 1986; Horton, Suda, Kinsman, Souhrada, & Spector, 1978; Janson-Bjerklie et 
al., 1986; Neild & Cameron, 1985; Pastorello et al. 1987). This methodological oversight 
restricts the conclusions that can be drawn about responses of individuals with asthma 
versus individuals without asthma. Further research has shown that responses to 
suggestion occur in a similar manner in individuals without asthma (as described above), 
throwing further doubt on the utility of the placebo bronchoconstrictor methodology 
(Wigal et al., 1988). 
In summary, although widely used, the placebo bronchoconstrictorl 
bronchodilator studies suffer from a lack of methodological soundness. Although a 
moderate percentage of individuals with asthma do appear to respond to these 
manipulations, the extent to which these findings are valid and generalizable is 
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questionable. Thus, the results of this type of study must be interpreted cautiously. 
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Currently, due to the variety of problems that commonly occur in placebo 
bronchoconstrictor studies, asthma researchers have been less likely to utilize this 
methodology. Rather, less intrusive stimuli (e.g., listening to aversive scenes, mental 
arithmetic) have been advocated when a task that affects lung function is to be studied 
(Dorhofer & Sigmon, in press). These stimuli may be more ecologically valid, similar to 
types of events that trigger asthma symptoms in everyday life. 
Emotional States and Asthma Symptoms 
Positive and negative emotional states may accompany or lead to symptoms of 
asthma. The relation between naturally occurring mood states (i.e., measured several 
times during the course of the day) and peak expiratory air flow has been investigated in 
several studies. Mood states and peak air flow are often measured at the same time 
during an individual’s usual daily activities. However, studies of this nature are generally 
correlational in nature. 
Frequently, individuals record their observations several times per day. In one 
study, boys in a treatment facility wore FM radio transmitters for 4 hours per day 
(Miklich, Chai, Purcell, Weiss, & Bradley, 1974). Approximately every 20 minutes, each 
boy was instructed via a transmitter to measure and record peak flow, as well as note 
mood. For 38% of the boys, significant negative correlations between emotional intensity 
and peak flow were found. 
More recent studies have generally corroborated the finding that peak flow and 
naturally occurring negative mood states are significantly correlated for some individuals 
with asthma (e.g., Hyland, 1990; Steptoe & Holmes, 1985). However, not all participants 
exhibit a negative correlation between mood state intensity and peak flow (as the mood 
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becomes more intense, peak flow decreases). In addition, the type of mood state (e.g., 
anger, sadness, joy) accompanied by decreased peak flow may vary from individual to 
individual. For example, some individuals may exhibit decreased air flow while 
experiencing anger, whereas other individuals may exhibit decreased air flow while sad, 
happy, or during other emotional states (Steptoe & Holmes, 1985). A review of studies 
that induce emotional states in participants in the laboratory identified a subgroup of 
individuals with asthma (40%) who respond to emotional stimuli (e.g., induction of 
anger, fear, anxiety) with increased airway resistance (Isenberg et al., 1992a). The 
authors, however, did not hypothesize why only a subset of individuals with asthma 
exhibit lung function that correlates with negative mood states. 
An additional difficulty in interpreting the results of studies examining the mood- 
peak flow relation reflects the cyclical nature of this relation (ie., mood-peak flow 
relationship is stronger in the evening; Hyland, 1990). Studies of circadian rhythms in 
asthma have shown that for some individuals, asthma symptoms occur more frequently at 
night, with increased severity (Barnes, 1985; Clark, 1985; Hetzel, 198 1 ; Hetzel & Clark, 
1980). Thus, it is possible that time of day should be carefully considered in studies 
examining the relations between mood, suggestion, and bronchoconstriction. 
Overall, some evidence has been found for a negative correlation between a few 
types of positive and negative mood states and lung function. However, this research 
needs to be replicated and extended before stronger conclusions can be made. The 
heterogeneity of mood states correlated with reduced lung function warrants further 
investigation. Possibly, mood state may be another avenue by which facial muscle 
tension or general arousal affects the vagus nerve, leading to bronchoconstriction. One 
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mood state in particular (e.g., anxiety) has been studied extensively in individuals with 
asthma. 
The Role of Anxiety in Asthma 
Asthma-Related Panic-Fear 
In individuals with asthma, panic-fear is hypothesized to be an anxious state 
experienced in response to asthma symptoms. The first type, illness-specific panic-fear, 
refers to the anxiety experienced in response to asthma symptoms (Kinsman, Dirks, 
Dahlem, & Heller, 1980). It is measured by a subscale of the Asthma Symptom Checklist 
(ASC; Kinsman, Dahlem, Spector, & Staudenmayer, 1977; Kinsman, Luparello, 
O’Banion & Spector, 1973). The second type, generalized panic-fear, is more stable and 
trait-like, and is measured by a subscale of the Minnesota Multiphasic Personality 
Inventory (MMPI; Carr et al., 1995; Dirks, Jones, & Kinsman, 1977). According to Dirks 
et al. (1 977), the panic-fear trait scale identifies individuals with asthma who are 
sensitive, emotionally labile, and either unable or unwilling to persist during stressful life 
events. 
For individuals with asthma, scores on the illness-specific panic-fear scale have 
been found to be positively correlated with a diagnosis of panic disorder and the tendency 
to report symptoms of panic in response to asthma symptoms, whereas scores on the trait 
scale are not (Carr et al., 1995). In addition, the illness-specific scale is related to 
measures of catastrophic cognitions (e.g., the Agoraphobic Cognitions Questionnaire and 
the Anxiety Sensitivity Index; Chambless, Caputo, Bright, & Gallagher 1984; Reiss, 
Peterson, Gursky, & McNally, 1986; Carr et al., 1995). Although both measures have 
been widely used in the asthma literature, the illness-specific scale appears to be the more 
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valid, reliable measure. Therefore, discussion of the panic-fear construct below will refer 
only to findings relevant to this scale. 
Research on the panic-fear construct has revealed that high panic-fear levels are 
related to several negative outcomes for individuals with asthma. Panic-fear levels are 
positively correlated with the intractability of asthma, increased steroid medication needs 
for maintenance and overuse of as-needed medication (Carr et al., 1995; Dirks, Fross, & 
Evans, 1977; Dirks, Jones et al., 1977). Prescription decisions by physicians tend to be 
influenced by the distress or anxiety level of the patient, not actual respiratory hnction 
(Hyland, Kenyon, Taylor, & Morice, 1993). In addition, requests for as-needed 
medications are more frequent for inpatients with high panic-fear as compared to those 
with low panic-fear (Dahlem, Kinsman, & Horton, 1979). These requests were 
independent of lung function for those with high panic-fear (Dahlem, Kinsman, & 
Horton, 1977). 
Although it may be maladaptive to have a high level of panic-fear, it may be just 
as maladaptive to have low panic-fear. Individuals with low panic-fear levels are often 
discharged from the hospital earlier than individuals with moderate or high levels (Dirks, 
Kinsman, Horton, Fross, & Jones, 1978). However, individuals with either very high or 
very low panic-fear levels are more likely to be rehospitalized than are individuals with 
moderate levels of panic-fear (Dirks, Kleiger, & Evans, 1978; Kaptein, 1982). 
Rehospitalization rates have been found to be independent of objective asthma severity 
(Dirks, Fross, & Paley, 1978). To explain these rates, one hypothesis posits that 
individuals with high levels of panic-fear tend to overreact to symptoms of asthma and 
overmedicate themselves during the attack (Dahlem et al., 1977). After the attack has 
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subsided, these individuals then sharply decrease their medication in order to reduce the 
medication’s side effects. According to these authors, undermedication may lead to the 
development of symptom recurrence leading to hospitalization or rehospitalization. 
In contrast, low levels of panic-fear in individuals with asthma may lead to 
discounting or minimization of symptoms until they are severe enough to require 
hospitalization (Dirks, Kinsman et al., 1978). Once individuals with low panic-fear are 
hospitalized, they may be anxious to be discharged and hurry their recovery. However, 
they may be discharged too early, leading to the necessity for rehospitalization (Carr et 
al., 1995). Thus, both high and low levels of panic-fear may lead to behaviors that can be 
detrimental to an individual’s health. 
One conceptualization of the panic-fear construct posits that it represents self- 
focused attention to breathing difficulties. The more attention paid to respiratory 
symptoms, the higher the resultant level of panic-fear (Jones et al., 1979). Two recent 
studies found that for individuals with asthma, anxiety sensitivity levels predicted the 
experience of panic-fear (Cam et al., 1995; Dorhofer et al., 1998). It is likely that these 
two constructs are related aspects of attention to bodily sensations, and may be important 
in further understanding how psychological factors affect asthma. 
Anxiety Sensitivity 
Anxiety sensitivity, the fear of bodily sensations related to the experience of fear 
(Reiss et al., 1986), represents an important construct in both anxiety and asthma 
research. High levels of anxiety sensitivity are positively related to anxiety disorders in 
general, but particularly to the experience of panic attacks. According to expectancy 
theory (Reiss, 1991), there are three fundamental fears: fear of injury, fear of anxiety, and 
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fear of negative evaluation. Anxiety sensitivity relates to fear of anxiety. More 
specifically, fear of anxiety refers to the belief that experiencing anxiety-related 
sensations may lead to harmful bodily, social, or psychological consequences (Taylor & 
Cox, 1998). Individuals with high levels of anxiety sensitivity report increased levels of 
fear of anxiety symptoms, whereas individuals with low anxiety sensitivity levels do not 
fear the experience of anxiety (Shostak & Peterson, 1990). 
Explanations of anxiety sensitivity have changed over the years. When the fear of 
anxiety or “fear of fear” concept was first developed, it was posited that fear of anxiety 
symptoms resulted from interoceptive conditioning related to the experience of panic 
attacks (Goldstein & Chambless, 1978). Some researchers posit that this hypothesis is 
unlikely given that some individuals who have never experienced a panic attack report 
high levels of anxiety sensitivity (Maller & Reiss, 1992). Anxiety sensitivity may thus 
function as an antecedent, rather than a consequence, of panic attacks. Further research 
indicates that anxiety sensitivity may develop as a result of childhood learning 
experiences. A recent study of undergraduates revealed that if an individual’s parents 
reinforced his or her sick-role behavior, the individual was more likely to have a high 
level of anxiety sensitivity (Watt, Stewart, & Cox, 1998). Thus, learning to catastrophize 
about general types of bodily sensations may lead to anxiety sensitivity levels that are 
higher than normal. Increased anxiety sensitivity may also result from environmental 
stressors such as trauma or relationship problems (Maller & Reiss, 1992). 
Anxiety sensitivity appears to function as a risk factor that is necessary but not 
sufficient for the development of panic attacks (Maller & Reiss, 1992). High levels of 
anxiety sensitivity may facilitate conditioning of anxious responses due to a vicious cycle 
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of amplification and interpretation of anxiety symptoms (Taylor, Koch, & McNally, 
1992). The experience of panic attacks increases anxiety sensitivity further, resulting in 
an escalation of panic due to sensitivity to body sensations (Reiss, 1987). Indeed, anxiety 
sensitivity levels have been found to predict the development of panic attacks over a 
three-year period (Maller & Reiss, 1992). A more recent line of research has investigated 
the effects of differing levels of anxiety sensitivity on participants’ responses to 
experimental tasks. Both individuals with and without asthma have been studied utilizing 
this methodology. 
Anxiety sensitivity levels have been found to predict responses to a variety of 
stressful tasks in individuals without asthma. After engaging in a hyperventilation task, 
undergraduates with high anxiety sensitivity levels reported experiencing more bodily 
sensations and more anxiety than participants with low anxiety sensitivity (Holloway & 
McNally, 1987). A second study (Donne11 & McNally, 1989) compared responses to a 
hyperventilation task in individuals with or without panic, who differed in anxiety 
sensitivity levels. Regardless of history of panic, high anxiety sensitivity participants 
reported more anxiety and more bodily sensations in response to hyperventilation than 
individuals with low anxiety sensitivity. Highest levels of bodily sensations were found 
in individuals who were high in anxiety sensitivity and had experienced at least one panic 
attack. It is important to note that individuals with a history of panic and low anxiety 
sensitivity responded similarly to individuals with low anxiety sensitivity and no history 
of panic. Thus, it appears that anxiety sensitivity levels, not history of panic attacks, 
influences anxiety and reports of bodily sensations in response to hyperventilation. 
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Less intrusive stressful tasks (e.g., mental arithmetic) employed with individuals 
varying in levels of anxiety sensitivity have led to mixed results. Anxiety sensitivity does 
not account for physiological arousal level after an arithmetic task, but does relate to self- 
reported anxiety after the task (Shostak & Peterson, 1990). Individuals with high anxiety 
sensitivity levels reported experiencing more anxiety symptoms and a greater level of 
cognitively experienced anxiety after engaging in mental arithmetic. These results 
indicate that although actual physiological changes may not occur during a stressful task, 
individuals with high anxiety sensitivity may erroneously perceive that threatening 
physiological changes have occurred. A second study examined physiological (EMG, 
heart rate, skin temperature, epidermal activity) reactions and self-reports of cognitions in 
response to relaxation and a mental arithmetic task (Borden & Lister, 1994) in individuals 
varying in anxiety sensitivity levels and history of panic versus no panic. Results 
indicated that only panic attack history, not anxiety sensitivity level, predicted reactions 
to physiological changes in response to the stressful task. The authors concluded that 
physiological and cognitive/subjective responses in individuals with high anxiety 
sensitivity are in some cases desynchronous. It is also possible that in this case, the 
stressful task did not activate sufficient arousal to activate fearful cognitions in 
participants. 
The relation between anxiety sensitivity and asthma is just beginning to be 
explored. Dorhofer and Sigmon (in press) found that women with asthma alone, with a 
history of panic attacks, or with asthma and panic attacks had similar levels of anxiety 
sensitivity. The anxiety sensitivity scores of the asthma alone and asthma and panic 
history groups were significantly higher than those of controls. In addition, researchers 
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have hypothesized that observed differences in anxiety sensitivity levels may be a partial 
cause of increased rates of panic disorder among individuals with asthma. The presence 
of panic disorder in individuals with asthma is not thought to be due to dyspnea or other 
asthma-related symptoms (Carr, 1998). Moreover, panic disorder in individuals with 
asthma appears to be influenced by catastrophic misinterpretation of bodily sensations, 
similar to individuals who do not have asthma but do have panic disorder (Carr et al., 
1994). According to proponents of the cognitive theory of panic disorder, without 
catastrophic misinterpretation, panic disorder does not occur (e.g., Clark, 1986). 
Overall, a rapidly growing body of literature has provided general support for the 
existence of anxiety sensitivity as an independent, valid construct. In addition to its key 
role in panic disorder research, recent studies have shown the importance of anxiety 
sensitivity in individuals’ responses to stressful tasks. Currently, the promising relation 
between anxiety sensitivity and the experience of asthma may, with further research, 
assist in the development of new theories about the relation between psychological 
variables and asthma symptoms. Because of the relation between anxiety sensitivity and 
both asthma and the development of panic disorder, it is important to further explore the 
nature of the relation between asthma and panic disorder. 
Panic Disorder 
Panic attacks involve a sudden sensation of intense fear or discomfort with a 
variety of accompanying symptoms (e.g., increased heart rate, sweating, shortness of 
breath, dizziness, nausea, numbness or tingling, and fear of losing control, going crazy, or 
dying; APA, 1994). Estimates of the lifetime prevalence of panic disorder in the general 
population range from 1.5% - 3.5%, with one-year prevalence rates of 1% - 2% (APA, 
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1994). For women, the rate of panic disorder is approximately twice that of men (APA, 
1994; McNally, 1990). Interestingly, the experience of panic attack symptoms can 
closely resemble symptoms of asthma. Indeed, asthma and panic disorder frequently 
coexist and may be exacerbated by one another (Shavitt et al., 1992; van Peski- 
Oosterbaan, Spinhoven, van der Does, Willems, & Sterk, 1996). Current models of panic 
disorder are currently being applied to conceptualizations of asthma in the hope of 
identifying common factors and points of intervention. 
Panic disorder has been the focus of an explosion of research interest since the 
publication of the 3‘d version of the DSM, which clearly delineated panic disorder as an 
independent diagnosis (APA, 1980; Barlow et al., 1985). Previous to DSM-111, panic 
attacks generally were of little interest except as a manifestation of other disorders (Rapee 
& Barlow, 1993). Since that time, disagreement has arisen concerning the possibility of 
truly “spontaneous” panic attacks (Margraf, Ehlers, & Roth, 1986a). Panic attacks with 
all their accompanying symptoms are now reproducible in the clinical or laboratory 
setting, indicating that perhaps panic attacks are not solely spontaneous as was once 
thought. A number of different panic challenge tasks have been developed that can elicit 
panic symptoms for the purpose of research and treatment. 
Although individuals who experience panic attacks may report that their attacks 
have no cue, findings suggest that there may be external precipitants to the occurrence of 
an attack (e.g., stress, exposure to a feared situation, Hibbert, 1984). In addition, internal 
events (e.g., the experience of bodily sensations) followed by catastrophic cognitions 
have been shown to be a frequent precursor of panic attacks (Clark, 1986; Ley, 1985). 
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Because panic attacks frequently have an identifiable and replicable precursor, it is 
possible to create symptoms similar to those of panic attacks in the laboratory. 
Panic challenge tasks. Many types of biological challenges have been utilized in 
order to study panic attacks in the laboratory setting or as aids in treatment studies. This 
type of study has investigated the effects of inducing panic-related physiological 
sensations in individuals with high anxiety sensitivity, panic attacks, panic disorder, and 
controls. These challenges typically involve an activity that produces bodily sensations 
similar to those experienced in a panic attack. In a typical challenge task, an individual is 
infused with sodium lactate, norepinephrine, or isoproterenol, given an oral dose of 
yohimbine or caffeine, or asked to inhale a mixture of carbon dioxide and oxygen 
(McNally, 1990). Each of these substances has led to self-reports of panic attack 
symptoms and/or attacks in most individuals with either a history of panic attacks or a 
diagnosis of panic disorder. However, other activities that do not involve ingestion of a 
chemical or other substance have been utilized in research on and treatment of panic 
disorder (e.g., voluntary hyperventilation, spinning in a chair). 
In the treatment of panic disorder, one common component includes exposure to 
panic sensations (e.g., Barlow & Craske, 1994; Hecker & Thorpe, 1992). Producing 
these sensations in a therapy setting is accomplished via such activities as voluntary 
hyperventilation, shaking the head from side to side, spinning in a chair, and breathing 
through a straw (Clark, 1993; Hecker & Thorpe, 1992). For example, turning one’s head 
from side to side produces sensations that often accompany a panic attack such as 
dizziness and nausea, whereas breathing through a straw can produce feelings of 
restricted air flow or dyspnea (Barlow & Craske, 1994). 
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Individuals who have never experienced a panic attack generally do not respond 
with panic or increased anxiety symptoms to panic challenge tasks (e.g., Balon, Yergani, 
Pohl, Muench, & Berchou, 1990; Donne11 & McNally, 1989; Fyer et al., 1987; van den 
Hout, van der Molen, Griez, Lousberg, & Nansen, 1987). Interestingly, individuals 
without panic report the same bodily sensations as those with panic, but they do not 
report the accompanying anxiety (Gaffney, Fenton, Lane, & Lake, 1988; Margraf, Ehlers, 
& Roth, 1986b). According to some researchers, it is a fearful response to the induced 
bodily sensations that leads to a panic attack (e.g., Clark, 1986; McNally, 1990). 
However, other researchers posit that although catastrophic cognitions in some cases can 
result in a panic attack, cognitions do not invariably accompany or lead to the experience 
of a panic attack (Rachman, Lopatka, & Levitt, 1988; Westling & Ost, 1993). Panic may 
occur in the reported absence of these thoughts in approximately 27% of attacks 
(Rachman et al., 1988). An additional study found that nearly all of the full-blown panic 
attacks (9 1%) were accompanied by catastrophic cognitions, with only 57% of the limited 
symptom attacks characterized by this type of thinking (Westling & Ost, 1993). Thus, the 
evidence for catastrophic cognitions as causal agents in panic disorder has been mixed 
and warrants further investigation. 
Comorbiditv of Asthma and Panic Disorder. A number of studies have examined 
comorbidity rates of asthma and panic disorder. Including estimates for asthma as well as 
other types of chronic obstructive pulmonary disease, these rates yield a conservative 
median of estimates of 9.7% (van Peski-Oosterbaan et al., 1996). Rates of panic attack 
history are higher, with approximately 45% of individuals with asthma experiencing at 
least one unexpected panic attack (Perna, Bertani, Politi, Colombo, & Bellodi, 1997). 
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The presence of panic disorder in individuals with asthma is not thought to be related to 
the degree of pulmonary impairment experienced (Carr et al., 1994). That is, more severe 
asthma is not necessarily accompanied by higher rates of panic disorder. However, panic 
attacks are more common for individuals with asthma if they have high levels of anxiety 
sensitivity. Among a sample of individuals with asthma who reported high anxiety 
sensitivity, 35.3% were diagnosed with panic disorder (Carr et al., 1994). 
It has been argued that these high comorbidity rates may be in part due to 
selection bias (van Peski-Oosterbaan et al., 1996). Individuals who experience both a 
chronic illness and panic disorder are more likely to seek treatment for either or both 
conditions. In turn, these treatment-seeking individuals are often recruited for study 
participation. The method by which the diagnosis is obtained also may have an effect on 
comorbidity rates. Different interview schedules have resulted in greatly discrepant 
estimates (van Peski-Oosterbaan et al., 1996). Therefore, it is important to consider 
carefully the type of measure used to diagnose panic disorder when estimating the 
prevalence of panic in asthma. However, even the lowest estimate of panic disorder 
found in individuals with asthma is much higher than the rate in the general population. 
This high rate of comorbidity suggests that there is a particular connection between 
asthma and panic disorder that merits further examination. 
Hypothesized Effects of Comorbidity. When individuals with asthma sense that 
they may be starting to have an asthma attack, they may experience sensations of fear or 
panic. This increased anxiety may make asthma symptoms worse through an increase in 
parasympathetic nervous system activation (Rumbak, Kelso, Arheart, & Self, 1993). 
However, for individuals with asthma, it has also been hypothesized that having 
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symptoms of panic disorder may actually be adaptive, rather than maladaptive (Carr, 
1998). To test this hypothesis, individuals with asthma, panic disorder, or both 
conditions engaged in stressful tasks (ie., arithmetic task, reaction time task, viewing 
gory films; Carr et al., 1996). In response to these tasks, individuals with either asthma or 
panic disorder exhibited decreased airway resistance. In addition, individuals with panic 
disorder, with or without asthma, exhibited lower airway impedance at baseline than 
those with asthma only at baseline. Surprisingly, individuals with asthma panic 
disorder exhibited lower airway impedance at baseline than individuals with asthma. 
After the tasks, no significant results were found for the interaction between asthma, 
panic, and task. However, at baseline, individuals with asthma were found to have 
significantly higher airway impedance (more difficulty breathing) in comparison with 
those with asthma and panic disorder. 
A nonsignificant trend for better lung function for the asthma and panic disorder 
group was noted following the film tasks. This contrast between the lung function of the 
asthma and asthma and panic disorder groups suggests that having both disorders may 
make it easier to breathe. At present, it is unclear what role psychological or 
physiological processes play in this phenomenon. Because only one published study 
reported this facilitation, replication is necessary. According to the researchers, these 
results are congruent with previous research indicating that low levels of panic-fear in 
asthma result in higher levels of asthma-related mortality. These deaths are thought to be 
a result of decreased sensitivity to bodily symptoms that can be fatal if ignored (Cam et 
al., 1996). 
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Individuals with asthma may suffer from several different types of anxiety, 
including illness-specific panic-fear, high anxiety sensitivity, panic attacks, and panic 
disorder. Some researchers hypothesize that excessive or insufficient panic-fear levels 
are detrimental to an individual’s ability to accurately assess their asthma symptoms, 
leading to increased medication intake or hospitalization (Carr et al., 1995). Possibly, 
panic-fear resembles anxiety sensitivity in that both constructs describe attention to and 
fear of bodily sensations. In addition, individuals who have asthma and high levels of 
anxiety sensitivity may be more vulnerable to the development of panic disorder. 
Preliminary research indicates that having both disorders may actually facilitate breathing 
during stressful tasks rather than impeding it (Carr et al., 1996). Therefore, it is important 
to explore the practical and theoretical implications of the comorbidity of panic and 
asthma. 
Relevance of Psychological Theories to Asthma 
Psychosomatic Theories of Asthma 
Historically, an influential literature review on psychogenic factors in asthma 
(French & Alexander, 194 1) strengthened the view of asthma as psychosomatic in nature. 
Using data from case studies, French and Alexander concluded that allergic and 
psychological factors worked in concert to produce asthma symptoms. In addition, they 
cited evidence of the efficacy of hypnosis in preventing asthma attacks in response to 
known allergens. According to psychoanalytic theory, individuals with asthma may be 
experiencing separation anxiety (expressed as a suppressed cry) that may lead to an attack 
(Purcell & Weiss, 1970; Turnbull, 1962). According to this view, treatment based on 
psychoanalytic theory could assist individuals with asthma in working through their 
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unconscious conflicts, resulting in reduced numbers of asthma attacks (French & 
Alexander, 1941). However, empirical studies have failed to confirm the tenets of the 
psychosomatic theory of asthma (Creer, 1982). 
Over time, this view has been generally superseded by a biopsychosocial view 
which emphasizes genetic and biological components that may be responsible for the 
initial development of asthma (e.g., Matts, 1984; Rees, 1980). However, as discussed 
above, psychological and social stimuli may also have an effect on the severity of 
symptoms and the manner in which treatment is conducted. Two psychological models, 
dyspnedsuffocation fear theory and cognitive theory, have been extended to the 
conceptualization of asthma severity and frequency. 
DyspnedSuffocation Fear Theory 
Ley (1 989) proposed the dyspnedsuffocation fear theory to explain the occurrence 
of panic attacks. In later articles, three types of panic attacks were described in order to 
account for individual differences in panic symptoms (Ley, 1992a; 1992b). Currently, the 
dyspnedsuffocation fear theory is most applicable to one of the three types of panic 
attacks, or hyperventilatory panic attacks (Ley, 1998). Because of the similarity of 
symptom experience between panic attacks and asthma, this theory has since been 
extended to asthma. 
Dyspnea is a commonly reported sensation during a panic attack (de Ruiter, 
Garssen, Rijken, & Kraaimaat, 1992; Ley, 1989). According to the dyspnedsuffocation 
fear theory, the fear that accompanies a panic attack results from severe dyspnea that is 
induced by hyperventilation. The panic attack itself occurs when an individual feels that 
he or she has little or no control over the dyspnea (Ley, 1998). 
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Further evidence for the role of dyspnea in panic comes from observations of the 
frenzied activity that can occur during a panic attack (Ley, 1989). Ley hypothesizes that 
this activity may serve to increase metabolic C02 levels, thus reducing the sensation of 
dyspnea. However, recent studies involving panic challenge tasks have utilized C02- 
enriched air to provoke panic-related sensations. Conversely, during relaxation, 
metabolic C02 levels are known to decrease. This decrease may account for the 
experience of panic cued by relaxation or those occurring during sleep (Ley, 1988a; 
1988b). Although these findings appear contradictory, Ley describes how CO;! inhalation 
may produce both panic-related sensations 
approximately 1 minute after inhaling C02-enriched air, participants generally report 
experiencing the sensation that breathing is uncontrollable, leading to acute anxiety. 
During this time, heart rate increases, dissipating the C02. After the first minute, when 
C02 levels decrease, participants may report a pleasant relaxation state. Excluding 
catastrophic cognitions, dyspnea and any resultant experience of fear are posited to be the 
sole triggers for hyperventilatory panic attacks. According to Ley (1 989), common 
cognitions reported during panic (that are of central importance in the cognitive theory of 
panic) may actually be due to cerebral hypoxia that occurs as a result of hyperventilation. 
pleasant sensations (Ley, 1989). For 
In contrast, other researchers argue that dyspnea, hyperventilation, and tachycardia 
(frequently observed in response to hyperventilation) are produced by cooling or water 
loss that occurs during overbreathing (de Ruiter et al., 1992). De Ruiter et al. suggest that 
it is just as likely that dyspnea leads to hyperventilation as vice versa. Regardless of 
which explanation is correct, individuals who experience panic attacks report that they 
notice dyspnea and/or other physiological symptoms before experiencing fear (Ley, 
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1985). According to the dyspnedsuffocation fear theory, the proposed sequence of 
events in a panic attack is as follows: Hyperventilation + fear + sensations + 
catastrophic cognitions. 
To test the tenets of the dyspnedsuffocation fear theory, Carr et al. (1 992) 
investigated dyspnea in individuals with panic disorder, asthma, and controls. The 
researchers hypothesized that the high rate of concordance of panic disorder in 
individuals who have respiratory disorders may be due to the experience of dyspnea. 
Tests of pulmonary function and self-reports of mood during and after a relaxation task 
revealed that compared to controls, individuals with asthma and individuals with panic 
disorder exhibited similar levels of dyspnea and similar levels of psychopathology. 
Results indicated that although individuals with asthma or panic disorder report 
comparable levels of dyspnea, panic symptoms are accounted for by different factors. A 
significant amount of variance in panic symptoms in individuals with asthma is explained 
by dyspnea, but not for individuals with panic disorder. In other words, panic symptoms 
in asthma may be due to dyspnea, but in panic disorder, they are not due to dyspnea 
levels. This difference in the contribution of dyspnea to the experience of panic 
symptoms suggests that the dyspnedsuffocation fear theory (rather than explaining panic 
attacks) may be better utilized to more fully understand dyspnea and its relation to 
asthma. 
According to Ley (1 994), however, individuals in the above study were selected 
according to DSM-111-R criteria for panic disorder, not for their experience of 
hyperventilatory panic attacks. Thus, Ley argues, the lack of support for the 
dyspnedsuffocation fear theory in relation to panic disorder is due to this methodological 
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flaw. In rebuttal, Carr and Lehrer (1 994) point out that Ley’s (1 992a; 1992b) subtypes of 
panic attacks have yet to be empirically validated. Furthermore, Carr and Lehrer (1 994) 
argue that individuals in both the panic disorder and asthma groups reported a level of 
dyspnea that was significantly greater than controls. Thus, individuals in the panic 
disorder group did indeed experience a high level of dyspnea. It is possible, however, 
that this sample was generally composed of individuals experiencing hyperventilatory 
panic attacks. Overall, the results of these studies must be replicated and extended in 
order to determine the specific role of dyspnedsuffocation fear in asthma and/or panic 
disorder. 
Cognitive Theory 
The cognitive theory of panic proposes that catastrophic misinterpretation of 
benign bodily sensations results in the experience of a panic attack (Clark, 1986). 
Extending this theory to asthma, it is possible that individuals with asthma and a tendency 
to misinterpret symptoms may experience more frequent and more severe asthmatic 
episodes. Mislabeling non-asthma related bodily sensations as symptoms of asthma may 
have serious consequences. In studies of asthma inpatients, 19% - 27% consistently 
mislabeled relatively benign bodily symptoms (e.g., fatigue, worry, irritability, anxiety) as 
an asthma attack. Those individuals who exhibited this tendency to mislabel symptoms 
were more likely to be rehospitalized for asthma at a 6-month follow-up. Forty to 84% of 
the mislabelers were rehospitalized by 6 months, whereas only 29% - 40% of the non- 
mislabelers were rehospitalized. There was no measured difference between symptom 
mislabelers and non-mislabelers in lung function (Dirks & Schraa, 1983). In individuals 
with asthma, the consequences of symptom misinterpretation may be due to the anxiety- 
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producing effects of the catastrophic interpretation of benign sensations that may lead to 
increased bronchoconstriction. 
According to Clark (1993), there are three criteria that must be fulfilled in order to 
demonstrate cognitive mediation of panic attacks induced by biological challenge tasks: 
1) panic disorder patients have a stronger tendency to misinterpret certain bodily 
sensations than controls; 
2 )  that thoughts based on the misinterpretation of bodily sensations accompany 
challenge induced panic attacks; and 
3) that experimental manipulations of cognitive variables have an influence on 
whether or not an individual panics during a biological challenge test (Clark, 
1993, p. 76). 
Clark (1  993) provides evidence that these three criteria have been fulfilled in the 
research on panic disorder. Thus, strong support for cognitive mediation of panic attacks 
during biological challenge tests has been reported in the panic literature. 
Criterion One. Criterion One has been confirmed through research utilizing the 
modified Interpretations Questionnaire (Butler & Matthews, 1983). This questionnaire 
assesses the extent to which individuals interpret ambiguous internal and external stimuli 
as threatening. Individuals with panic disorder tend to mistakenly interpret bodily 
sensations as symptoms of an approaching physical or mental catastrophe more than 
individuals with other types of anxiety disorders or controls (Clark, 1993). Research with 
expanded versions of the Interpretations Questionnaire revealed that individuals with 
panic disorder are less likely to be able to reinterpret stimuli as nonthreatening once they 
have made an anxiety-related response (e.g., Kamieniecki, Wade, & Tsourtos, 1997). 
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Criterion Two. The second criterion (thoughts based on the misinterpretation of 
bodily sensations are present during challenge induced panic attacks) has also been 
supported. Individuals with panic disorder were exposed to feared situations (e.g., 
walking alone into a supermarket). Participants completed measures of their level of fear, 
a checklist of bodily sensations, and a checklist of fearful cognitions after each trial. 
Approximately 73% of the panic attacks experienced by the participants were 
accompanied by self-reports of fearful cognitions (Rachman et al., 1988). Significantly 
more fearful cognitions were reported on the trials that led to panic than those that did 
not, indicating that panic is generally accompanied by these types of catastrophic 
cognitions. 
Criterion Three. The third criterion (manipulating cognitions either leads to or 
prevents panic attacks in experimental settings) is perhaps the most important of the three 
criteria. Yet, this hypothesis has been more difficult to unambiguously support. Many 
studies have revealed that the manipulation of cognitive variables can affect the 
likelihood of panic symptoms or attacks during challenge tests (Margraf, 1993; 
Salkovskis & Clark, 1990; van der Molen, van den Hout, Vroemen, Lousberg, & Griez, 
1986). To test this hypothesis, studies alter the information participants are given before 
a challenge task begins. 
Instructing two groups of controls that the sensations of hyperventilation are either 
symptoms of impending fainting or signs of a higher state of consciousness produces very 
different results (van der Molen et al., 1986). Although the same bodily sensations and 
changes in heart rate and pCO2 were produced in both groups, these sensations were rated 
as either pleasant or unpleasant, depending entirely on the instructions given (Salkovskis 
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& Clark, 1990). A similar study examined the effects of instructions on self-reported 
mood in response to sodium lactate infusion. Two groups of controls were informed that 
they would either experience anxious tension or pleasant excitement in response to the 
infusion. As was expected, the group that received the anxious tension suggestion 
reported significantly higher levels of negative, anxious mood. 
Expectations about what symptoms a C02/02 challenge task will produce also 
alter the likelihood of experiencing a panic attack. Individuals with either panic disorder 
or social phobia were given one of two different explanations of the symptoms they 
would experience as a result of C02/02 inhalation (e.g., Rapee, Mattick, & Murell, 1986). 
The first explanation gave the individual no expectation about what he or she would 
experience, whereas the second explanation listed symptoms that are commonly reported 
during a panic attack. After the inhalation trial, participants were given a list of 10 
neutral and panic related cognitions and were asked to indicate what went through their 
mind when they began to feel the bodily sensations associated with the gas. Individuals 
in both conditions reported similar levels and types of bodily sensations. However, many 
more of the individuals who were in the “no explanation” condition experienced a panic 
attack. The cognitions reported by this group were significantly more likely to be 
catastrophic in nature (Rapee et al., 1986). The results of this study provide strong 
evidence that an individual’s fearful cognitions in an ambiguous situation can lead to 
panic symptoms. Conversely, if an individual can attribute ambiguous bodily sensations 
to a known cause, then he or she may be less likely to have a panic attack. 
Cognitions about situational control may also alter the anxiety responses of 
individuals with panic disorder. In one study, participants were allowed to “turn down” 
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the level of C02 they were receiving if a light turned on (for half the participants, the light 
never turned on; for the others, the light was turned on during the entire procedure; 
Sanderson, Rapee, & Barlow, 1989). In actuality, the dial did not alter the C02 level in 
any way. However, participants who believed they had control over the gas reported 
fewer and less severe symptoms of panic, less resemblance to panic sensations, and fewer 
occurrences of actual panic attacks (Sanderson et al., 1989). Studies of this type provide 
support for the role that cognitions play in the production andor reduction of panic 
symptoms and attacks. 
In addition, anticipating the negative effect of C02 inhalation can produce 
increased self-reports of physiological responses that indicate increasing levels of anxiety. 
In comparison, when neutral expectations are fostered for participants with panic 
disorder, hyperventilation does not result in strong physiological responses (Margraf, 
1993). Thus, it appears that it is negative interpretations of bodily sensations that lead to 
the experience of panic. The symptoms of hyperventilation or any other experience alone 
do not result in a panic attack. 
summary 
The relationship of asthma with psychological factors has been studied for many 
years (e.g., French & Alexander, 1941; MacKenzie 1886). A variety of methodologies, 
including exposure to real or imagined aversive events (Creer et al., 1991; Dorhofer et al., 
1997), suggestion of bronchoconstriction (Kotses et al., 1989; Luparello et al., 1968; 
Janson-Bjerklie et al., 1986), and naturalistic observation of mood states (Hyland, 1990; 
Miklich et al., 1974; Steptoe & Holmes, 1985), have been used to identify factors that are 
related to alterations in lung fbnction. These factors include type of task (active versus 
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passive) and mood (positive versus negative). Classical conditioning and stress 
provocation have both been suggested as possible causal factors in alterations in lung 
function (Dekker et al., 1956; Miller & Kotses, 1995). 
Recently, the relationship of anxiety with asthma has been investigated in the 
psychological literature (e.g., Carr, 1998). High panic-fear levels have been linked to 
negative outcomes (e.g, medication overuse, rehospitalization) for individuals with 
asthma (Carr et al., 1995; Dahlem et al., 1979; Dirks, Fross et al., 1977; Dirks, Jones et 
al., 1977; Hyland et al., 1993). High anxiety sensitivity levels also appear to be related to 
asthma, and may pose an additional risk factor in the development of panic disorder 
(Dorhofer et al., 1997). In addition, it is well established that individuals with asthma are 
more likely to develop panic disorder than are individuals without asthma (Carr et al., 
1994; van Peski-Oosterbaan et al., 1996). Further, the mechanisms and consequences 
surrounding the frequent comorbidity of asthma and panic disorder have been of interest 
to researchers (e.g., Carr et al., 1996; van Peski-Oosterbaan et al., 1996). Specifically, the 
presence of both panic disorder and asthma may lead to better lung functioning in 
response to stressful stimuli than for individuals with asthma alone (Carr, 1998). At 
present, it remains unclear what role psychological or physiological processes play in this 
phenomenon. 
Because of the similarity and frequent comorbidity of asthma and panic disorder, 
two theories (dyspnedsuffocation fear theory and cognitive theory) have been used to 
explain how asthma symptoms are affected by psychological factors. New studies 
examining these theories in relation to asthma have resulted in some support for each 
(Carr et al., 1992; Carr, 1998; Dorhofer et al., 1997). At the present time, no published 
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research has examined both theories within the same study. These theories may 
contribute to further understanding the mechanisms underlying the comorbidity and 
experience of asthma and panic disorder. 
Statement of Purpose 
The present research project was designed to investigate dyspnedsuffocation fear 
theory and cognitive theory in relation to asthma. In addition, Carr’s hypothesis 
regarding the possible beneficial effects of comorbid panic disorder and asthma on lung 
function was tested. Using experimental challenge tasks that produce asthma and/or 
panic-like sensations, tenets of these theories and C a d s  hypothesis were investigated in 
women with asthma. Lung function and self-reports of cognitions, bodily sensations, and 
dyspnea levels were assessed. For individuals with asthma, the presence of panic 
disorder may actually assist breathing efforts (Can et al., 1996). Therefore, it may be 
important to identify what elements of the panic experience are associated with increased 
lung function (e.g., changes in level of catastrophic cognitions, perception of dyspnea). 
In the present study, comparison groups will include individuals with asthma, 
asthma and panic disorder, panic disorder alone, and controls. The utilization of these 
four groups allowed comparisons of individuals who may 1) experience aversive bodily 
sensations and anxiety on a regular basis and 2) may be able to pinpoint or explain the 
source of the bodily sensations (e.g., individuals with asthma). In addition, comparison 
of these groups allowed for replication and extension of dyspnealsuffocation fear theory, 
cognitive theory, and Carr’s hypothesis in relation to asthma. 
The dyspnedsuffocation fear theory was tested in a manner similar to that of a 
previous study that used a passive relaxation condition (Carr et al., 1992). In a replication 
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of previous research, individuals relaxed as deeply as possible with their eyes closed for 5 
minutes. In an extension of dyspnedsuffocation fear theory, changes in dyspnea level 
were assessed before and after engaging in breathing through a straw and head turning. 
Breathing through a straw and turning one’s head from side to side are active tasks 
designed to induce sensations that are dyspneic (affect perception of lung function) and 
panic-related (dizziness), respectively (Barlow & Craske, 1994; Hecker & Thorpe, 1992). 
According to dyspnedsuffocation fear theory, it was expected that individuals with 
asthma and/or panic disorder would report greater changes in dyspnea levels than controls 
after a passive task. Similarly, after the head turning task, individuals with asthma and/or 
panic disorder were expected to report greater changes in dyspnea levels than controls. In 
contrast, greater changes in dyspnea levels were expected for controls after the straw task, 
as this group may not have experience with shortness of breath. 
To test C a d s  hypothesis that having both asthma and panic disorder is adaptive 
for lung function, an active task was utilized. According to Carr, producing panic-like 
sensations led to an increase in lung function observed for the comorbid group in 
previous research. To replicate and extend this hypothesis, individuals with and without 
asthma and panic disorder engaged in the head turning task (producing panic-like 
sensations) as well as Carr’s relaxation task. 
An adaptation of Clark’s cognitive model of panic (extended to asthma) and the 
criteria for evidence of a cognitive component to panic disorder were used to investigate 
differences in cognitions experienced after the tasks for individuals with or without 
asthma and panic disorder (Clark, 1986). In addition, changes in panic-related cognitions 
were assessed after each task. 
Extending Clark’s model to asthma included the following hypotheses: 
1) compared to controls, individuals who have asthma fear and misinterpret 
certain bodily sensations more; 
2) thoughts based on the misinterpretation of bodily sensations accompany 
challenge induced asthma symptoms or attacks; and 
3) experimental manipulations of cognitive variables have an influence on 
whether or not an individual has asthma symptoms, increased air flow resistance, or an 
asthma attack during a challenge task. 
Unlike the panic disorder literature, the asthma literature is less clear on whether 
or not these hypotheses have been supported. Hypothesis one, that individuals with 
asthma fear and misinterpret bodily sensations more than controls, has not yet been 
investigated. However, previous research (Dorhofer & Sigmon, in press) indicates that as 
a group, individuals with asthma report higher levels of anxiety sensitivity or fear of 
anxiety sensations. The present study investigated this hypothesis by having participants 
complete questionnaires that assessed an individual’s tendency to fear, focus on, and 
misinterpret ambiguous situations or sensations. 
Hypothesis two, that thoughts based on the misinterpretation of sensations 
accompany induced asthma symptoms, has not been investigated in the asthma literature. 
The present study examined this hypothesis by assessing panic-related cognitions after the 
experimental tasks. 
Hypothesis three, that experimental manipulations of cognitive variables have an 
influence on whether or not an individual has asthma symptoms, increased air flow 
resistance, or an asthma attack during a biological challenge test, has been supported 
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through use of placebo bronchoconstrictor methodology. As discussed previously, this 
type of study generally produces alterations in lung function depending on the suggestion 
given (e.g., Isenberg et al., 1992a). For individuals with asthma, it appears that specific 
cognitions (e.g., expecting that lung function will decrease) do indeed affect the 
likelihood of changes in airway function. 
Hypotheses 
Hypothesis One 
Compared to baseline, individuals with asthma, panic disorder, and asthma and 
panic will experience a greater decrease in dyspnea level after the relaxation task and 
head turning task than controls. After the straw task, controls are expected to experience 
a greater decrease in dyspnea level than the other three groups. 
Hmothesis Two 
After the relaxation task, the panic and asthma and panic groups will report a 
greater increase in panic-related symptoms from baseline than the asthma group. In turn, 
the asthma group will report a greater increase in these symptoms than the control group. 
After the head turning task, the panic and asthma and panic groups are expected to 
experience a greater increase in panic sensations than the asthma and control groups. 
Panic-related symptoms will be equivalent for all groups after the straw task. 
Hypothesis Three 
Individuals in the asthqa and panic group will experience an increase in lung 
function after the relaxation and head turning tasks in comparison to baseline. In 
contrast, the control group will exhibit no change in lung function. The asthma and panic 
groups will exhibit a decrease in lung function after these tasks. Following the straw 
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task, it is expected that the asthma and asthma and panic groups will both show an 
increase in lung function. No change is expected for the control group, and a decrease is 
expected for the panic group. 
Hypothesis Four 
After the relaxation and head turning tasks, individuals with panic disorder and 
asthma and panic will report an increase in panic-related cognitions in comparison to the 
asthma and control groups. After the straw task, the asthma and asthma and panic 
groups will report a greater increase in panic-related cognitions than the panic group, with 
the control group reporting no increase. 
Hmothesis Five 
Individuals in the asthma, panic, and asthma and panic groups are expected to 
report more self-focus on bodily sensations than the control group. 
Hwothesis Six 
Individuals in the asthma, panic, and asthma and panic groups will report more 
misinterpretation of bodily sensations than the control group. 
Hypothesis Seven 
Individuals in the panic and asthma and panic groups are expected to report more 
fear of anxiety sensations than the asthma group. In turn, the asthma group will report a 
higher level than the control group. Panic-fear levels will be higher for the asthma and 
panic group than the asthma group, and the panic group’s level will be higher than that of 





Sixty female participants over the age of 18 were recruited on the University of 
Maine campus and in the community. The sample included four groups of 15 participants 
who were diagnosed with asthma, panic disorder, asthma and comorbid panic disorder, or 
had no diagnosis (control group). A power analysis (based on an effect size calculated 
utilizing group means from previous research; Carr et al., 1996; see Appendix A) 
revealed that 15 participants per group would result in a power of .94. 
Participants were recruited through psychology classes and through flyers posted 
at the University of Maine and at stores in Bangor, Maine. For undergraduates in 
psychology classes, extra course credit was offered. Other participants were offered 
payment for their participation. All participants read and signed an informed consent 
form (Appendix B). At the conclusion of the experiment, they were debriefed and 
received a referral list for psychological treatment. 
Participants with asthma and panic disorder were selected based on criteria similar 
to that used by Carr et al. (1 995). An attempt to verify that participants had been 
diagnosed with asthma was made via contact with the participant’s physician. 
Participants signed a release of information form (Appendix C )  that was sent to their 
physician. The physician completed the form, indicating the individual’s diagnosis and 
age at diagnosis, asthma severity, and any medications that may have been prescribed. 
Participants had to indicate during the diagnostic interview that their panic symptoms and 
their asthma symptoms occurred independently (e.g., panic has occurred at times when an 
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individual’s asthma was well controlled). The panic disorder section of a structured 
diagnostic interview (Anxiety Disorders Interview Schedule for DSM-IV [ADIS-IV]; 
Brown, Di Nardo, & Barlow, 1994) was utilized to diagnose the presence of panic 
disorder according to DSM-IV criteria. 
Experimenters 
The experiment was primarily conducted by the principal investigator and another 
advanced graduate student in clinical psychology. Interrater reliability for the ADIS-IV 
interviews was established by a second rater (an advanced graduate student in clinical 
psychology). This individual was blind to the experimental conditions. He or she 
listened to audiotapes of the diagnostic interviews and provided a second rating for each 
participant. The second rater was trained by the principal investigator in ADIS-IV 
scoring procedures. 
Dependent Measures 
The Anxiety Disorders Interview for DSM-IV. The Anxiety Disorders Interview 
for DSM-IV (ADIS-IV; Brown et al., 1994) was utilized to establish a diagnosis of panic 
disorder. Reliability and validity information on the ADIS-IV is not yet available, 
however, these data are available for the previous versions, the ADIS (Di Nardo, O’Brien, 
Barlow, Waddell, & Blanchard, 1983), based on DSM-111 criteria (APA, 1980), and the 
ADIS-R (Di Nardo & Barlow, 1988), which was based on DSM-111-R criteria (APA, 
1987). Interrater reliability for the ADIS has been examined in several studies. Two 
outpatient samples resulted in a kappa value of .68 for anxiety disorders in general and 
kappas for specific disorders ranged between .56 and .90 (Di Nardo et al., 1983). A third 
study comparing independent diagnoses made by psychiatrists and lay interviewers 
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utilizing the ADIS led to somewhat lower kappa values (range = .47 - .67). The interrater 
reliability of the ADIS-R is generally acceptable; kappas range from .57 to .82 (Di Nardo, 
Moras, Barlow, Rapee, & Brown, 1993). 
Anxiety Sensitivity Index. The Anxiety Sensitivity Index (ASI; Reiss et al., 1986; 
Appendix D) is a 16-item self-report measure that assesses the fear of experiencing 
anxiety symptoms. Items on the AS1 take the form of statements about the possible 
negative consequences of anxiety symptoms (e.g., “When I notice that my heart is beating 
rapidly, I worry that I might have a heart attack”). Each item is rated on a 5-point Likert 
scale (O=very little; 4=very much), and scores range from 0 to 64. High scores on the AS1 
are highly correlated with agoraphobia, panic disorder, or other anxiety disorders 
(Peterson & Reiss, 1992). The AS1 has acceptable reliability (test-retest at two weeks: = 
.75; at three years: = .71; coefficient alpha = .88; Maller & Reiss, 1992; Peterson & 
Reiss, 1992). Validity studies indicate that the AS1 is positively related to the Taylor 
Manifest Anxiety Scale (Taylor, 1953) and the Anxiety Frequency Checklist (Reiss et al., 
1986). However, the AS1 accounts for a significant portion of variance in Fear Survey 
Schedule-I1 (Geer, 1965) scores above and beyond the other two measures (Reiss et al., 
1986). In addition, the AS1 predicts anxiety levels after hyperventilation, whereas 
measures of trait anxiety do not (McNally, 1989). Thus, it appears that anxiety sensitivity 
assesses a component of anxiety not tapped by trait anxiety measures. 
Scores on the AS1 reliably differentiate between individuals diagnosed with 
agoraphobia or panic disorder and those with other types of anxiety disorders. In 
addition, AS1 scores discriminate between controls and individuals with anxiety disorders 
(Peterson & Heilbronner, 1987; Reiss et al., 1986). Thus, it appears that the AS1 has 
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clinical utility for differentiation of individuals with anxiety disorders. This measure is 
particularly relevant for panic disorder. 
Several studies of the factor structure of the AS1 have led to the identification of at 
least three factors. These factors include fear of somatic sensations, fear of cognitive 
dyscontrol, and fear of publicly observable symptoms. Recently, a new instrument, the 
Anxiety Sensitivity Profile (see below) has been developed to further explore these 
factors (Taylor & Cox, 1998). In this study, the AS1 was utilized as a measure of group 
differences in level of fear of anxiety sensations and resulted in a coefficient alpha of .9 1. 
Anxiety Sensitivity Profile. The Anxiety Sensitivity Profile (ASP; Taylor & Cox, 
1998; Appendix E) is a 60-item self-report measure that was developed in response to 
criticisms of the ASI’s factor structure. The ASP includes 60 items that question 6 
domains of anxiety symptoms and their perceived dangerousness: cardiovascular, 
respiratory, gastrointestinal, publicly observable anxiety reactions, dissociative and 
neurological symptoms, and cognitive dyscontrol. Each item is rated with regard to the 
likelihood that the sensation would lead to a negative outcome for the individual on a 1 
(not at all likely) to 7 (extremely likely) Likert scale. 
Coefficient alpha for the six subscales of the ASP range from .88 to .94. The ASP 
subscales correlate significantly with both the AS1 ( I S  between .41 and .66) and the Trait 
version of the State-Trait Anxiety Inventory (gs between . 1 1 and .29; Spielberger, 
Gorsuch, Lushene, Vagg, & Jacobs, 1982; Taylor & Cox, 1998). Further reliability and 
validity studies on the ASP have yet to be published. In the present study, only the 
respiratory subscale of the ASP was utilized as a measure of the perceived dangerousness 
of respiratory symptoms. 
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Asthma Symptom Checklist. The Asthma Symptom Checklist (ASC; Kinsman et 
al., 1977; Kinsman et al., 1973; Appendix F) is a 36-item list of somatic and mood 
symptoms that are related to asthma. Each item is rated on frequency of occurrence 
during asthma attacks (1 = never; 5 = always). The ASC is composed of five factors: 
Panic-fear, irritability, fatigue, hyperventilation-hypocapnia, and bronchoconstriction. 
The ASC provides an index of the specific symptoms an individual experiences during an 
attack, and may be related to measures of bother, anxiety, and depression. Cluster 
internal consistency reliabilities for the subscales range from .78 to .92 (Kinsman et al., 
1977). 
The panic-fear subscale (ASC-PF) has been extensively used to estimate an 
individual’s level of anxiety in response to asthma symptoms. This subscale is 
hypothesized to measure illness-specific panic-fear (Carr et al., 1995). ASC-PF scores 
are not related to pulmonary function, indicating that an individual’s level of anxiety 
about their symptoms is not related to the severity of their asthma. However, scores are 
positively correlated with level of prescribed steroids, excessive use of as-needed 
medications, and more frequent hospitalizations and rehospitalizations (Dirks, Fross et 
al., 1977). The ASC was used in two ways. First, it was used to assess the general level 
of symptoms typically experienced by individuals with asthma during an attack. Second, 
it was used with all four groups as a state measure after each task to assess the current 
level of asthma-related symptoms. 
Body Vigilance Scale. The Body Vigilance Scale (BVS; Schmidt, Lerew, & 
Trakowski, 1997; Appendix G) is an 18-item measure that assesses the degree to which 
individuals focus conscious attention on internal bodily sensations. Each item is rated on 
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a 1-1 0 Likert scale (1 = No attention paid to this sensation, 10 = Extreme amount of 
attention paid to this sensation). Test-retest reliability over a 5-week period is .58 in a 
sample of individuals with panic disorder. Internal consistency of the BVS is high, with 
Cronbach’s alpha = .82 for both a sample of undergraduates and a sample of individuals 
with panic disorder (Schmidt et al., 1997). In a sample of individuals diagnosed with 
social phobia, Cronbach’s alpha was slightly lower (.74; Schmidt et al., 1997). In the 
present study, Cronbach’s alpha was 3 2 .  Body vigilance is significantly correlated with 
anxiety sensitivity as well as anxiety measured by the Beck Anxiety Inventory, but not 
STAI Trait anxiety or depression symptoms (Schmidt et al., 1997). In this study, the BVS 
provided a measure of participants’ focus on their bodily sensations. 
Born Category Scale. The Borg Category Scale (Borg, 1982; Appendix H) is a 
visual analog scale that assesses an individual’s level of dyspnea. This measure ranges 
from 0 (nothing at all) to 10 (maximal) ratings of difficulty breathing. The Borg Scale 
was utilized between tasks to assess participants’ level of dyspnea. This provided a self- 
report measure of the level of breathing difficulty participants perceive that they are 
experiencing. 
Brief Body Sensations Interpretation Ouestionnaire. The Brief Body Sensations 
Interpretation Questionnaire (BBSIQ; Clark et al., 1997; Appendix I) is a 14-item 
measure based on the Interpretation Questionnaire (McNally and Foa, 1987). The BBSIQ 
includes two categories of ambiguous events: panic body sensations and external events. 
There are several steps to completing the BBSIQ. Participants first read each item and 
then write down “why” the event occurred. Next, they turn the page and are given three 
explanations (negative, positive, or neutral) to rank-order. Finally, participants return to 
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the beginning of the measure and rate how much they would believe each explanation if 
they were in that situation. The ratings range from 0 (not at all likely to be true) to 8 
(extremely likely to be true). Clark et al. (1997) note that the written “why” responses are 
very time consuming to score and do not provide additional information above and 
beyond the ranking information. Indeed, in the second study in the Clark et al. (1 997) 
article, the “why” responses are not scored at all. Following this convention, these 
responses were not scored for the purposes of this study. 
Internal consistency is satisfactory (Cronbach’s alpha = .86 for ranking of panic 
body sensations, .90 for ratings of panic body sensations, .74 for ranking of external 
events, and .SO for external event belief ratings). For individuals diagnosed with panic 
disorder, the BBSIQ panic body sensation items correlate significantly with the ACQ 
Physical Concerns factor, but not with the ACQ Social-Behavioral Consequences factor 
or the STAI. BBSIQ external event items correlate with the ACQ Social-Behavioral 
Consequences factor and STAI Trait anxiety, but not with the ACQ Physical Concerns 
factor. Test-retest reliability has not yet been examined for the BBSIQ. In this study, the 
BBSIQ provided a measure of the degree to which participants tend to interpret 
ambiguous situations in a threatening way. 
General Histow. The General History (GH; Appendix J) questionnaire was 
constructed specifically for the purpose of this study. It assesses use of prescription 
medications, known triggers of asthma symptoms, involvement in sports or other types of 
physical exercise, and cigarette smoke exposure. The GH provided information about 
environmental stimuli that the individual is exposed to on a daily basis. 
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Panic Attack Cognitions Questionnaire. The Panic Attack Cognitions 
Questionnaire (PACQ; C l m ,  Broyles, Borden, & Watkins, 1990; Appendix K) is a 35- 
item self-report checklist that assesses negative cognitions associated with panic attacks. 
The PACQ was utilized as a state measure of catastrophic, panic-related cognitions 
between tasks. The degree of preoccupation with each cognition during a panic attack is 
rated on a 1 (not at all) to 4 (totally dominated) Likert scale. 
The PACQ has been found to reliably differentiate between individuals who 
experience panic attacks versus individuals diagnosed with other anxiety disorders (Clum 
et al., 1990). Cronbach’s alpha for the PACQ was .88. In addition, the PACQ was found 
to contribute uniquely to the differentiation between individuals with and without panic 
attacks (depression, state and trait anxiety measures were also included; Clum et al., 
1990). 
Profile of Mood States. The Profile of Mood States (POMS; McNair, Lorr, & 
Droppleman, 197 1 ; Appendix L) is a 63-item self-report questionnaire that assesses 
transient mood states. It was utilized throughout the experiment to detect alterations in 
mood due to the experimental tasks. The POMS is composed of 6 subscales: Depression- 
Dejection, Tension-Anxiety, Anger-Hostility, Fatigue-Inertia, Vigor-Activity, and 
Confusion-Bewilderment. Each item is rated with regard to how much an individual is 
currently experiencing that emotion on a 0 (not at all) to 4 (extremely) Likert scale. For 
this study, only the Tension-Anxiety subscale was used. This subscale assess somatic 
tension. Internal consistency for this scale is .90, and a high degrees of test-retest 
reliability in a sample of outpatients has been found (I = .70; McNair et al., 1971). 
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State-Trait Anxiety Inventory. The State-Trait Anxiety Inventory (STAI; 
Spielberger et al., 1982, Appendix M) is a 40-item self-report measure that assesses two 
aspects of anxiety. Twenty items measure an individual’s general or “trait” level of 
anxiety, and 20 items assess an individual’s current or “state” level of anxiety. For the 
State version, items are rated according to how the individual feels at the moment, from 0 
(not at all) to 4 (very much so). The items on the Trait version are rated according to how 
the individual generally feels (0 = almost never, 4 = almost always). The test-retest 
reliability for the state version in college students (. 16 to .54) is lower than that of the trait 
version (.73 to .86), as may be expected (Spielberger et al., 1982). In this study, the STAI 
provided measures of the general and current levels of anxious mood that participants 
experience. Coefficient alpha in the present study was .80 for the state version and .74 
for the trait version. 
Symptom Checklist. Because no single measure of both asthma and panic 
symptoms exists in the published literature, a new measure was devised as a state 
measure of both types of symptoms. The Symptom Checklist (Appendix N) comprises 
all the items of the ASC (five subscales) plus a sixth subscale comprised of 14 items from 
the Panic Attack Symptoms Questionnaire (PASQ; Clum et al., 1990). PASQ items were 
selected that did not overlap with items already on the ASC. The PASQ itself is a 36- 
item checklist of symptoms frequently experienced during a panic attack. It reliably 
differentiates between individuals with panic attacks and individuals diagnosed with other 
anxiety disorders (Clum et al., 1990). In addition, the PASQ contributes uniquely to the 
differentiation between individuals with and without panic attacks (depression, state, and 
trait anxiety measures were also included; Clum et al., 1990). 
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Visual Analog Scales. A 7-point Likert scale (Appendix 0) was utilized between 
tasks to assess the similarity of sensations experienced during the task to those 
experienced during a panic attack. The scale ranges from 0 (not at all similar) to 7 
(extremely similar). Because the sensations that individuals with panic disorder 
experience differ from individual to individual (Barlow & Craske, 1994), some challenge 
tasks may not be as salient as others. This visual analog scale provided a measure of how 
similar sensations during the tasks were to those experienced during panic attacks. 
A second 7-point Likert scale (Appendix P) assessed how stressful the task was 
for the participant. The scale ranges from 0 (not at all stressful) to 7 (extremely stressful). 
Because some researchers have proposed that stress reactivity causes increased air flow 
resistance (Kotses et al., 1989), it is important to measure the participant’s perception of 
stress level. 
A third 7-point Likert scale (Appendix Q) assessed how similar the sensations 
produced during the tasks were to an asthma attack. The nature of symptoms experienced 
by individuals with asthma varies from individual to individual (Purcell & Weiss, 1970). 
Therefore, it was important to utilize a self-report measure of how similar the sensations 
experienced during the tasks were to an asthma attack. 
Participants completed a fourth 7-point Likert scale (Appendix R) that assessed 
how much control they believed they had over the sensations experienced during each 
task. According to Ley (1 998), dyspnea produces panic sensations when the individual 
believes he or she has little or no control over the dyspnea. 
Measurement of Lung Function. Pulmonary function was assessed via 
spirometry, using methodology similar to previous studies (e.g., Carr et al., 1992; Carr et 
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al., 1994; Isenberg et al., 1992b). At each assessment, participants exhaled forcefully 3 
times at maximal lung capacity, or until at least 2 equivalent readings (+/- 5%) are 
obtained. No more than 5 exhalations were attempted at any assessment. A nose clip 
was utilized to reduce air escaping through the nasal passages. Measures examined 
included FEVl and the ratio of FEVl to FVC (FEVlRVC). Because the level of expected 
lung capacity differs based on an individual’s body height, age, weight, and gender, FEVl 
was analyzed as percent predicted based on the participant’s characteristics, calculated by 
the spirometer. 
Procedure 
Participant Selection. Students in numerous Psychology courses completed 
screening questionnaires that assessed presence or absence of asthma and history of panic 
attacks. Approximately 1,500 women were screened over a 1.5 year period. Interested 
participants who met the initial screening criteria for one of the groups were contacted by 
telephone and asked a series of short questions relating to their medical and psychiatric 
history. If the responses to these questions indicated that the individual continued to meet 
criteria, the individual was asked to take part in the structured interview (ADIS-IV). 
Those who did not meet the inclusion criteria were provided with a brief explanation of 
why they were not be able to take part in the study (e.g., “We are looking for people who 
did not experience the onset of both panic and asthma within a year’s time.”) and thanked 
for their interest in the experiment. Women who met initial inclusion criteria were 
scheduled for the experiment during the first 7 days of their menstrual cycle in order to 
control for hormonal levels that may affect lung function (e.g., Chandler, Shuldheisz, 
Phillips, & Muse, 1997; Cross, 1994; Settipane & Simon, 1989). 
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Upon arrival at the laboratory, the experimenter verbally explained the 
information in the consent form, and participants were asked to read and sign the consent 
form. Individuals were informed that they would be engaging in tasks not expected to be 
more stressful than those encountered in daily living, and that they could discontinue 
participation in the experiment at any time without penalty. After signing the informed 
consent form, each participant was interviewed utilizing the panic disorder section of the 
ADIS-IV . 
Exclusionary Conditions. In addition to assessment for panic disorder, 
participants were screened for history of schizophrenia or psychotic episode(s), and 
alcohol and drug abuse or dependence within the past year. Medical conditions that 
resulted in exclusion included vestibular disorders and other chronic diseases (i.e., 
diabetes, hypo or hyperthyroidism, etc.). 
Following the structured interview, those who met criteria for participation 
immediately began the experimental session. Individuals who did not meet criteria were 
debriefed, thanked for their participation, paid or given course credit, and given a list of 
treatment referral information. 
Questionnaire Assessment. During the experimental session, participants 
completed the packet of questionnaires and engaged in the experimental tasks. 
Questionnaires included the ACQ, ASI, respiratory subscale, ASC, BBSIQ, BVS, GH, 
and STAI, and were presented in random order to minimize the possibility of order 
effects. Participants were asked to read the instructions for each questionnaire carefully 
before completing it. 
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Tasks. Once the questionnaire packet was completed, participants engaged in the 
three experimental tasks: turning head from side to side, breathing through a straw, and 
relaxation. To control for order effects, the tasks were counterbalanced. A 5-minute 
baseline preceded each task. During each baseline, participants sat in a comfortable chair 
and were told: 
“Now we are going to take a short, 5-minute break. During this time, simply sit 
back and rest. After 5 minutes, we will measure your lung function and you will have a 
short set of questionnaires to complete.” 
After each baseline and after each task, spirometry measures were taken, and each 
participant completed the anxiety subscale of the POMS, PACQ, PASQ, ASC, Borg 
Scale, and the visual analog scales. 
Head Turning, Task. The head turning task involved the participant turning her 
head from side to side while seated in a chair for 2 minutes. This task was designed to 
cause symptoms reminiscent of a panic attack (i.e., dizziness), without affecting lung 
finction or increasing heart rate (Barlow & Craske, 1994). It is particularly important to 
avoid activity that affects heart rate, because heart rate is related to respiratory rate 
(Lehrer, Hochron, Rausch, & Can, 1994a). If heart rate is inadvertently increased, then 
respiratory rate also increases. 
Participants were seated in a chair and told: 
“During this task, please turn your head from side to side (experimenter 
demonstrates). This task will last 2 minutes. Your task is to focus on your thoughts, 
feelings, and the sensations you experience while turning your head. After the minute is 
up, I will measure your lung function, and have you will complete the short questionnaire 
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packet again. If it becomes absolutely necessary for you to stop this activity before the 2 
minutes are up, that is okay, but please do your best to continue for as long as you can.” 
To avoid the loss of participants due to possible inability to complete 2 full 
minutes of the head turning task, the length of time the participant continued was 
recorded. Data for participants completing at least 30 seconds of the task was retained. 
Straw Task. Breathing though a straw lasted 2 minutes. This task was designed 
to mimic the sensations of dyspnea experienced during an asthma attack (Barlow & 
Craske, 1994). 
Participants were seated in a comfortable chair and a nose clip was placed on their 
nose. They were told: 
“In this task, you will be breathing through this straw for 2 minutes. Your task is 
to focus on your thoughts, feelings, and the sensations you experience while breathing 
through the straw. Again, after this task, I will measure your lung function and ask you to 
complete the short questionnaire packet. If it becomes absolutely necessary for you to 
stop this activity before the 2 minutes are up, that is okay, but please do your best to 
continue for as long as you can.” 
Again, to reduce participant attrition, the length of time participants continued 
was recorded. Data for participants who continued the straw task for at least 30 seconds 
was retained. 
Relaxation Task. Relaxation was 5 minutes in length. This task served as a 
comparison and also replicated the findings of Carr et al. (1992). 
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Participants were seated in a comfortable chair and told: 
“During this task, please relax as completely as possible with your eyes closed. 
You will have 5 minutes to simply sit back and relax. After the task, I will measure your 
lung function and have you complete the short questionnaire packet.” 
Spirometry Procedure. Instructions for the participants regarding how their lung 
function was measured were modeled after American Thoracic Society guidelines (ATS, 
1995). Participants were shown the equipment and the disposable mouthpiece they 
exhaled into. The following instructions were provided: 
“This is a spirometer. It is a machine that measures how well your lungs are 
working. You will be exhaling into this mouthpiece (show mouthpiece). I am going to 
put this nose clip on your nose in order to prevent air from escaping. It is very important 
that you inhale completely before you put the mouthpiece in your mouth. If you inhale 
into the mouthpiece, this will alter the readings. When you put the mouthpiece in, make 
sure you have made a good seal with your lips to prevent air from escaping on the sides 
(experimenter demonstrates with another mouthpiece). When you exhale, it is important 
that you blast the air from your lungs and then continue exhaling as fully as possible 
(experimenter demonstrates). We will be doing at least 3 exhalations after each task. Do 
you have any questions?” 
The experimenter demonstrated the procedure and, as the participant exhaled, 
encourage her to exhale as fully as possible. At least 3 acceptable (<0.2 L variation; 
ATS, 1995) maneuvers were necessary. No more than 5 total maneuvers were attempted 
at any task interval. 
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Debriefing. After the completion of the series of tasks, lung function assessments, 
and questionnaire measures, participants were thanked for their participation and 
debriefed. Participants not receiving experimental credit were paid $10.00 to assist in 
defiaying travel costs associated with their participation in the study. 
Modifications to Procedure. Because of the difficulty in obtaining participants, 
two of the constraints that had originally been placed on participation had to be 
abandoned. It was hoped that women would be able to be scheduled during the first week 
of their menstrual cycle in order to hold hormonal factors constant. It is well-established 
that hormone fluctuations during the menstrual cycle may lead to exacerbations for some 
women during the premenstrual phase (e.g., Chandler et al., 1997; Cross, 1994; Settipane 
& Simon, 1989). Furthermore, the menstrual cycle appears to impact frequency and 
severity of panic attacks (e.g., Cameron, Kuttesch, McPhee, & Curtis, 1988; Cook et al., 
1990; Kaspi, Otto, Pollack, Eppinger, & Rosenbaum, 1994; Sigmon et al., 2000). 
However, potential participants were less likely to follow through with scheduled 
assessments when planned dates were more than a few weeks away. Instead, women 
indicated which phase of the menstrual cycle they were in and that information was 
recorded as part of data collection. 
Several women in each of the groups smoked cigarettes on a regular basis. 
Previous research in the asthma and panic area has excluded individuals who smoke in 
order to rule out reasons for lung dysfunction other than asthma (e.g., Carr et al., 1992; 
Carr et al., 1996). If the study had been conducted with a larger sample size, it is possible 
that a more homogeneous sample without confounds (i.e., smoking status, menstrual 




In this section, participant characteristics, interrater reliability statistics for 
diagnostic interviews using the panic section of the Anxiety Disorders Interview for 
DSM-IV (ADIS-IV; Brown et al., 1994), and results for each hypothesis are presented. 
Additional related findings are included in the results for each hypothesis as well as at the 
end of the Results section. All data analyses were conducted with SPSS version 10.0 
software for Windows. Where possible, power and effect size (eta2) were calculated for 
each analysis. According to Cohen (1 988), effect sizes of .  10, .25, and .40 are considered 
to be small, medium, and large, respectively. Post hoc comparisons were conducted 
using Tukey’s HSD test with alpha set at .05. 
Sample Characteristics 
Demographic Information 
Female participants were 93% Caucasian, 3% Hispanic, and 3% Native American. 
All but one participant was an undergraduate at the University of Maine (99%). The four 
groups of participants (Asthma only, Panic only, Asthma and Panic, Control) did not 
significantly differ in age, F(3,55) = .43, G. The mean age of participants by group was 
as follows: Asthma only, M = 19.47, 
9.24; Panic, M = 20.93, 
Asthma Groups 
= 1.81; Asthma and Panic, 
= 3.08; Control, M = 21.07, SD = 4.67. 
= 22.80, SD = 
Women in the Asthma only and Asthma and Panic groups were compared on 
several variables that related to their asthma condition. Women in the Asthma only group 
were first diagnosed with the disease at a mean age of 1 1.38 years (SD = 5.84), whereas 
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women in the Asthma and Panic group were diagnosed at a mean age of 16.83 years (a 
= 12.59). However, these means were not significantly different F(1,23) = .56, m. 
Women in the two asthma groups did not significantly differ with regard to the number of 
medications taken. Women in the Asthma group reported taking an average of 1.8 
medications, and women in the Asthma and Panic group reported taking 3.33 
medications, c( 1,28) = 2.48, m. Types of medications taken by both groups were similar, 
most frequently beta agonists (60% of Asthma group, 47% of Asthma and Panic group), 
followed by corticosteroids (1 3% of Asthma group, 13% of Asthma and Panic group) and 
allergy medications (13% of Asthma group, 20% of Asthma and Panic group). Similarly, 
there was no significant difference in length of time from last asthma attack in weeks 
between the Asthma (M = 46.38, SD = 71.53) and Asthma and Panic groups (M= 32.87, 
- SD = 83.66), F( 1,26) = .OO, 3. 
Several t tests were performed on the subscales of the Asthma Symptom Checklist 
(ASC) comparing the responses of women in the Asthma only and Asthma and Panic 
groups (see Table 3.1). Women in the Asthma and Panic group reported higher levels of 
asthma symptoms than the Asthma only group on total scale score, I( 1,28) = -2.67, p < 
.01, the Panic Fearf(1,28) = -2.96, p < .006, Irritability, 1(1,28) = -2.41, p < .02, and 
Fatigue t( 1,28) = -2.17, p < .03 subscales. Means for the Hyperventilation i( 1,28) = -.58, 
ns, and Bronchoconstriction 1(1,28) = -1.74, ns, subscales were not significantly different 
between the Asthma only and Asthma and Panic groups. 
Panic Groups 
Women in the Asthma and Panic and Panic only groups were compared on panic- 
related variables assessed on the Anxiety Disorders Interview Schedule for DSM-IV 
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Table 3.1 
Means and Standard Deviations for Asthma Symptom Checklist Subscales 
Asthma Asthma & Panic 
Total Score 98.26 (27.57) 122.78 (18.95) -2.67* 
Panic Fear 19.06 (8.08) 27.20 (6.87) -2.96** 
Irritability 14.00 (5.50) 19.00 (5.85) -2.41 * 
Fatigue 11.53 (4.89) 15.28 (4.32) -2.17* 
Hyperventilation 20.60 (6.25) 21.73 (4.25) -.58 
Bronchoconstriction 33.06 (8.97) 38.00 (7.43) -1.74 
* p < .05. ** p < .01. 
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(Brown et al., 1994). Both groups reported having experienced panic attacks for a similar 
length of time (Asthma only: M = 78.93 months, SD = 54.43; Asthma and Panic: M = 
68.40 months, SJ = 65.00), F(l,27) = .538, ns. Women in the Panic only group reported 
an average of 7.33 panic attacks (SJ = 9.63) over the past month, and 36.73 attacks (B 
= 59.84) over the past 6 months. These values were not significantly different from those 
reported by the Asthma and Panic group, who reported an average of 7.93 attacks (SJ = 
7.90) in the past month, F(l,28) = .001,  IS- and 39.00 attacks (m = 43.09) over the past 6 
months, F(l,28) = .32, ns. When asked to rate the amount they worried about having 
another panic attack during the past month on a 0 (no worry/apprehension) to 8 
(constantly worriedextreme apprehension) Likert scale, the average response of the 
women in the Panic only group was 4.60 (SJ = 2.56), whereas women in the Asthma and 
Panic group reported less worry, 3.73 (SJ = 2.60). These means, however, were not 
significantly different, F( 1,28) = . 0 0 1 , ~ .  Similarly, no significant differences were 
found between the Panic only and Asthma and Panic groups on measures of panic attack 
life interference and distress, F( 1,28) = 2.89, ns, and F( 1,28) = .89, ns, respectively. 
An advanced clinical graduate student reviewed audiotapes of the ADIS-IV 
interviews and rated which group criteria the participant met. These ratings were 
compared with the principal investigator. Unfortunately, 13 out of 60 interviews were not 
recorded due to equipment failure. On the remaining 47 participant interviews, the 
principal investigator and the advanced clinical graduate student agreed 100% that 
women in the Panic only and Asthma and Panic groups met DSM-IV criteria for Panic 




Oneway ANOVAs were performed on total scores for the following questionnaire 
measures. Means and standard deviations for these measures appear in Table 3.2. 
On the State version of the State-Trait Anxiety Inventory (STAI; Spielberger et al., 1983), 
no significant differences between groups were found, €33,56) = 1.68,s .  On the Trait 
version, however, a significant effect for group was found, F(3,56) = 9.71, p < .0001 (see 
Figure 3.1). Women in the Panic only group reported significantly more trait anxiety than 
women in the Asthma only and Control groups, and women in the Asthma and Panic 
group reported more trait anxiety than the Asthma only group. Mean scores for the 
Asthma only and Control groups did not significantly differ, nor did the Asthma and 
Panic and Panic only groups. 
Profile of Mood States 
A oneway ANOVA was conducted on baseline Profile of Mood States (POMS; 
McNair et al., 197 1) Tension-Anxiety subscale scores to identify group differences, 
- F(3,56) = 5.41, p < .002 (see Table 3.3). Post hoc analyses revealed that the Panic only 
group reported significantly more anxiety at baseline than the Asthma only and Control 
groups. The Asthma and Panic group did not differ from any other group, and the 
Asthma only group did not differ from the Control group. To calculate POMS scores for 
each task taking into account baseline differences, change scores were derived for each 
task from baseline. A MANOVA on POMS change scores from all three tasks revealed a 
significant overall effect for group, Wilks’ lambda F(9,129) = 2.58, p < .009, power = 
.85, eta2 = .12. Followup oneway ANOVAs and post hoc tests indicated that on the head 
turning task, F(3,55) = 5.67, p < .002, women in the Asthma and Panic group reported 
Table 3.2 
Means and Standard Deviations for Questionnaires 
~~ 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
State Anxiety 
Trait Anxiety 
48.60 (4.13) 52.66 (8.53) 53.20 (8.94) 49.26 (4.05) .18 
47.60b,, (3.73) 55.26, (6.78) 57.06,d (5.90) 50.93, (4.21) 9.71*** 
Note: Groups are significantly different from means subscripted. 




Means and Standard Deviations for Profile of Mood States Tension-Anxiety Scores 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Baseline 5.26, (3.41) 9.73 (7.73) 
Head Turning 6.26b (4.74) 17.13%,,d(9.53) 
Change -1 .oo -7.40 
Straw 7.46 (6.73) 16.86d (9.01) 
Change -2.20 -7.13 
Relaxation 3.33 (3.15) 6.06 (5.50) 
Change +1.93 +3.67 
14.46,d (10.90) 






4.93, (5.70) F(3,56) = 5.41** 
5.8Ob (5.26) F(3,55) = 5.67** 
-37  
5.86b (5.04) F(3,55) = 2.62 
-.93 
3.21 (4.67) l33,55) = .31 
+1.72 
Note. Negative change scores reflect intensification of anxiety relative to baseline; positive change scores reflect decrease in anxious 
mood relative to baseline. Groups are significantly different from means subscripted. 
** p < .01. 
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more anxiety compared to baseline than the other three groups (see Figure 3.2). Women 
in the Asthma only group did not score differently from women in the Panic only or 
Control groups, and the Panic only and Control groups did not differ on their self-report 
of anxious mood. On the straw task, F(3,55) = 2.62, p < .06, a trend toward significance 
was identified. The Asthma and Panic group exhibited a larger increase in anxiety during 
the straw task than the other three groups, although this was not statistically significant. 
Finally, no significant mood changes were identified for the relaxation task, F(3,55) = 
.31,m. 
Results for Hypotheses 
Hypothesis One 
According to Hypothesis One, in comparison to baseline scores, individuals in the 
Asthma only, Panic only, and Asthma and Panic groups would experience a greater 
increase in dyspnea level after the relaxation and head turning tasks than the Control 
group. Controls were expected to experience greater dyspnea after the straw task. 
Baseline Borg Dyspnea Scale (BDS; Borg, 1982) scores were compared via a oneway 
ANOVA (see Table 3.4). No baseline group differences were found, F(3,56) = 2.03, ns, 
In order to compare BDS scores after each task to baseline, change scores were calculated 
for each task. BDS scores from the head turning, straw, and relaxation tasks were 
subtracted from baseline scores. A oneway ANOVA revealed no significant differences 
between groups on BDS change scores following the straw, F(3,56) = 1.66, gs, or 
relaxation tasks, F(3,56) = . 4 4 , ~ .  Group differences on the head turning task, however, 
approached significance, F(3,56) = 2.57, p < .06. Post hoc analyses, however, did not 
identify significant differences between any pairs of groups. During the head turning 
Anxious mood change score for head turning task - h) w P vl Q\ 4 00 0 
I , I 1 , 1 








Means and Standard Deviations for Borg Dyspnea Scale Scores 
~ 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Baseline 1.67 (1.23) 1.87 (1.67) 1.53 (1.25) .SO (1 -26) 2.03 
Head Turning 1.87 (1.19) 2.80 (1.37) 2.27 (1.75) .47 (S2) 2.57 
Change -.20 -.93 -.74 -.33 
Straw 2.53 (1.19) 4.00 (1.13) 3.40 (2.56) 2.13 (1.64) 1.66 
Change -.86 -2.13 -1.87 -1.33 
Relaxation 1.13 (1.19) 1.13 (1.19) .87 (1.19) .14 (.36) .44 
Change -.54 -.74 +.66 +.66 
Note. Negative change scores reflect intensification of dyspnea relative to baseline; positive change scores reflect decrease in dyspnea 
relative to baseline. Groups are significantly different from means subscripted. 
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task, women in the Asthma and Panic and Panic only groups reported more anxiety than 
women in the Asthma and Control groups. 
Hypothesis Two 
According to Hypothesis Two, after the relaxation task, the Panic only and 
Asthma and Panic groups would report a greater increase in panic-related symptoms from 
baseline than the Asthma only group. In turn, the Asthma only group was expected to 
report a greater increase in these symptoms than the Control group. After the head 
turning task, the Panic only and Asthma and Panic groups were expected to report a 
greater increase in panic sensations than the Asthma only and Control groups. After the 
straw task, panic-related symptoms were expected to be equivalent for all groups. 
Baseline scores from the six subscales of the Symptom Checklist (five subscales 
of the ASC, plus panic specific symptoms) were analyzed via ANOVA. Five out of the 
six subscales resulted in a significant oneway ANOVA and significant group differences 
with post hoc testing (see Table 3.5). On the Panic-Fear, F(3,56) = 4.09, p < .01, 
Fatigue 9 -  F(3,56) = 4.38, p < .008, and Hyperventilation subscales, F(3,56) = 4.77, p < 
.005, an identical pattern of scores was identified. For these three subscales, women in 
the Panic only group scored higher than women in the Asthma only and Control groups. 
The Asthma and Panic group did not significantly differ from any other group. On the 
Irritability subscale, F(3,56) = 4.65, p < .006, women in the Panic only group scored 
significantly higher than women in the Asthma only group. No differences were found 
for the Asthma and Panic or Control groups. On the Bronchoconstriction subscale, 
- F(3,56) = 1.92, ns, no significant group differences were identified. Finally, on the Panic- 
Specific subscale, women in the Panic only group scored higher than women in the 
Table 3.5 
Means and Standard Deviations for Baseline Symptom Checklist Subscales 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Panic-Fear .73, (1.09) 3.53 (5.15) 5.53,d (6.10) 1.27, (4.54) 4.09** 
Irritability 1.06, (.79) 3.60 (2.94) 5.20, (5.14) 2.06 (2.52) 4.65** 
Fatigue 2.26, (3.01) 3.26 (3.63) 5.80,d (4.58) 1.33, (2.71) 4.38** 
Hyperventilation 1.73, (2.12) 1.86 (2.94) 4.53qd (4.08) .SO, (1.56) 4.77** 
Bronchoconstriction 6.00 (5.27) 5.13 (5.89) 7.06 (6.70) 2.40 (4.11) 1.92 
Panic Symptoms 2.26 (1.75) 5.60 (7.51) 7.40d (7.5 1) 2.00, (2.07) 3.45* 
Note: Groups are significantly different from means subscripted. 




Control group. No significant differences were identified for the Asthma and Panic or 
Asthma only groups. 
In order to compare Symptom Checklist subscale scores while taking into account 
baseline differences, change scores for each task were calculated (see Table 3.6). For the 
head turning task, a MANOVA on the six subscale scores did not reveal any significant 
group differences, Wilks’ lambda E( 18,144) = 1.39, ns, power = 32,  effect size = .13. 
Likewise, the overall MANOVA on the relaxation task was nonsignificant, Wilks’ 
lambda F( 18,144) = 1.8 1, ns, power = .93, effect size = .17. No followup ANOVAs were 
conducted for these two tasks. On the straw task, however, a significant Wilks’ lambda 
was revealed, E( 18,144) = 2.76, p < .0001, power = .99, effect size = .24. Followup 
oneway ANOVAs were significant for two of the six subscales, Hyperventilation, F(3,56) 
= 5.26, p < .003, and Bronchoconstriction, F(3,56) = 3.17, p < .03. Post hoc testing for 
the Hyperventilation subscale revealed that the Panic only group scored significantly 
higher than the Asthma only and Control groups. The Asthma and Panic group did not 
differ from any other group. On the Bronchoconstriction subscale, women in the Asthma 
and Panic group scored higher than the Asthma only group. No significant differences 
were found for the Panic only or Control groups. Post hoc tests on the remaining 
subscale scores, Panic-Fear, F(3,56) = 1.07, ns, Irritability, F(3,56) = 1.58, ns, Fatigue, 
- F(3,56) = .87, ns, and Panic Specific, F(3,56) = 2.10, ns, revealed no significant findings. 
Hwothesis Three 
According to Hypothesis Three, individuals in the Asthma and Panic group were 
expected to experience an increase in lung function after the relaxation and head turning 
tasks in comparison to baseline. In contrast, the Control group was expected to exhibit no 
Table 3.6 
Means and Standard Deviations for Task Symptom Checklist Subscales 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 









.SO (2.07) 4.60 (5.66) 
-.06 -1.06 
1.00 (1.41) 5.66 (4.46) 
-.06 -2.06 
2.00 (2.44) 4.60 (4.89) 
+.26 -1.33 








1 1.264 (8.25) 
-6.73 
.40 (.91) 1.83 
-.66 
3.00 (3.09) 2.00 
-.93 
1.60 (2.50) 1.83 
-.26 
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2.00 (2.39) .87 
-.66 
1.40, (3.26) 5.26** 
-.60 
10.25 (8.05) 3.17* 
-3.53 
3.40 (3.13) 2.10 
-1.40 
Table 3.6 Continued 
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.35 (.92) .62 
+1 .oo 
1.64 (3.27) .61 
+.57 
2.42 (2.56) .55 
-1 .oo 




Table 3.6 Continued 
Measure 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
M (SD) M (D) M (rn) M (SD) - F(3 7 5  6) 
Relaxation Task 
Bronchoconstriction 2.80 (2.95) 3.40 (5.67) 6.20 (1 1.30) .64 (1.15) .77 
Change +3.20 +1.73 +.86 +.78 
Panic Symptoms 1 .80 (2.04) 4.13 (3.64) 9.06 (12.31) 4.10 (7.17) .75 
Change +.46 +1.46 -1.66 +.85 
Note. Negative change scores reflect intensification of symptoms relative to baseline; positive change scores reflect decrease in 
symptoms relative to baseline. Groups are significantly different from means subscripted. 
Q <  .05. **  Q <  .01. 
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change in lung function. The Asthma only and Panic only groups were expected to 
exhibit a decrease in lung function after these tasks. Following the straw task, it was 
expected that the Asthma only and Asthma and Panic groups would both show an 
increase in lung function. No change was expected for the Control group, and a decrease 
was expected for the Panic only group. 
The spirometric equipment calculates the degree to which the three exhalation 
trials are consistent with each other, and selects the “best” exhalation (i.e., values as large 
as possible, but also consistent with the other two exhalations) as the one to use for 
interpretation. The accepted level of reliability is less than 0.5 L variation between the 
three trials. If no two of the three trials are within 0.5 L of each other, additional 
measurements are made (Hyatt, Scanlon, & Nakamura, 1997). Because some of the 
participants were not able to provide spirometric values that were reliable even after four 
or five exhalations, a number of readings were not included in analyses. The pattern of 
unreliable spirometric performance is in and of itself interesting. The Asthma only 
group’s percentage of unreliable measurements was low compared to that of the other 
groups (12%), Asthma and Panic group 30%, Panic only group 29%, and the Control 
group 16%. In order to use as much data as possible, ANCOVA was utilized with the 
spirometric percent variance as a covariate. In addition, eliminating data that fell below 
the 5% variance cutoff would have decreased the cell sizes for the Asthma and Panic and 
Panic only groups in a disproportional manner. 
An ANCOVA on baseline forced vital capacity (FVC) percent predicted data 
using percent variance as a covariate revealed no significant group differences, F(3,55) = 
.84, ns. A similar analysis on baseline forced expiratory volume at 1 second (FEV,) 
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percent predicted data was also nonsignificant, F(3,55) = 1.24, ns. Because of the lack of 
significant baseline differences between groups on any of these measures, change scores 
were not calculated. Rather, each measurement was analyzed via ANCOVA with the 
percent variance used as a covariate (see Table 3.7). 
No significant differences were identified for any spirometric measure following 
any task. ANCOVAs for FVC, F(3,55) = .90, ns, FEVl, F(3,53) = .91, ns, and an 
ANOVA on the ratio of FEV1/FVC, F(3,55) = .89, ns, for the head turning task failed to 
reach significance. Likewise, for the straw task, no significant differences were identified 
via ANCOVAs on FVC, F(3,55) = 1.95, ns, FEV1, F(3,55) = 1.63, ns, or an ANOVA on 
FEVl/FVC, F(3,56) = 1 30, ns. Relaxation task results were similar, with an ANCOVA 
on FVC, F(3,54) = .60, ns, and FEVl, F(3,54) = 1.28, ns, resulting in nonsignificance. 
Likewise, an ANOVA on relaxation FEVIEVC, F(3,55) = 1.38, ns, was not significant. 
Hypothesis Four 
After the relaxation and head turning tasks, individuals with Panic Disorder and 
both Asthma and Panic were expected to report an increase in panic-related cognitions in 
comparison to the Asthma only and Control groups. After the straw task, the Asthma 
only and Asthma and Panic groups were expected to report a greater increase in panic- 
related cognitions than the Panic only group, with the Control group reporting no 
increase. 
Total scores for the Panic Attack Cognitions Questionnaire (PACQ; Clum et al., 
1990) were compared at baseline (see Table 3.8). Results of an ANOVA on the PACQ 
scores revealed a significant group effect, F(3,56) = 6.24, p < .001. Post hoc tests 
indicated that women in the Panic only group reported significantly more panic related 
1 
Table 3.7 
Means and Standard Deviations for Spirometry 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Forced Vital Capacity 
Baseline 93.40 (9.27) 91.06 (10.91) 94.06 (14.58) 98.33 (16.64) F(3,55) = .84 
Head Turning 94.93 (7.90) 89.20 (16.98) 92.06 (13.64) 97.00 (17.79) F(3,55) = .90 
Straw 93.06 (10.61) 86.00 (12.29) 92.86 (11.64) 97.66 (17.22) F(3,55) = 1.95 
Relaxation 93.86 (10.39) 90.20 (10.21) 94.40 (14.84) 97.57 (17.24) F(3,54) = .60 
Forced Expiratory Volume at 1 second 
Baseline 97.00 (9.77) 90.33 (19.42) 92.93 (13.16) 100.26 (16.64) F(3,55) = 1.24 
Head Turning 99.14 (7.24) 88.86 (18.69) 90.46 (17.49) 97.46 (17.77) F(3,53) = .91 
Straw 95.93 (10.29) 86.86 (1 8.50) 86.86 (14.59) 96.80 (19.45) F(3,55) = 1.63 
Table 3.7 Continued 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
__ ~ ~ 
Forced Expiratory Volume at 1 second 
Relaxation 95.66 (10.44) 87.73 (17.60) 89.40 (16.72) 98.57 (19.63) F(3,54) = 1.28 
FEV 1 /FVC 
Baseline .92 (.05) 1.13 (.88) .87 (.07) .90 (.05) - F(3,56) = .38 
Head Turning .92 (.04) .88 (.15) .86 (.09) .89 (.05) - F(3,55) = .89 
Straw .91 (.02) .88 (.13) .83 (.12) .88 (.09) - F(3,56) = 1.80 
Relaxation .91 (.06) .85 (.15) .84 (.11) .90 (.07) - F(3,55) = 1.38 
Table 3.8 
Means and Standard Deviations for Panic Attack Cognitions Questionnaire Scores 
~~ 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Baseline 25.73, (1.27) 
Head Turning 25.33 (7.57) 
Change +.40 
Straw 27.13 (3.75) 
Change -1.40 
Relaxation 25.40 (0.73) 
Change +.33 
28.86 (4.06) 25.86,d (1.80) 
32.13 (5.12) 36.86 (12.27) 
-3.20 -11.00 
32.33 (5.89) 37.86 (17.04) 
-3.47 -.12 
27.13 (2.32) 32.13 (10.34) 
+1.73 -6.27 
26.26, (1.80) F(3,56) = 6.24*** 
26.26 (1.16) F(3,55) = 2.29 
0.00 
26.26 (0.96) F(3,55) = .93 
0.00 
25.42 (1.15) F(3,55) = .24 
+.84 
Note. Negative change scores reflect intensification of symptoms relative to baseline; positive change scores reflect decrease in 
symptoms relative to baseline. Groups are significantly different fiom means subscripted. 
*** p < .001. 
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thoughts than women in the Asthma only and Control groups. Interestingly, although the 
PACQ mean for the Asthma and Panic group appeared to be higher than the Panic only 
group mean, it was not significantly different at the .05 level. No significant baseline 
differences were found for the Asthma and Panic group. 
Change scores were calculated for each task in comparison to baseline. A 
MANOVA on change scores revealed an overall significant Wilks’ lambda, F39,129) = 
2.32, p < .01, power = .80, eta2 = .11. Oneway ANOVAs revealed no significant 
differences on the straw F(3,55) = .93, ns, power = .24, eta2 = .04, or relaxation tasks l33, 
55) = .24, ns, power = .09, eta2 = .01. However, on the head turning task, a trend toward 
significance was found, €33’55) = 2.29, 
hoc tests did not identify any group differences for the head turning task, visual 
inspection of the PACQ change scores for this task suggests that women in the Asthma 
and Panic and Panic only groups reported more panic-related thoughts than women in the 
Asthma only and Control groups. 
Hvpothesis Five 
< .08, power = .54, eta2 = .11. Although post 
Women in the Asthma only, Panic only, and Asthma and Panic groups were 
expected to report more self-focus on bodily sensations than women in the Control group. 
Analysis of the total scores on the Body Vigilance Scale (Schmidt et al., 1997; see Table 
3.9) revealed significant group differences, F(3,56) = 10.08, p < .OOOl). On this measure, 
women in the Asthma and Panic and Panic only groups reported more bodily self-focus 
than women in the Asthma and Control groups. 
Table 3.9 
Means and Standard Deviations for Anxiety Sensitivity Measures 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Measure 
Anxiety Sensitivity Index 16.86b,c (6.67) 
Body Vigilance Scale 15.54b,, (5.93) 
Anxiety Sensitivity Profile 
Cardiovascular 26.001, (7.74) 
Respiratory 25.20b (9.25) 
Gastrointestinal 26.93b (8.37) 
Public anxiety 25.20b (7.08) 
33.06,d (1 1.39) 30.26,d (15.62) 15.53b,c (6.64) 10.55*** 
23.63a:d (9.76) 23.53,d (6.95) 11.40b,, (6.36) 10.08*** 
39.934 (13.36) 35-53 (13.88) 25.60b (9.30) 5.87*** 
41.00,d (14.81) 37.93d (16.00) 23.60b,c (1 1.72) 6.66*** 
39.33,d (12.65) 35.20 (14.98) 25.13b (1 1.65) 4.61** 
38.06,d (12.73) 34.86 (13.34) 26.60b (1 1.83) 4.44** 
Table 3.9 Continued 
~~ 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Anxiety Sensitivity Profile 
Dissociative/Neurological 27.60b (8.97) 40.73,d (13.72) 36.60 (14.89) 28.00b (12.66) 3.89** 
Cognitive Dyscontrol 25.53b (8.67) 40.20,d (12.41) 34.66d (13.41) 22.93b,, (10.80) 7.33*** 
Note: Groups are significantly different from means subscripted. 
** Q < .01. *** Q < .001. 
Hypothesis Six 
Individuals in the Asthma only, Panic only, and Asthma and Panic groups were 
expected to report more misinterpretation of bodily sensations than women in the Control 
group. Because three participants failed to complete the Brief Body Sensations 
Interpretation Questionnaire (BBSIQ; Clark et al., 1997), the Asthma and Panic group 
totaled 13 and the Panic only group totaled 14 for the following analyses. A MANOVA 
on the BBSIQ subscales revealed an overall significant group effect Wilks’ lambda, 
- F(18,136) = 2.37, p < .003, power = .98, eta2 = .22 (see Table 3.10). Followup ANOVAs 
indicated no significant group differences on measures of external explanation rankings 
or neutral explanations for either the panic or external scenes, F(3,53) = .25, ns. and 
- F(3,53) = .32, ns, respectively. The panic explanations were rated higher than the neutral 
explanations by the Panic only group in comparison to the Control group, F(3,53) = 3.81, 
p < .01. No differences were found for this subscale for the Asthma only or Asthma and 
Panic groups. The panic explanations were rated higher by women in the Asthma and 
Panic and Panic only groups compared to women in the Asthma only and Control groups, 
- F(3,53) = 10.71, p < .0001. Finally, women in the Panic only group rated the external 
explanations as more likely than the Asthma only group, €3333) = 3.32, p < .02. No 
differences were found for the Control or Asthma and Panic groups on this subscale. 
A MANOVA on Anxiety Sensitivity Profile (ASP; Taylor & Cox, 1998) subscale 
scores (see Table 3.9) revealed a significant overall group effect, Wilks’ lambda F(3,56) = 
1.73, p < .04, power = .92, effect size = .41. Followup oneway ANOVAs and post hoc 
comparisons identified two patterns of significant differences. On the Cardiovascular, 
- F(3,56) = 5.87, Q < .001, Gastrointestinal, F(3,56) = 4.61, p < .006, Public Anxiety, 
Table 3.10 
Means and Standard Deviations for Brief Body Sensations Interpretation Questionnaire 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Panic explanation rank 2.76 (.28) 2.48 (S1) 2.36d (.54) 2.81, (.28) 3.18** 
External explanation rank 2.63 (S2) 2.48 (S9) 2.33 (S9) 2.58 (.43) .86 
Panic explanation rating 1.47b,c (1.17) 3-60,d (1.95) 3 . 0 0 ~  (1.41) .89b,c (1.21) 10.71*** 
External explanation rating 1.90, (1.07) 3.36 (2.01) 3.48,(1.62) 2.46 (1.47) 3.32* 
Neutral explanations- panic scenes 5.7 1 (1.04) 5.65 (1.23) 5.98 (.78) 5.65 (1.12) .32 
Neutral explanations-external scenes 6.2 1 (.97) 6.09 (1.5 1) 6.05 (1.02) 6.04 (1.02) .07 
Note: Groups are significantly different from means subscripted. 
* p. < .05. **  p. < .01. *** p. < .001. 
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- F(3,56) = 4.44, p < .007, and DissociativelNeurological subscales, F(3,56) = 3.89, p < 
.01, the Asthma and Panic group scored significantly higher than the Asthma and Control 
groups. No differences were identified on these subscales for the Panic only group. For 
the Respiratory, F(3,56) = 6.66, p < .001, and Cognitive Dyscontrol, F(3,56) = 7.33, p < 
.001, subscales, the Asthma and Panic group scored higher than the Asthma only and 
Control groups. In addition, the Panic only group scored higher than the Control group 
on the above subscales. 
Hypothesis Seven 
Women in the Panic only and Asthma and Panic groups were expected to report 
more fear of anxiety sensations than the Asthma group. In turn, the Asthma only group 
was expected to report a higher level than the Control group. Panic-fear levels were 
expected to be higher for the Asthma and Panic group than the Asthma only group. 
Significant differences between groups (see Table 3.9, Figure 3.3) were identified on the 
Anxiety Sensitivity Index (ASI; Reiss et al., 1986), F(3, 56) = 10.55, p < .0001. Women 
in the Asthma and Panic and Panic only groups scored higher than women in the Asthma 
only and Control groups. However, women in the Asthma only group did not report 
greater fear of anxiety sensations than women in the Control group. As discussed above, 
women in the Asthma and Panic group scored higher than women in the Asthma only 
group on four of six subscales of the ASC, including the Panic-Fear subscale. 
Ancillary Analyses 
Visual Analog Scales 
Several women did not to complete one or more of the visual analog scales (VAS; 









task). As a result, cell sizes are not consistent for these measures. In cases where cell 
sizes differ, the associated E test degrees of freedom have been listed along with means 
and standard deviations in Table 3.1 1. Oneway ANOVAs on baseline VAS scores were 
calculated. No significant group differences were identified for the panic VAS F(3,56) = 
2.16, 
significance was found, F(3,56) = 2.57, E < .06. Women in the Panic only group rated the 
or asthma VAS, F(3,46) = 2.12, ns. On the stress VAS, a trend approaching 
baseline as more stresshl than women in the Control group. No differences were 
identified for the Asthma only or Asthma and Panic groups. On the control VAS, a 
similar pattern was identified, with women in the Panic only group reporting that they had 
less control over the sensations experienced at baseline than women in the Control group, 
- F(3,56) = 3.81, p < .01. Again, no significant differences were identified for the Asthma 
only or Asthma and Panic groups. 
In order to control for baseline VAS scores, change scores for each VAS from 
baseline were calculated for each of the three tasks. A MANOVA on the VAS for each 
task was conducted. For the panic VAS, Wilks’ lambda F(9,129) = 1.78, p < .07, power 
= .66, eta2 = .09, a trend toward significance was identified. Post hoc tests, however, 
--. 
revealed no significant group differences on the head turning F(3,55) = 2.27, a and 
relaxation tasks F(3,55) = .29, ns, On the straw task, F(3,55) = 5.22, p < .003, women in 
the Asthma and Panic group reported that the task was much more like a panic attack than 
women in the Asthma only or Control groups. No differences were identified for the 
Panic only group. 
For the MANOVA on the asthma VAS, a group main effect was significant, 
Wilks’ lambda, F(9,99) = 2.58, Q < .01, power = 34,  eta2 = .15. Followup ANOVAs 
Table 3.1 1 
Means and Standard Deviations for Visual Analog, Scales 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Panic Visual Analog Scale 
Baseline 2.13 (1.51) 1.67 (.62) 2.73 (1.79) 1.67 (1.11) F(3,56) 2.16 
Head Turning 2.40 (1.50) 3.20 (1.42) 3.73 (2.12) 2.47 (1.41) l33,55) = 2.27 
Straw 2.53b (1.19) 3.73a.d (1.03) 4.20 (1.78) 2.47b (1.25) l33,55) =5.22** 
Relaxation 1.47 (1.13) 1.33 (.62) 2.13 (1.85) 1.14 (.36) - F(3,55) = .29 
Asthma Visual Analog Scale 
Baseline 2.67 (1.50) 1.80 (1.21) 3.00 (2.14) 1.67 (1.30) F(3,46) = 2.12 
Head Turning 3.00 (1.56) 2.80 (1.15) 4.38 (1.77) 2.09 (1.22) F(3,43) = 1.17 
Straw 3.73b (1.58) 4.67,d (1.11) 5.14 (1.21) 3.00b (2.32) F(3,43) = 4.80** 
Relaxation 1.73 (1.44) 1.33 (.82) 2.00 (1.55) 1.09 (.30) - F(3,43) = 1.16 c 
s 
Table 3.1 1 Continued 
Asthma (a) Asthma & Panic (b) Panic (c) Control (d) 
Stress Visual Analog Scale 
Baseline 1.93 (1.22) 2.07 (1.44) 2.47 (.83) 1.40 (.51) - F(3,56) = 2.57 
Head Turning 2.47 (1.30) 3.40 (1.88) 3.93 (1.91) 2.33 (1.29) F(3,55) = 1.53 
Straw 2.87 (1.46) 3.80 (1.15) 4.20 (1.70) 2.80 (1.52) F(3,55) = 1.24 
Relaxation 1.67 (1.29) 1.73 (.88) 2.40 (1.84) 1 S O  (1.34) €33,55) = .28 
Control Visual Analog Scale 
Baseline 4.67 (1.72) 5.27 (1.39) 4.33d (1.84) 6.13, (1.25) F(3,56) = 3.81** 
Head Turning 4.27 (1.87) 3.73 (1.39) 3.07 (1.98) 4.60 (1.55) €7(3,55) = 2.27 
Straw 3.87 (1.60) 3.27 (1.03) 3.27 (1.75) 4.40 (1.87) €7(3,55) = 2.25 




Note: Groups are significantly different from means subscripted. **  p < .01. 
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indicated no significant differences on the head turning, F(3,46) = 1.17, ns, or relaxation 
tasks, F(3,43) = 1.16, ns. On the straw task, the ANOVA was significant, €33,43) = 4.80, 
Q < .006. Post hoc tests revealed that the Asthma and Panic group rated the straw task as 
more like an asthma attack than the Asthma only and Control groups. No differences 
were identified for the Panic only group. 
On the stress VAS, a MANOVA revealed no group effect, Wilks’ lambda F(9, 
129) = 39,  ns, power = .34, eta2 = .04. Similarly, the analysis for the control VAS was 
not significant, Wilks’ lambda F(9, 129) = 1.60, ns, power = .61, eta2 = .08. Hence, no 
followup ANOVAs were calculated for these two measures. 
Correlations between Questionnaire Measures 
Correlations between several of the questionnaire measures (ASI, STAI-S, STAI- 
T, BVS) were calculated (see Table 3.12). Significant positive correlations were found 
between all four of these measures. Each measure was significantly correlated with each 
other measure. 
Additional correlational analyses were completed to examine relationships 
between the AS1 and subscales of the ASP and ASC. For the AS1 and ASC correlations, 
data from the Asthma only and Asthma and Panic groups was used, as the other two 
groups did not complete the ASC (Tables 3.13 and 3.14). Interestingly, for women in the 
Asthma only group, the AS1 was not significantly correlated with any of the ASP 
subscales (Cardiovascular, Respiratory, Gastrointestinal, Public Anxiety, Dissociative/ 
Neurological, and Cognitive Dyscontrol), but for women in the Asthma and Panic group, 
the AS1 was positively correlated with every subscale of the ASP. Subscales of the ASC 
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significantly correlated with the AS1 for the Asthma only group included the Panic-Fear, 
Irritability, and Hyperventilation subscales. For the Asthma and Panic group, only the 
Panic-Fear subscale correlated significantly with the ASI. In examining correlations 
between ASC and ASP subscales, for women in the Asthma only group, the 
Hyperventilation and Cardiovascular subscales were positively correlated. The 
Gastrointestinal subscale was significantly correlated with the Panic-Fear, Irritability, and 
Hyperventilation subscales. For women in the Asthma and Panic group, the only 
subscale that was correlated with any subscale of the ASP was the Panic-Fear subscale. 
This subscale was significantly positively correlated with all six ASP subscales (see 
Table 3.14). 
For the Panic only and Control groups, correlations between the AS1 and the 
subscales of the ASP were calculated (see Table 3.15). For the Panic only group, the AS1 
was significantly positively correlated at p < .O 1 for all six ASP subscales. For the 
Control group however, no ASP subscale was significantly correlated with the ASI. 
Exploratory Within-Sub-iect Analyses 
The three experimental tasks in the present study were conceptualized as being 
different with regard to the testing of three key theories. The hypotheses were phrased so 
that between-groups variables were the primary variables of interest. For this reason, 
when this study was in its design phase, repeated measures MANOVA was not 
considered as an analysis tool. However, given that so few of the predicted relations 
emerged, further exploratory analyses using repeated measures MANOVA were 
conducted in order to explore within groups effects. Investigating changes in lung 
function and the questionnaire measures for each group across tasks allows for the 
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Table 3.15 
Correlations between subscales of the Anxietv Sensitivity Profile and the Anxiety 
Sensitivity Index 
Panic Control 
Cardiovascular .69** S O  
Respiratory .67** .3 1 
Gastrointestinal .71** .32 
Public Anxiety .67** .4 1 
Dissociative/Neurological .75 * * .37 
Cognitive Dyscontrol .70** .30 
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identification of tasks that might elicit more asthmdpanic related symptoms or changes in 
lung function for a particular group. The questionnaire and spirometric data following 
the tasks were re-analyzed with 4 (Group: Asthma only, Panic only, Asthma and Panic, 
Control) x 3 (Task Change Score: Head Turning, Straw, Relaxation) MANOVAs. The 
task change score represents the repeated measures and the change from baseline for each 
dependent variable for each task. No significant Group main effects were found for any 
of the post-task measures. To test within-groups differences across tasks, paired t-tests 
were performed with alpha set at .05. A summary of the results is presented in Table 
3.16. 
Profile of Mood States. Although a significant Task main effect was found for 
anxious mood, Wilks’ lambda F(2,54) = 35.94, p < .0001, eta2 = .57, power = 1.00, no 
significant Group main effect was found, Wilks’ lambda F(3, 122) = 1.88, ns. However, 
a significant Group x Task interaction was found, Wilks’ lambda F(6,108) = 3.37, p < 
.004, eta2 = .15, power = .92. No significant Task simple main effect was found for the 
Control group, F(2,54) = 1.93, ns. However, significant Task simple main effects were 
found for the Asthma only, F(2,54) = 3.98, p <.024, Panic only, F(2,54) = 9.64, p < .0001, 
and Asthma and Panic groups, F(2,54) = 32.00, p < .0001. 
Post hoc t-tests indicated that participants in the Asthma only group reported more 
anxious mood &om baseline to the straw task than from baseline to head turning task or 
relaxation task (see Table 3.3). No significant differences were identified for the head 
turning and relaxation tasks for the Panic only group. For the Panic only group, anxious 
mood scores increased more from baseline to straw task and head turning task than from 
Table 3.16 
Summary of Within-Subjects Results 
Measure Asthma Asthma & Panic Panic Control 
Profile of Mood States - Anxiety 
ns -S T > H T = R L  ST=HT>RL ST = HT > RL 
Subscale 
ns Panic Attack Cognitions Questionnaire - ns ST = HT > RL S T = H T > R L  -
ST > HT > RL ST > HT > RL S T > H T > R L  ST>HT>RL Borg Category Scale 
ns FEV 1 - ns ns ns -
ns FVC ns ns - ns -
ns ns -ns HT > ST FEVl/FVC -
RL = HT, ST 
Note. ST = straw task, HT = head turning task, RL = relaxation task. 
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baseline to relaxation task. No differences were found between the straw and head 
turning tasks for the Panic only group. For the Asthma and Panic group, participants 
reported more anxious mood from baseline to head turning task and straw task than from 
baseline to relaxation task. No significant differences were identified for the Asthma and 
Panic group’s head turning and straw task anxious mood change scores. 
Panic Attack Cognitions Questionnaire. For the PACQ, a significant Task main 
effect, Wilks’ lambda F(2,54) = 19.19, p < .0001, eta2 = .4 1, power = 1 .OO, and Group x 
Task interaction, Wilks’ lambda F(6,108) = 3.01, p < .009, eta2 = .14, power = .89, was 
found. No significant Group main effect was identified, F(3,55) = .79, p < .50, eta2 = .04, 
power = .21. Breaking down the interaction, no significant simple main effect was found 
for the Control group, F(2,54) = .34, ns, or the Asthma only group, F(2,54) = 1.10, ns. 
For the Panic only group, a significant simple main effect for Task was found, F(2,54) = 
14.55, p < .0001, as well as for the Asthma and Panic group, F(2,54) = 13.35, p < .0001 
(see Table 3.8). Post hoc tests revealed that women in the Panic only and Asthma and 
Panic groups reported more panic related cognitions from baseline to the head turning and 
straw tasks relative to the relaxation task. No significant differences were identified 
between change scores for the head turning and straw tasks for either group. 
Born Catenow Scale. The BCS analyses resulted in a significant Task main 
effect, Wilks’ lambda F(2,54) = 19.19, E < .OOO 1, eta2 = .4 1, power = 1 .OO, and a 
significant Group x Task interaction, Wilks’ lambda F(6,108) = 3.01, p < .009, eta2 = .14, 
power = .89. No significant Group main effect was found, Wilks’ lambda F(3,55) = .79, 
ns, eta2 = .04, power = .21. Breaking down the interaction, significant simple main 
effects were found for the Control, Wilks’ lambda F(2,54) = 13.38, p < .0001, Panic only, 
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Wilks’ lambda F(2,54) = 28.88, p < .0001, Asthma and Panic, Wilks’ lambda F(2,54) = 
38.26, p < .0001, and Asthma only groups, Wilks’ lambdaF(2,54) = 8.53, p < .001. For 
all four groups, post hoc tests revealed that the straw task produced greater reports of 
dyspnea symptoms than the head turning task, and that the straw and head turning tasks 
resulted in greater reports of dyspnea than the relaxation task (see Table 3.4). 
Spirometric Measures. Percent predicted values for FEV 1 and FVC were utilized, 
as well as the ratio of FEVl /FVC. For FEVI, no significant main effects or interactions 
were identified for the change scores. For Task, Wilks’ lambda l?(2,53) = 2.46, ns, eta2 = 
.08, power = .47, for Group, Wilks’ lambda F(3,54) = 1.49, ns, eta2 = .07, power = .37, 
and for Group x Task, Wilks’ lambda F(6,106) = .46, ns, eta2 = .02, power = .18. 
For FVC, a Task main effect was found, Wilks’ lambda F(2,54) = 3.21, p < .04, 
eta2= .lo, power = .59. No Group main effect, Wilks’ lambda €3335) = .99, ns, eta2 = 
.05, power = .25, or Group x Task interaction was found, Wilks’ lambda F(6,lOS) = 93, 
ns, eta2 = .04, power = .35. In order to follow up the Task main effect, paired t-tests with 
a more conservative p value of .01 were utilized to control for Type I errors. No 
significant simple main effects were identified for Task, head turning vs. straw, i( 1,58) = 
-2.25, ns, head turning vs. relaxation, i(1,57) = -35, ns, or straw vs. relaxation change 
scores, I( 1,58) = 1.27, ns. 
For the ratio of FEVl /FVC, a significant Task main effect was found, Wilks’ 
lambda F(2,53) = 4 . 4 4 , ~  < .01, eta2 = .14, power = .73. No significant Group main 
effect, Wilks’ lambda F(3,54) = 1.24, ns, eta2 = .06, power = .37, or Group x Task 
interaction was identified, Wilks’ lambda F(6,106) = 1.22, ns, eta2 = .06, power = .46. 
Again, following up the Task main effect, no significant simple main effects were found 
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for head turning vs. straw, t( 1,58) = -2.35, ns, head turning vs. relaxation, I( 1,57) = -2.5 1, 
ns, or straw vs. relaxation change scores, I( 1,58) = -.29, ns. 
Symptom Checklist Subscales. For the subscales of the SCL, no Group main 
effect was identified, Wilks’ lambda F(3,55) = 2.09, ns, eta2 = .lo, power = .50. A 
significant Task main effect Wilks’ lambda F(2,54) = 65.14, p < .0001, eta2 = .70, power 
= 1 .OO, and a significant Group x Task interaction was found, Wilks’ lambda F(6,108) = 
4.20, p < .001, eta2 = .19, power = .97. See Table 3.6 for means, standard deviations, and 
change scores for the subscales of the SCL. 
Breaking down the interaction, no significant differences were found for the 
Panic-Fear subscale for the Control group, Wilks’ lambda F(2,54) = .40, ns, or the 
Asthma and Panic group, Wilks’ lambda F(2,54) = 1.03,m. However, for the Panic only 
and Asthma and Panic groups, significant differences were found, Wilks’ lambda F(2,54) 
= 12.77, p < .0001, Wilks’ lambda F(2,54) = 23.68, p < .0001. Post hoc tests revealed no 
significant differences in Panic-Fear change scores between the straw and head turning 
tasks for the Asthma only and Panic only groups. Women in both the Asthma only and 
Panic only groups reported greater changes in Panic-Fear ratings for the head turning and 
straw tasks than the relaxation task. 
On the Irritability subscale, no significant differences were found for the Control 
group, Wilks’ lambda F(2,54) = 2.28, ns, or the Asthma only group, Wilks’ lambda 
- F(2,54) = .37, ns. However, significant differences were identified for the Panic only 
group, Wilks’ lambda F(2,54) = 13.36, p < .0001, as well as for the Asthma and Panic 
group, Wilks’ lambda F(2,54) = 8.55, p < .001. Post hoc tests revealed no significant 
differences in irritability ratings between the straw and head turning tasks for the Asthma 
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and Panic group and Panic only groups. However, women in the Asthma and Panic 
group reported greater irritability for the head turning and straw tasks from baseline than 
the relaxation task. No significant difference was found for the Panic only group between 
the head turning task and relaxation tasks although a significant difference emerged 
between the straw task and relaxation task, with the straw task producing greater self- 
reports of irritability from baseline. 
For the Bronchoconstriction subscale, significant differences for all four groups 
were found, Control, Wilks’ lambda F(2,54) = 10.12, p < .0001, Panic only, Wilks’ 
lambda F(2,54) = 17.89, p < .0001, Asthma and Panic, Wilks’ lambda F(2,54) = 45.76, E 
< .0001, Asthma only, Wilks’ lambda F(2,54) = 1 1 . 2 2 , ~  < .0001. Women in the Asthma 
only, Panic only, and Asthma and Panic groups reported more bronchoconstriction after 
the straw task than the head turning task, and women in these groups reported more 
bronchoconstriction after the head turning task and the straw task compared to the 
relaxation task. Participants in the control group reported more bronchoconstriction on 
the straw task than the head turning and relaxation tasks. No significant difference was 
found for the head turning and relaxation tasks for the Control group. 
Analysis of the Fatigue subscale resulted in significance for the Panic only group, 
Wilks’ lambda F(2,54) = 5.20, p < .009. No significant effect was found for the Control 
group, Wilks’ lambda E(2,54) = .42, ns, Asthma and Panic group, Wilks’ lambda F(2,54) 
= S9, p < .55, or the Asthma only group, Wilks’ lambda F(2,54) = .06, p < .93. Post hoc 
tests for the Panic only group revealed that these women reported more fatigue for the 
head turning task than the relaxation task. No significant differences between the straw 
and head turning or straw and relaxation task were found. 
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The Hyperventilation subscale analyses revealed a significant effect for the Panic 
only, Wilks’ lambda F(2,54) = 13.19, p < .OOO 1, Asthma only, Wilks’ lambda F(2,54) = 
3.20, p < .04, and Asthma and Panic groups, Wilks’ lambda F(2,54) = 17.59, p < .0001. 
No significant effect was found for the Control group, Wilks’ lambda F(2,54) = 2.88, ns, 
Post hoc tests for the Asthma only and Panic only groups revealed no significant 
difference between the head turning and straw tasks, but the head turning and straw tasks 
produced greater reports of hyperventilation than the relaxation task. Women in the 
Asthma and Panic group reported more hyperventilation for the head turning task than the 
straw task. In addition, the head turning and straw tasks resulted in greater self-reports of 
hyperventilation than the relaxation task. 
Finally, for the Panic Specific subscale, no significant differences were identified 
for the Control group, Wilks’ lambda F(2,54) = 2.22, ns. However, a significant effect 
was found for the Panic only, Wilks’ lambda F(2,54) = 12.47, p < .0001, Asthma and 
Panic, Wilks’ lambda F(2,54) = 18.60, p < .0001, and Asthma only groups, Wilks’ 
lambda F(2,54) = 3.39, p < .04. Post hoc testing revealed no differences between the 
head turning and straw tasks for the Panic only, Asthma only, and Asthma and Panic 
groups, but head turning and straw tasks resulted in increased reports of panic specific 




In this study, three theories that relate to the comorbidity of asthma and panic 
disorder were tested. Women with or without asthma and with or without panic disorder 
were assessed on both spirometric and self-report measures of their responses to three 
tasks designed to test aspects of each theory. 
Self-Report 
State and Trait Anxiety 
Previous research conducted by Dorhofer & Sigmon (in press), utilizing groups of 
women with or without asthma, and with or without panic attacks, found differences in 
state anxiety. In the Dorhofer & Sigmon (in press) study, women with both asthma and a 
history of panic attacks reported significantly more state anxiety than controls. They 
endorsed less state anxiety overall than women in the present study. The differences in 
the means for the two studies may explain the apparent discrepancy in results. Both 
controls gnJ women with both asthma and panic disorder endorsed more state anxiety 
than in the previous study. It is possible that anticipation of the experimental tasks in this 
study contributed to increases in self-reports of state anxiety for participants compared to 
participants in the previous study. 
Differences in trait anxiety are consistent with previous research that found that 
individuals with both asthma and panic disorder reported significantly higher levels of 
trait anxiety than individuals with asthma only (van Peski-Oosterbaan et al., 1996). In 
addition, using the Taylor Manifest Anxiety Scale (Taylor, 1953) to assess trait anxiety, 
Can et al. (1996) found that individuals with both asthma and panic disorder reported 
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more trait anxiety than individuals with asthma only or controls, and that individuals with 
panic disorder reported more trait anxiety than individuals with asthma only. Thus, 
converging lines of evidence suggest that having panic disorder with or without asthma 
leads to greater reports of trait anxiety in general, in addition to having episodes of panic. 
One possible sequelae regarding the effectiveness of cognitive-behavioral treatment for 
panic disorder may lie in its ability to not only provide skills for coping with panic 
attacks, but to lower levels of trait anxiety through cognitive restructuring as well. 
Asthma Symptoms 
It is unclear why women in the Asthma and Panic group would report more 
irritability and fatigue but not more hyperventilation or bronchoconstriction symptoms 
than women with asthma alone. Hyperventilation and bronchoconstriction are symptoms 
that may be characteristic of a panic attack, as well as an asthma attack. It may be that 
questionnaire instructions were specific enough to limit participants’ ratings to actual 
asthma attack and not panic attack symptoms (“Please rate the following symptoms you 
may experience when you are having an asthma attack.”). To date, no other published 
study has compared respiratory symptoms for individuals who have asthma with or 
without panic disorder. Future research should investigate more thoroughly and with a 
more diverse sample the effects that having comorbid asthma and panic disorder may 
have on self-reports of asthma symptoms. 
Focus on Bodily Sensations 
It was predicted that women in the Asthma only group would report more self- 
focusing than women in the Control group. However, this was not the case. It appears 
that meeting diagnostic criteria for panic disorder is concomitant with increased focus on 
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bodily sensations, but a diagnosis of asthma does not necessarily lead to greater reports of 
bodily self-focus. 
Previous research has utilized the Body Sensations Questionnaire (BSQ; 
Chambless et al., 1984) as a measure of fear of specific bodily sensations in populations 
with or without asthma and with or without panic disorder (Carr et al., 1994). The Carr et 
al. (1 994) study found no significant differences in fear of bodily sensations between 
individuals with or without asthma only. Participants with panic disorder (with or 
without asthma) reported higher levels of fear or bodily sensations. These results parallel 
current findings. However, no published research has specifically examined the amount 
of focus on bodily sensations in a population with asthma. Future research should 
develop measures that can assess the amount of focus on bodily sensations and fear of 
bodily sensations that includes symptoms that are specific to asthma. 
Anxiety Sensitivity 
Extensive research has documented the role that anxiety sensitivity plays in the 
development and maintenance of panic disorder (Maller & Reiss, 1992, Reiss, 1987; 
Taylor et al., 1992), consistent with higher self-reports of anxiety sensitivity of women in 
the two panic groups. Consistent with some previous research, no anxiety sensitivity 
differences were identified between individuals with and without asthma. For example, 
Carr et al. (1 994) found no anxiety sensitivity differences between groups with asthma 
alone and controls. However, it should be noted that the Carr et al. (1994) study had 
uneven groupings and some groups had a small sample size. This limitation may have 
prevented the identification of significant findings for the anxiety sensitivity construct. 
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Although the present study’s lack of significant differences in anxiety sensitivity 
level between the Asthma only and Control groups is consistent with some research, the 
results are in sharp contrast to Dorhofer & Sigmon (in press). Dorhofer and Sigmon (in 
press) did find clear differences between women with asthma only and controls. It is not 
clear why these two studies, conducted with similar numbers of participants drawn from a 
similar student population, have inconsistent results. It is possible that the criteria used to 
determine group inclusion in the Dorhofer & Sigmon (in press) study may not have 
adequately divided individuals with and without a history of panic attacks. The authors 
used a time criterion, panic attacks within the last year. Women with a history of panic 
attacks longer than 1 year previous to the study may have been included in the Asthma 
only group. This inclusion may have led to a higher mean level of anxiety sensitivity for 
the Asthma group. Further research in this area is necessary to provide additional 
evidence as to whether or not individuals with asthma alone have higher levels of anxiety 
sensitivity than individuals who do not have asthma. In addition, if high levels of anxiety 
sensitivity are found for individuals with asthma only, the implications for the 
development of panic disorder in this population will need to be thoroughly examined. 
Interestingly, although it is logical to expect that women with both asthma and 
panic disorder would score higher in comparison to women with asthma only on 
measures of fear of respiratory, dissociative/ neurological, and cognitive dyscontrol 
symptoms, these women also scored higher on scales that assess severity of fear of 
gastrointestinal, public anxiety, and cardiovascular symptoms. In contrast, women with 
panic disorder only scored higher on the respiratory and cognitive dyscontrol scales. It 
may be that women with both asthma and panic disorder learn to fear a wider array of 
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symptoms because they are vigilant about two different types of attacks- panic 
asthma attacks. Anecdotally, women with asthma and panic disorder report that they 
frequently have trouble identifying whether sensations are asthma or panic related. It may 
be that these women fear any bodily sensation, regardless of the cause of the sensation. 
Again, it is not known whether this fear arises as a consequence of having a chronic 
illness, or if it is a separate phenomenon. 
Future research should focus on helping individuals who have both asthma and 
panic disorder identify the source of anxiety producing bodily sensations. This skill may 
be crucial, because what an individual does to cope with the sensations will greatly differ 
depending on the origin of the sensations. If the sensations are perceived as being 
asthma-related, the individual may use a short-acting inhaler (i.e., albuterol) to treat the 
symptoms. If the sensations are perceived as panic-related, the individual may use 
cognitive, relaxation, or other techniques to address the sensations. Unfortunately, 
because short-acting inhalers often cause anxiety symptoms, mistaking panic sensations 
for asthma symptoms and treating oneself with an inhaler may actually lead to increased 
anxiety. Treatment involving exposure to asthma or panic sensations, as currently 
practiced in cognitive-behavioral therapy for panic disorder, may also be beneficial to 
reduce anxiety about these sensations. 
Results are consistent with previous findings that panic-fear scale is positively 
correlated with a diagnosis of panic disorder (Carr et al., 1995). Given that panic-fear 
levels are associated with a variety of negative outcomes for individuals with asthma, the 
difference in women with or without panic disorder is an important one. Future research 
should examine whether a diagnosis of panic disorder in individuals with asthma is linked 
~~ 
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to higher numbers of visits to primary health care practitioners, increased numbers of 
hospitalizations, and higher numbers of prescriptions. Overall health care costs may be 
higher for individuals with both diagnoses. Furthermore, treatment of panic disorder in 
individuals with asthma may be able to reduce numbers of visits, hospitalizations, 
prescriptions, and overall health care costs. 
Mood After Tasks 
Previous research has identified correlational differences in mood that are related 
to peak air flow measurements for individuals diagnosed with asthma (Hyland, 1990). 
No consensus has been reached as to which specific emotions are associated with 
decreases in peak air flow, but it is suspected that negative mood states are more likely to 
be linked to reduced lung function (Steptoe & Holmes, 1985). Although individuals with 
asthma have been found to exhibit greater physiological changes in response to stressful 
activities than controls, controls also show some changes in oscillatory resistance that are 
correlated with self-reports of intense emotions (Ritz, Steptoe, DeWilde, & Costa, 2000). 
These findings were supported by the present study. For the sample as a whole, as 
anxious mood increased, lung capacity decreased. 
Although the combination of both asthma and panic disorder may lead to a similar 
level of anxiety on a general basis, having both disorders did not result in greater self- 
reports of transitory anxious mood during this particular baseline situation. These results 
differ from baseline anxiety mood scores for women in the Dorhofer & Sigmon (in press) 
study, where the group with both asthma and a history of panic attacks reported 
significantly higher baseline anxious mood than the Control group. Again, it may be that 
differences in group assignment criteria led to the discrepant results between these two 
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studies. Nevertheless, taking the results of both studies together, it appears that having 
panic attacks or panic disorder with or without asthma leads to reports of higher baseline 
anxious mood. 
The present study is limited in its ability to more thoroughly examine correlations 
between anxious mood and lung function for each group separately because of its small 
sample size and problems with reliability of the lung function measures. In addition, 
because of high correlations between several measures, multiple regressions predicting 
lung function measures could not be conducted. Thus, only mood and lung function 
correlations were calculated for the entire sample, and were not broken down by group. 
To date, no published study has specifically examined how the relation between mood 
and lung function may differ for individuals who have asthma with or without panic 
disorder. It is important that future research investigate potential differences in the 
correlation between anxious mood and lung function utilizing these two groups of 
individuals. 
Cognitive Theory 
Several hypotheses addressed the role that cognitions may play in the relation 
between asthma and panic disorder. An adaptation of Clark’s cognitive theory of panic to 
asthma suggests that thoughts about bodily sensations may lead to a worsening of asthma 
symptoms or a panic attack. Mislabeling non-asthma related sensations as asthma-related 
has been found to be related to increases in rehospitalization (Dirks & Schraa, 1983), and 
may be connected to other negative outcomes for individuals with asthma (e.g., overuse 
of medications). 
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Clark (1 993) outlines three criteria that must be fulfilled in order for cognitive 
mediation of panic attacks to be supported by research. These criteria were adapted to 
the asthma literature for the purposes of the present study. 
Criterion One 
The adaptation of Criterion One stated that individuals with asthma fear and 
misinterpret certain bodily sensations more than controls. Taking the results of the three 
anxiety sensitivity questionnaire measures together, it appears that women who have 
asthma without panic disorder do not tend to misinterpret bodily sensations more than 
women without asthma. Therefore, Criterion One was not supported by the results of this 
study as it pertains to individuals with asthma only. However, women with both panic 
disorder and asthma misinterpret, fear, and focus on various types of bodily sensations 
more than both women with asthma only and controls. 
Future research should investigate the types of sensations that individuals with 
both asthma and panic disorder fear, and how these sensations differ from those feared by 
individuals with asthma or panic disorder only. As discussed above, research examining 
how individuals with both asthma and panic disorder interpret and differentiate physical 
symptoms is crucial. It will be important in the future to develop treatments to assist 
individuals in learning how to discriminate between various types of bodily sensations, 
and how to react to them in a more adaptive manner. 
It should be noted that results for women with panic disorder were in the predicted 
direction and support Clark’s (1 993) original theory as it pertains to panic. Clark (1 993) 
predicted that individuals with panic disorder would interpret ambiguous internal 
sensations as threatening. Women in the Panic only group reported more negative 
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interpretations of bodily sensations than controls, more fear of respiratory and cognitive 
dyscontrol symptoms, and focused more on bodily sensations than women without panic 
disorder. These results clearly support Clark’s cognitive theory of panic disorder. 
Criterion Two 
Criterion Two stated that thoughts based on the misinterpretation of bodily 
sensations accompany challenge induced asthma symptoms or attacks. Criterion Two 
was not supported in relation to individuals with asthma only, but was supported as it 
relates to individuals with panic disorder. In addition, increases in panic-related 
cognitions for the Panic only and Asthma and Panic groups were significantly greater 
than those produced by the relaxation task. This is consistent with previous research that 
suggests that for individuals with panic disorder, experimentally induced bodily 
sensations are accompanied by self-reports of increased fearful cognitions (e.g., Rachman 
et al., 1988). 
A number of reasons may have contributed to the lack of significant findings for 
women with asthma only. It may be that participants were aware of the source of the 
sensations (i.e., that the sensations were induced by the task, not an unknown internal 
source) and were less likely to misinterpret them as being catastrophic in nature. 
Sensations that are produced in the laboratory, with an experimenter in the room, might 
not be as frightening as if they are experienced “out of the blue” and with no one else 
nearby. 
It is also possible that the tasks were not salient enough to produce sensations that 
these women fear or are likely to misinterpret. Of the 60 women who participated in the 
study, only two stopped the tasks before the 2 minute time period was completed. Both 
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participants had been diagnosed with panic disorder (one in the Asthma and Panic group, 
one in the Panic only group) and were unable to complete either the head turning or straw 
task. Given that half the sample had been diagnosed with panic disorder, and therefore 
the tasks should have been extremely aversive, it is surprising that nearly all women were 
able to complete the tasks. However, not all individuals with panic disorder fear the same 
sensations. During the exposure component of cognitive-behavior therapy for panic 
disorder, tasks that are specific to sensations that an individual fears are selected as 
exposure assignments (Barlow & Craske, 1994). It may be that the head turning and 
straw tasks produced sensations that were simply not feared by women in this study. 
Future research in this area could investigate tailoring tasks used for exposing participants 
to the individual, rather than expecting that any single task will induce panic-related 
cognitions and sensations in all participants. 
Criterion Three 
The third criterion stated that manipulations of cognitive variables have an 
influence on whether or not an individual experiences asthma symptoms, increased air 
flow resistance, or an asthma attack during a challenge task. This criterion was not 
directly examined. However, as discussed in Chapter 1, previous research has supported 
this hypothesis both for individuals with panic disorder and individuals with asthma only. 
Manipulation of cognitions for individuals with panic disorder leads to increased 
likelihood of panic symptoms or attacks during panic challenge tasks (e.g., Margraf, 
1993; Salkovskis & Clark, 1990; van der Molen et al., 1986). 
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Conclusions about Cognitive Theory 
Overall, both of the criteria proposed by Clark (1 993) that were extended to 
asthma and tested in this study were not supported. It appears that women who have 
asthma and no history of panic disorder do not interpret bodily sensations more negatively 
than women who do not have asthma, nor do they focus more on bodily sensations, or 
report more fear of these sensations than women without asthma. Women with asthma 
did not report more catastrophic cognitions during the tasks than women without asthma. 
It should be noted, however, that women with panic disorder (with or without asthma) 
reported more fear of bodily sensations, more bodily self-focus, and at baseline, more 
panic-related cognitions than the other groups. In addition, the head turning and straw 
tasks produced greater increases in panic-related cognitions than the relaxation task for 
the Panic only and Asthma and Panic groups. These results are consistent with previous 
research and Clark’s (1 993) original theory. 
DyspnedSuffocation Fear Theory 
In testing Ley’s (1 989) dyspnedsuffocation fear theory, four aspects of the theory 
were addressed. First, the relaxation task represented an attempt to replicate the findings 
of Carr et al. (1 992). In the Carr et al. (1 992) study, individuals with asthma only and 
individuals with panic disorder reported similar levels of dyspnea and similar levels of 
psychopathology. The authors noted that variance in panic symptoms in individuals with 
asthma is better accounted for by dyspnea scores compared to individuals with panic 
disorder. In other words, panic symptoms in asthma may be due to dyspnea, but in panic 
disorder, they are not due to dyspnea levels. 
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It was predicted that women in the Asthma only, Panic only, and Asthma and 
Panic groups would report similar levels of change in dyspnea scores fiom baseline to 
afler the relaxation task. These levels were predicted to be significantly higher than those 
reported by women in the Control group. All four groups reported similar levels of 
dyspnea both at baseline and after the relaxation task. However, when within-subjects 
differences were examined, the straw task produced the greatest increase in dyspnea 
reports, followed by the head turning task for all four groups. The relaxation task 
produced the smallest changes in dyspnea reports. These results suggest that the straw 
task did produce increased dyspneic sensations, but that all groups, including the Control 
group, reported similar levels of dyspnea after the tasks. 
A number of differences between the Carr et al. (1992) study and the present study 
may have led to the discrepant between-groups results for the relaxation task. In the 
previous study, participants recruited from the community included both males and 
females with an average age of 45. Furthermore, in the Carr et al. (1992) study, 
participants were seated in a reclining chair with the lights off for the relaxation task. In 
the present study, participants sat upright in the same chair that was used for the other 
tasks, and lights remained on during the relaxation task. It is possible that sample and 
methodological differences contributed to the lack of significant findings for the 
relaxation task in the present study. 
Women in the three experimental groups were expected to report significantly 
greater dyspnea levels after the head turning task in comparison to controls. Although 
between-group differences were not found for the head turning task, it is clear that the 
task itself did produce an increase in dyspnea reports relative to baseline for all groups. 
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Due to their unfamiliarity with the sensation, women in the Control group were 
expected to report more dyspnea during the straw task than women in the other three 
groups. However, no significant group differences were identified. Within-subjects 
analyses revealed that for all four groups, the straw task produced the greatest increase in 
dyspnea relative to the other two tasks. 
There are several possible reasons that may have contributed to the lack of 
between-groups differences in the present study. It may be that individuals who have not 
experienced dyspnea on a regular basis (as individuals with asthma or panic disorder 
might) pay less attention to the sensation of dyspnea. As noted above, women in both of 
the panic disorder groups focus more on bodily sensations and might therefore be 
expected to notice more subtle changes in dyspnea level in comparison to controls. 
Again, examination of dyspnea change scores for the straw task shows that all four 
groups reported an increase in dyspnea during the straw task in comparison to the other 
two tasks. The task itself may have been strong enough to produce uniform changes in 
perceived dyspnea. Future research should use more than one task specifically designed 
to induce dyspneic sensations and compare self-reports across these tasks, rather than 
relying on one task that appears to produce similar changes in all participants. 
A fourth hypothesis testing the dyspnedsuffocation fear theory suggested that 
differences would be identified in panic sensation levels after each task. The head turning 
and relaxation tasks did not produce changes in panic symptoms. After the straw task, 
women in the Panic only group reported more hyperventilation symptoms than women in 
the Asthma only and Control groups, and women in the Asthma and Panic group reported 
more bronchoconstriction than women in the Asthma only group. These results may 
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appear to conflict with the findings discussed above, where no group differences in 
dyspnea levels were identified. However, examination of the measures used may explain 
the differences. The Borg scale is a 0- I0 Likert scale that asks individuals to rate the 
amount of difficulty breathing that they experienced during the task. The 
hyperventilation and bronchoconstriction subscales of the ASC ask about much more 
specific symptoms (i.e., “shallow breathing,” “tingly in spots,” “chest tightening,” 
“mucous congestion”). When asked to rate difficulty breathing in general, participants 
may tend to minimize their symptoms, or not think of symptoms like “shallow breathing,” 
as constituting “difficulty breathing”. When participants are asked specifically about 
ways their breathing may be impaired, this may elicit increased self-reports of 
hyperventilation and bronchoconstriction. 
These results suggest that it is important for future research to use more specific 
measures of breathing difficulty and dyspnea than the Borg scale. Respiratory symptoms 
such as perceived hyperventilation and bronchoconstriction are hypothesized to play an 
important role in the onset of panic attacks (Ley, 1989). Therefore, it is particularly 
important to use measures of specific respiratory symptoms rather than a global rating of 
breathing difficulty when studying individuals with both asthma and panic disorder. 
When within-subj ects differences were examined for the Bronchoconstriction 
subscale, it was evident that the straw task produced the greatest increase, followed by the 
head turning task, and lastly the relaxation task. These findings applied to the Asthma 
only, Panic only, and Asthma and Panic groups. Women in the Control group exhibited a 
slightly different pattern, with the straw task producing the largest increase in self- 
reported bronchoconstriction in comparison to the head turning and relaxation tasks, 
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which were not significantly different from each other. These results are very similar to 
those for the dyspnea self-reports. Furthermore, examination of within-subjects 
differences on sensations specific to panic, the Asthma only, Panic only, and Asthma and 
Panic groups reported equivalent levels of change from baseline for the head turning and 
straw tasks. The levels of change reported for both the head turning and straw task were 
equivalent for these groups. This finding indicates that the head turning and straw tasks 
did indeed produce changes in panic sensation levels, but that these changes did not 
necessarily differ across groups. 
Overall, the between-groups hypotheses related to the dyspnedsuffocation theory 
were generally not supported in this study. Dyspnea levels did not differ for any of the 
groups at baseline or after any of the tasks. Self-reports of asthma-related and panic 
sensations were greater for women in the Panic only group at baseline. No significant 
differences between groups were identified for the head turning or relaxation tasks on 
bodily sensations measures. After the straw task, however, women with panic disorder 
only reported more hyperventilation symptoms than women in the Asthma only and 
Control groups. In addition, women in the Asthma and Panic group reported more 
bronchoconstriction during the straw task than women with asthma only. Therefore, the 
hypothesis put forth by Carr et al. (1 992) that suggested that the high rate of concordance 
of panic disorder in individuals who have respiratory disorders may be due to the 
experience of dyspnea was not supported by the results of the present study. 
Arguments by Ley (1 992a; 1992b) regarding using individuals who meet DSM 
criteria for panic disorder also apply to the present study. Ley notes that his theory 
applies to individuals who experience hyperventilatory panic attacks only. The use of 
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DSM-IV criteria rather than Ley’s criteria for hyperventilatory panic attacks in selecting 
participants in the present study may account for the lack of significant group differences. 
Selection of participants who have hyperventilatory panic attacks for studies similar to the 
present study might lead to results that would be more in line with the tenets of dyspned 
suffocation fear theory. 
Carr’s Hypothesis 
Carr et al. (1 996) conducted an experiment that involved having individuals with 
asthma, panic disorder, or both disorders engage in baseline and stressful tasks. The 
authors found that at baseline, individuals with asthma had more difficulty breathing than 
individuals with both asthma and panic disorder. Furthermore, a nonsignificant trend was 
identified that suggested that individuals with both asthma and panic disorder 
experienced improved lung function after a stressful task. Thus, Carr (1 998) concluded 
that it is possible that having both asthma and panic disorder may actually improve lung 
function and in some cases may serve as a protective function for individuals with 
asthma. 
The present study attempted to replicate the findings of Carr et al. (1 996) by 
measuring lung function after each task. However, no between-groups differences after 
any of the tasks were identified for the spirometry measures. Similarly, when within- 
subjects analyses were conducted, no differences in FEVl change scores were found for 
any of the groups. For FVC however, the Asthma and Panic group’s change scores for 
the relaxation task were greater than for the straw task. There were no significant 
differences for the straw and head turning tasks nor for the head turning and relaxation 
tasks. These results indicate that women in the Asthma and Panic group experienced a 
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decrease in lung function after the straw task in comparison to the relaxation task. This 
finding directly contradicts Carr’s hypothesis that having both asthma and panic disorder 
serves as a protective factor. 
For the ratio of FEVl/FVC, no within-subjects differences were found for the 
Asthma only, Asthma and Panic, and Control groups. However, women in the Panic only 
group experienced decreased lung function during the head turning task compared to the 
straw task. There were no significant differences between the head turning and relaxation 
tasks nor for the straw and relaxation tasks for this group. This finding suggests that for 
the Panic group, the straw task produced greater lung obstruction than did the head 
turning task. 
It must be noted that the problems with the reliability of the spirometry readings 
led to the need for different analyses than were originally proposed. Because many of the 
participants’ spirometric efforts produced readings that were less reliable than would be 
ideal, the variability readings for the spirometry measurements were used as covariates 
rather than excluding measurements that did not fall within the cutoff for reliability. 
Future research should utilize much larger samples than was possible in the present study, 
and ensure as much as possible that spirometry efforts are consistent. Furthermore, the 
type of lung function measurement equipment used in these two studies was not the same. 
Carr et al. (1 996) used forced oscillation pneumography, whereas the present study 
utilized spirometry. This difference in equipment may have led to disparate findings. 
Spirometry involves 3 separate blasts of air after the task and is effort-dependent. Forced 
oscillation pneumography can continuously monitor breathing via a mouthpiece, and is 
not effort-dependent. It is possible that use of forced oscillation pneumography might 
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have identified brief alterations in lung function during the tasks, and it would have 
eliminated the problems with participant effort that the spirometry caused. 
Interestingly, there have been no published studies to date that clearly confirm 
Carr’s hypothesis that having both asthma and panic disorder may lead to better lung 
function. Dorhofer & Sigmon (in press) measured participants’ lung function after they 
listened to neutral and asthma-related audiotaped scenes. In that study, peak air flow 
measurements were taken with a simple plastic device. The authors found a non- 
significant trend that suggested that having both asthma and panic attacks might protect 
against a drop in peak flow experienced by individuals with asthma only. It is also 
possible that Carr’s original finding was an anomaly that is not replicable in further 
research. However, studies that replicate these findings are needed before a definitive 
statement is made regarding the possible beneficial effects of panic attacks or panic 
disorder on the lung function of individuals diagnosed with asthma. 
Study Limitations 
Numerous limitations to the present study are noteworthy. The small sample size 
of 60 participants across four groups may have led to a lack of significant findings for 
some analyses. Comparisons between subsets of individuals within each group were not 
possible because of the small sample size. Although several reasons led to the use of 
women only in this study, the lack of men in this sample limits the generalizability of 
study results. Future research should make a point of comparing groups of men and 
women who suffer from both asthma and panic disorder. 
The use of primarily Caucasian undergraduates as experimental participants raises 
various concerns in and of itself. It is unclear how generalizable these results are to other 
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populations such as males, middle-aged individuals, the elderly, or minority groups. 
Research has indicated that changes in the prevalence of both asthma and panic disorder 
occur with age (Dodge & Burrows, 1980; Pearlman & Bierman, 1988). In particular, 
following women as they go through menopause and documenting how their asthma 
and/or panic disorder symptoms change will be important for future research to 
investigate. 
One serious limitation is that for some individuals with asthma, simply taking a 
deep breath before exhaling into a spirometer can cause short-lived lung function 
decreases (Gayrard et al., 1975; Gayrard et al., 1979; Orehek et al., 1975). Unfortunately, 
spirometry is the most widely used, least expensive, and least intrusive of a number of 
measures of lung function. Until alternative ways of measuring lung function become 
more affordable and less intrusive, the use of spirometry is likely to continue. 
The tasks that were used in the present study may not have been salient enough to 
lead to increases in anxiety for the majority of the participants. It is also possible that the 
tasks were either too long or too short to produce an anxiety experience that would lead to 
group differences. For example, if the tasks were too short, the threshold for anxiety may 
not have been reached. If the tasks were too long, participants may have habituated to the 
sensations. Anecdotally, several participants mentioned that the straw task bothered them 
when they first began the task, but after a few seconds they relaxed and became less 
anxious as they became used to the sensations. Using a smaller straw (a coffee stirrer 
rather than a drinking straw) may also lead to an increase in sensations and anxiety during 
this task. In addition, standardizing the speed at which participants turn their heads 
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during the other experimental task could ensure that the task was more consistent 
between participants. 
Future Directions 
It is only within the last 10 years that interest has emerged in researching the 
effects of comorbidity of asthma and panic disorder. Therefore, there are numerous areas 
that future research can and should address. Many of these have been discussed above, 
but deserve additional attention here. 
First, the relation between the anxiety sensitivity construct and the onset and 
maintenance of panic disorder in individuals with and without asthma needs to be 
examined more thoroughly. Conflicting findings have been reported regarding whether 
or not individuals with asthma only report higher levels of anxiety sensitivity than 
controls. Further study is required with a more demographically diverse sample than the 
present study used to help shed light on this issue. If individuals with asthma only do 
indeed report higher levels of anxiety sensitivity, longitudinal studies could examine the 
rates with which high anxiety sensitivity individuals with asthma develop panic disorder. 
The onset and course of panic disorder in individuals with asthma has not been 
investigated to date. Longitudinal studies will be able to address this issue as well. 
Treatment for individuals with comorbid asthma and panic disorder represents 
another important area for future research. The results of the present study suggest that 
using panic challenge tasks with these individuals will not be detrimental to lung function 
in the short term. However, it remains unknown how effective and safe behavioral 
treatments are for use with individuals with asthma over the long term. 
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In general, the results of the present study indicate that having asthma and panic 
disorder leads to increases in trait anxiety, self-focus on bodily sensations, fear of bodily 
sensations, and anxiety sensitivity (on one of two measures of anxiety sensitivity) in 
comparison to controls or individuals with asthma only. Cognitive theory was supported 
for individuals in both panic groups. Finally, the head turning and straw tasks were 
successful in producing increases in anxious mood, increases in panic and asthma 
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Power analyses were calculated based on statistics presented in Carr et al. (1 996): 
F(3,109) = 20.77 
k = 4  
k*n = 109 
w2 = Jk - 1)(F - 1) 
( k - l ) ( F -  1 ) + h  
w2 = (4 - 1)(20.77 - 1) 
(4 - 1)(20.77 - 1) + 109 
w2 = .352 
a =  n7w2 
1 - w 2  
cD= n’.352 
.648 
cD= .737 n’ 
Substituting 15 participants per cell in for n’, @ = 2.85. Looking these values up on 
charts from Pearson and Hartley (1 95 l), a power value of .94 is obtained. 
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APPENDIX B 
Asthma and Anxiety 
Informed Consent Form I 
I have been asked to participate in this study because I am at least 18 years old and 
responded to media recruitment efforts for a study on asthma and anxiety. The purpose of 
this study is to gain more information about the relation between psychological events 
and physical health. My participation in this study will help further the understanding of 
the psychological processes involved in asthma and anxiety disorders. First, I will 
undergo a psychological assessment to see if I qualify for the experiment. This 
assessment will involve completion of a diagnostic interview (e.g., Do you currently have 
times when you feel a sudden rush of intense fear or discomfort?). If I qualify, I will 
participate in an experimental session. During this session, I will complete some 
questionnaires. If a question makes me feel uncomfortable, I don’t have to answer it. I 
will be asked to respond to various questions assessing: 
0 
0 
How I feel about various bodily sensations (e.g., “It scares me when I feel 
faint”, “Your heart is pounding”) 
Symptoms of asthma that I may experience (e.g., “Coughing,” “Chest 
congestion”) 
My mood (e.g., “I do not feel sad,” “I am worried”) 
My interpretations of everyday situations 
In addition to the interview and questionnaires, I will complete three tasks. In one 
task, I will briefly turn my head fiom side to side. In another task, I will breathe through 
a straw for a short period of time. A third task involves relaxing. Between these tasks, I 
will complete some questionnaires and have my lung function measured. Lung function 
will be assessed by a spirometer. I will be asked to take a deep breath and then forcefully 
exhale into a device that measures how well my lungs are working. 
I understand that 1 will be paid for my participation in this study. If I qualify, I 
will receive $10 for the interview and experimental session, which will require a 
maximum of 2 hours. 
The risks associated with this project are minimal. However, if I experience any 
distress associated with completing questionnaires or the experimental session, I may 
speak with a licensed psychologist (Dr. Sandy Sigmon, 207-58 1-2052). I may also 
contact Dr. Sigmon long-distance by calling her collect. If I want more information about 
this study, I may contact the experimenter, Diana Dorhofer, at 58 1-203 1 (30 1 Little Hall, 
University of Maine, Orono, ME 04469). If I live long-distance from the University and 
have a question for Diana, I may call Dr. Sigmon collect and leave a message for her. At 
any point in the study, I may request a referral for treatment. I may terminate my 
participation at any point without penalty. If I desire, a summary of the results of this 
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project will be made available to me at the end of the study. If I wish to receive a 
summary of the results, I may indicate so at the bottom of this form. 
My responses will remain anonymous and all of the information I provide will be 
stored in a locked laboratory. My participation in this study is strictly voluntary and I 
may withdraw at any time without penalty. 
I acknowledge that I have received a copy of this consent form. 
Participant’s signature: Date: 
Printed name: Phone: 
Please indicate if you would like a summary of the results of this study: 
If yes, please write your permanent mailing address below: 
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Asthma and Anxiety 
Informed Consent Form I1 
I have been asked to participate in this study because I am at least 18 years old and 
responded to media recruitment efforts for a study on asthma and anxiety. The purpose of 
this study is to gain more information about the relation between psychological events 
and physical health. My participation in this study will help further the understanding of 
the psychological processes involved in asthma and anxiety disorders. First, I will 
undergo a psychological assessment to see if I qualify for the experiment. This 
assessment will involve completion of a diagnostic interview (e.g., Do you currently have 
times when you feel a sudden rush of intense fear or discomfort?). If I qualify, I will 
participate in an experimental session. During this session, I will complete some 
questionnaires. If a question makes me feel uncomfortable, I don’t have to answer it. I 
will be asked to respond to various questions assessing: 
How I feel about various bodily sensations (e.g., “It scares me when I feel 
faint”, “Your heart is pounding”) 
Symptoms of asthma that I may experience (e.g., “Coughing,” “Chest 
congestion”) 
My mood (e.g., “I do not feel sad,” “I am worried”) 
My interpretations of everyday situations 
In addition to the interview and questionnaires, I will complete three tasks. In one 
task, I will briefly turn my head from side to side. In another task, I will breathe through 
a straw for a short period of time. A third task involves relaxing. Between these tasks, I 
will complete some questionnaires and have my lung function measured. Lung f ic t ion  
will be assessed by a spirometer. I will be asked to take a deep breath and then forcefully 
exhale into a device that measures how well my lungs are working. 
I understand that I will receive experimental credit for my participation in this 
study. If 1 qualify, I will receive 2 credits for the interview and experimental session, 
which will require a maximum of 2 hours. If I do not qualifl, I will receive 1 credit for 
the interview portion of the study. 
The risks associated with this project are minimal. However, if I experience any 
distress associated with completing questionnaires or the experimental session, I may 
speak with a licensed psychologist (Dr. Sandy Sigmon, 207-58 1-2052). I may also 
contact Dr. Sigmon long-distance by calling her collect. If I want more information about 
this study, I may contact the experimenter, Diana Dorhofer, at 581-203 1 (301 Little Hall, 
University of Maine, Orono, ME 04469). If I live long-distance from the University and 
have a question for Diana, I may call Dr. Sigmon collect and leave a message for her. At 
any point in the study, I may request a referral for treatment. I may terminate my 
participation at any point without penalty. If I desire, a summary of the results of this 
project will be made available to me at the end of the study. If I wish to receive a 
summary of the results, I may indicate so at the bottom of this form. 
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My responses will remain anonymous and all of the information I provide will be 
stored in a locked laboratory. My participation in this study is strictly voluntary and I 
may withdraw at any time without penalty. 
I acknowledge that I have received a copy of this consent form. 
Participant’s signature: Date: 
Printed name: Phone: 
Please indicate if you would like a summary of the results of this study: 
If yes, please write your permanent mailing address below: 
APPENDIX C 
Physician Release of Information 
Physician name: 
Physician address: 
I, have participated in an experiment at the University of 
Maine that examines psychological factors that may influence asthma symptoms. This 
experiment requires that participants have been diagnosed with asthma. Please complete 
the following questions and return this form in the enclosed self-addressed stamped 
envelope. I give permission for you to release information regarding my diagnosis of 
asthma only to Diana Dorhofer, the primary experimenter for this study. 
Participant signature Date 
Print name 
Please complete the following questions: 
Has been diagnosed with asthma? YES NO 
At approximately what age was she diagnosed? 
What medications have you prescribed for her for her asthma symptoms (please include 
dosage information)? 
Please rate the severity of her asthma: Mild Moderate 
Severe 
Is her asthma: Well-controlled 
Not controlled well 
Moderately well-controlled 
Thank you for completing this information. Please return this form in the enclosed 
envelope. If you have any questions, please contact Diana Dorhofer (207-581-203 l), 301 
Little Hall, Orono, ME 04469. 
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APPENDIX D 
Anxiety Sensitivity Index 
Respond to each item by indicating the number of the phrase which best 
represents the extent to which you agree with the item. If any of the items addresses 
something that is not part of your experience (i.e., "it scares me when I feel shaky'' for 
someone who has never trembled or had the 'khakes"), answer on the basis of how you 
think you might feel if you had such an experience. Otherwise, answer all items on the 
basis of your own experience. Be careful to make only one choice for each item and 
please answer all items. 
0 = Very little 
1 = A little 
2 = Some 
3 = Much 
4 = Very much 
__ 1. It is important to me not to appear nervous 
2. When I cannot keep my mind on a task, I worry that I might be going crazy 
3. It scares me when I feel "shaky" (trembling) 
4. It scares me when I feel faint 
5. It is important to me to stay in control of my emotions 
6. It scares me when my heart beats rapidly 
8. It scares me when I am nauseous 
9. When I notice that my heart is beating rapidly, I worry that I might have a 
heart attack 
10. It scares me when I am short of breath 
1 1. When my stomach is upset, I worry that I might be seriously ill 
12. It scares me when I am unable to keep my mind on a task 
13. Other people notice when I feel shaky 
14. Unusual body sensations scare me 
15. When I am nervous, I worry that I might be mentally ill 
- 7. It embarrasses me when my stomach growls 
- 16. It scares me when I am nervous 
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APPENDIX E 
Anxiety Sensitivity Profile 
Instructions: It is very important that you read these instructions carefully so that you will be 
able to answer the questions that follow. The purpose of this questionnaire is to measure 
your level of fear of anxiety-related sensations. There are many anxiety-related sensations, 
including the following: palpitations (pounding heart or accelerated heart rate), sweating, 
trembling, shortness of breath, chest pain or discomfort, nausea, dizziness, feelings of 
unreality, chills, and hot flashes. People differ in their fears of these sensations: some 
people have little or no fear, others have mild or moderately severe fears, while others have 
very strong fears. 
Anxiety sensations are feared if a person believes that these sensations have bad 
consequences. For example, people are frightened of palpitations if they believe these 
sensations could lead to a heart attack. People are frightened of dizziness if they believe 
that this sensation could mean that they are going crazy. People are frightened of publicly 
observable anxiety reactions (e.g., blushing or trembling) if they believe these reactions 
could cause others to ridicule or reject them. 
We would like you to do two things for each of the items on the following pages: 
1. Imagine that you are experiencing the sensation. Try to imagine this as vividly as 
possible. 
2. Using the scale provided, rate the likelihood that if YOU experienced the sensation, it 
would lead to something bad happening to you, such as dying, going crazy, losing control, 
or being ridiculed or rejected by others. There are no right or wrong answers, and all 
responses will remain anonymous. Please note: We are not assessing whether or not you 
experience these sensations as a result of being anxious. We want to assess whether you 
believe that anxiety-related sensations would lead to something bad happening to you. 
Practice item: 
that this sensation would LEAD to something BAD happening to YOU? Circle the number 
that best indicates your choice: 
Imagine that you’re experiencing the following sensation. What is the likelihood 
Not at all Somewhat Extremely 
likely likely likely 
0. Your legs feel unsteady 1 2 3 4 5 6 7 
Before you answer the following questions, please place a check mark here if you fully 
understand the instructions you have read: 
If you don’t understand the instructions, please ask for clarification. 
166 
What is the likelihood that this sensation would LEAD to something BAD happening to 
YOU? 
1 = Not at all likely 
2 
3 = Somewhat likely 
4 
5 = Extremely likely 
1. Your heart is pounding 
2. Your thoughts seem slower than usual 
3. You feel like you can’t take a deep breath 
4. Your stomach is making loud noises 
5.  You have tingling sensations in your hands 
6. You have pain in your chest 
7. Your thoughts seem jumbled 
8. Your heart is beating so loud that you can hear it 
9. You feel like you’re in a fog 
10. Hot flushes sweep over you 
1 1. You have diarrhea 
12. You are “jumpy” or easily startled 
13. You keep getting distracted by unwanted thoughts 
14. Your heart beats rapidly 
15. You feel like you’re suffocating 
16. You have a knot in your stomach 
17. You feel numb all over 
18. Thoughts seem to race through your mind 
19. You feel out of breath even though you haven’t been exerting yourself 
20. Your heart pounds in your ears 
2 1. You feel like something is stuck in your throat 
22. Your body feels strange or different in some way 
23. Your face sweats even though you’re not hot 
24. Your voice quavers (trembles or sounds shaky) 
25. You can’t keep your mind on a task 
26. You have difficulty swallowing 
27. Your stomach aches 
28. You have burning sensations in your chest (heartburn) 
29. Familiar surroundings seem strange or unreal to you 
30. You feel like you’re choking 
3 1. You feel your heartbeat pulsing in your neck 
32. You are constipated 
33. You feel faint or lightheaded 
34. Your heart starts beating slower 
35. You shiver even though you’re not cold 
36. You have trouble thinking clearly 
37. You feel that there’s a lump in your throat 
38. You feel like you’re about to vomit 
1 = Not at all likely 
2 
3 = Somewhat likely 
4 
5 = Extremely likely 
39. You’re awake but you feel like you’re in a daze 
40. Your stomach is upset 
4 1. You have trouble remembering things 
42. Your heart beats erratically 
43. You have tingling sensations in your lips 
44. Your mind goes blank 
45. Your throat feels tight 
46. You feel “spacey” or spaced out 
47. You feel like you’re not getting enough air 
48. Your face blushes red 
49. You feel bloated (gassy) 
50. You feel sick in your stomach (nausea) 
5 1. Your heart skips a beat 
52. Your face feels numb 
53. The muscles in your face twitch 
54. You are easily distracted 
56. You have difficulty concentrating 
57. You have to urinate more frequently than usual 
58. Your hands are trembling 
59. You feel like you can’t breathe properly 
60. You feel like things are spinning around you 
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APPENDIX F 
Asthma Symptom Checklist 
Please rate the following symptoms you may experience when you are having an asthma 
attack. 





1. Shallow breathing 
2. Choking 




7. Itchy throat 
8. worn out 
9. Frustrated with things 
10. Worried about myself 
1 1. Worried about attack 
12. Dizzy 
13. Itchy lungs 
14. Nauseated 
15. No energy 
16. Tingly in spots 
17. Scared 
18. Short tempered 
Worried 
20. Headache 
21. Afraid of dying 
22. Itchy skin 
23. Panicky 
24. Short of breath 
25. Chest filling up 
26. Chest congestion 




3 1. Irritable 
32. Rapid breathing 
33. Chest tightening 
34. Frightened 
35. Weak 
36. Hard to breathe 
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APPENDIX G 
Body Vigilance Scale 
Instructions: This measure is designed to index how sensitive you are to internal 
bodily sensations such as heart palpitations or dizziness. Fill it out according to how you 
have felt for the past week. 
1. I am the kind of person who pays close attention to internal bodily sensations. 
10 0 _ _ _ _ _ _ _ _ _  1 _ _ _ _ _ _ _ _ _  2 _ _ _ _ _ _ _ _  3 _ _ _ _ _ _ _ _  4 _ _ _ _ _ _ _ _  5 _ _ _ _ _ _ _ _  6 _ _ _ _ _ _ _ _  7 _ _ _ _ _ _ _ _  8 _ _ _ _ _ _ _ _  9 _ _ _ _ _ _ _ _  
Not at all Moderately Extremely 
like me like me like me 
2. I am very sensitive to changes in my internal body sensations. 
10 0 _ _ _ _ _ _ _ _ _  1 _ _ _ _ _ _ _ _ _  2 _ _ _ _ _ _ _ _  3 ________  4 _ _ _ _ _ _ _ _  5 _ _ _ _ _ _ _ _  6 _ _ _ _ _ _ _ _  7 _ _ _ _ _ _ _ _  8 _ _ _ _ _ _ _ _  9 _ _ _ _ _ _ _ _  
Not at all Moderately Extremely 
like me like me like me 
3. On average, how much time do you spend each day “scanning” your body for 
sensations (e.g., sweating, heart palpitations, dizziness)? 
0 _ _ _ _ _ _ _  1 0 _ _ _ _ _ _ _ _  20 _ _ _ _ _ _ _  30 _ _ _ _ _ _ _  40 _ _ _ _ _ _ _  50 _ _ _ _ _ _ _  60 _ _ _ _ _ _ _  70 _ _ _ _ _ _ _  80 _ _ _ _ _ _ _  90 _ _ _ _ _ _ _  100 
No time Half of the All of the 
time time 
4. Rate how much attention you pay to each of the following sensations using this scale: 
1. Heart palpitations 10. Dizziness 
2. Chest paiddiscomfort 
3. Numbness 12. Sweatinglclammy hands 
4. Tingling 13. Stomach upset 
5. Short of breathkmothering 
6. Faintness 15. Chokindthroat closing 
7. Vision changes 
8.  Feelings of unreality 
9. Feeling detached from self 




Borg Category Scale 
Please rate the amount of difficulty breathing that you experienced during the task 
you just completed. 
0 Nothing at all 
0.5 Very, very slight (just noticeable) 





6 Somewhat severe 
7 Severe 
8 Very severe 




Brief Body Sensations Interpretation Questionnaire 
Here are some outline descriptions of situations in which it is not quite clear what 
is happening. Read each one, and then answer the question below it very briefly. Write 
down the first thing that comes into your mind without thinking too long about it. Please 
write what you think is happening before you turn over the page. Be as specific as 
possible. 
When you have done that, turn the page over and you will see three possible 
explanations for the situation. Arrange these in the order in which they would most likely 
come to your mind if you found yourself in a similar situation. So the one that you would 
consider most likely to be true should come first, and the one that you would consider 
least likely to be true should come third. Do not think too long before deciding. We want 
your first impressions, and do not worry if none of them fits with what you actually did 
think. 
la. You have visitors over for a meal and they leave sooner than you expected. 
Why? 
1 b. a) They did not wish to outstay their welcome. 
b) They had another pressing engagement to go to. 
c) They did not enjoy the visit and were bored with your company. 
1 St 2nd 3 rd 
2a. You feel short of breath. 
Why? 
2b. a) You are developing the flu. 
b) You are about to suffocate or stop breathing. 
c) You are physically “out of shape.” 
3a. Your vision has become slightly blurred. 
Why? 
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3b. a) You have strained your eyes slightly. 
b) You need to get glasses or change your existing glasses. 
c) This is a sign of a serious illness. 
4a. You go into a shop and the clerk ignores you. 
Why? 
4b. a) They are bored with their job, and this makes them rude. 
b) They are concentrating very hard on something else. 
c) They find you irritating and resent your presence. 
5a. You feel lightheaded and weak. 
Why? 
5b. a) You are about to faint. 
b) You need to get something to eat. 
c) You didn't get enough sleep last night. 
6a. You smell smoke. 
Why? 
6b. a) Your house is on fire. 
b) Some food is burning. 
c) Someone is smoking a cigarette. 
7a. A friend suggests that you change the way that you're doing a job in your own 
house. 
Why? 
7b. a) They are trying to be helpful. 
b) They think you're incompetent. 
c) They have done the job more often and know an easier way. 
8a. Your chest feels uncomfortable and tight. 
Why? 
8b. a) You have indigestion. 
b) You have a sore muscle. 
c) Something is wrong with your heart. 
9a. You wake with a start in the middle of the night, thinking you heard a noise, but 
all is quiet. 
What woke you up? 
9b. a) You were woken by a dream. 
b) A burglar broke into your house. 
c) A door or window rattled in the wind. 
1 st 2nd 3rd 
1 Oa. You are introduced to someone at a party who fails to reply to a question you ask 
them. 
Why? 
1 Ob. a) They did not hear the question. 
b) They think you are uninteresting and boring. 
c) They were preoccupied with something else at the time. 
1 1 a. You notice your heart is beating quickly and pounding. 
Why? 
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1 1 b. a) Because you have been physically active. 
b) Because there is something wrong with your heart. 
c) Because you are feeling excited. 
1 St 2nd 3‘d 
12a. You suddenly feel confused and are having difficulty thinking straight. 
Why? 
12b. a) You are going out of your mind. 
b) You are coming down with a cold. 
c) You’ve been working too hard and need a rest. 
1 st 2nd 3‘d 
13a. A letter marked “URGENT” arrives. 
What is in the letter? 
13b. a) It is an advertisement designed to attract your attention. 
b) You forgot to pay a bill. 
c) News that someone you know has died or is seriously ill. 
1 st 2nd 3rd 
14a. You notice that your heart is pounding, you feel breathless, dizzy and unreal. 
Why? 
14b. a) You have been overdoing it and are overtired. 
b) Something you ate disagreed with you. 
c) You are dangerously ill or are going mad. 
1 st 2”d 3 rd 
175 
Now that you have answered the preceding questions we would be grateful if you 
would answer one more question about each of the ambiguous situations. Please return to 
the start of the booklet and then rate the extent to which you think each of the three 
explanations would be likely to be true if you found yourself in that situation. 
Use the scale below for your ratings. Put a number between 0 and 8 next to 
of the three explanations in the text. Do not worry if your ratings appear to be different 
from your previous answers, and please do not change any of your original answers. 
0 _ _ _ _ _ _ _ _ _  1 _ _ _ _ _ _ _ _ _  2 _ _ _ _ _ _ _ _ _  3 _ _ _ _ _ _ _ _ _  4 _ _ _ _ _ _ _ _ _  5 _ _ _ _ _ _ _ _ _  6 _ _ _ _ _ _ _ _ _  7 _ _ _ _ _ _ _ _ _  8 





AGE HEIGHT WEIGHT DATE TIME 
At what age were you diagnosed with asthma? 
Have you been diagnosed with any other chronic illness? (e.g., diabetes, high blood 
pressure, etc.) 
-Yes ~ no 
If yes, what illness? 
What medications do you take, at what dosages, and how often? Please include birth 
control pills. 
Do you take these medications as prescribed or less frequently 
Describe increase or decrease 
more frequently 
How often do you have asthma attacks? 
Once per day or more 
Once per week or more 
Once per month 
Once per year 
Less than once every couple of years 
How often do you have asthma symptoms (e.g., wheezing, coughing, tightness of chest, 
mucus, etc.)? 
Once per day or more 
Once per week or more 
Once per month 
Once per year 
Less than once every couple of years 
When was your last asthma attack? 
Is your asthma exercise induced, allergy induced, or both? 
If allergy induced, list things that trigger symptoms or an attack 
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During what months do you usually have asthma symptoms? 
All months 
January February ~ March April 
September October November December 
~ May June July August 
Do you use a peak flow meter at home? Y N 
If yes, how often do you use it? 
If yes, what is your usual peak flow? 
What sport(s) or other types of exercise do you regularly engage in, if any? 
How often and for how long? 
Do you smoke? Y N If yes, how many cigarettes per day? 
Do you live with someone who smokes? Y N 
If yes, how many hours per day are you exposed to household smoke? 
APPENDIX K 
Panic Attack Cognitions Questionnaire 
Instructions: Using the scale below, rate each one of the following thoughts 
according to the degree to which you thought it during and after the task you 
just completed. Remember to rate each thought twice, once for during and 
once for after the task. 
1 =Not at all 
2 = Some, but not much 
3 = Quite a lot 
4 = Totally dominated your thoughts 
During 
1. I am going to die. 
2. I am going insane. 
3. I am losing control. 
4. This will never end. 
5. I am really scared. 
6. I am having a heart attack. 
7. I am going to pass out. 
8. I don’t know what people will think. 
9. I won’t be able to get out of here. 
10. I don’t understand what is happening to me. 
1 1. People will think I am crazy. 
12. I will always be this way. 
13. I am going to throw up. 
14. I must have a brain tumor. 
15. I will choke to death. 
16. I am going to act foolish. 
17. I am going blind. 
18. I will hurt someone. 
19. I am going to have a stroke. 
20. I am going to scream. 
21. I am going to babble or talk funny. 
22. I will be paralyzed by fear. 
23. Something is really physically wrong with me. 
24. I will not be able to breathe. 
25. Something terrible will happen. 
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APPENDIX L 
Profile of Mood States 
Instructions: Below is a list of words that describe feelings that people have. 
Please read each one carefully. Then select one of the numbered descriptors that best 
describes how you feel right now. Place that number on the small line to the left of each 
word. Do not skip any items, and print your numbers clearly. 
0 = Not at all 
1 = A  little 
2 = Moderately 
3 = Quite a bit 
4 = Extremely 
1. Tense 
__ 2. Unhappy 
- 3. Sorry for things done 
__ 4. Shaky 
__ 5. Sad 
__ 6. Onedge 
- 7. Blue 
8. Panicky 





- 14. Discouraged 






- 21. Helpless 
22. Worthless 




State-Trait Anxiety Inventory- State 
Instructions: A number of statements which people have used to describe 
themselves are given below. Read each statement and then, using the scale below, place 
the number that indicates how you feel right now, that is, at this moment, in the blank 
before the number. There are no right or wrong answers. Do not spend too much time on 
any one statement but give the answer which seems to describe your present feelings best. 
1 =Not at all 
2 = Somewhat 
3 = Moderately so 
4 = Very much so 
1. I feel calm 
2. I feel secure 
3. Iamtense 
4. I feel strained 
- 5. I feel at ease 
6. I feel upset 
7. I am presently worrying over possible misfortunes 
8. I am satisfied 
9. I feel frightened 
10. I feel comfortable 
1 1. I feel self-confident 
12. I feel nervous 
13. Iamjittery 
14. I feel indecisive 
15. I am relaxed 
16. I feel content 
17. I am worried 
18. I feel confused 
19. I feel steady 
20. I feel pleasant 
181 
State-Trait Anxiety Inventory- Trait 
Instructions: A number of statements which people have used to describe 
themselves are given below. Read each statement and then, using the scale below, place 
the number that indicates how you generally feel in the blank before the number. There 
are no right or wrong answers. Do not spend too much time on any one statement, but 
give the answer which seems to describe how you generally feel. 
1 = Almost never 
2 = Sometimes 
3 = Often 
4 = Almost always 
- 21. I feel pleasant 
- 22. I feel nervous and restless 
23. I feel satisfied with myself 
24. I wish I could be as happy as others seem to be 
25. I feel like a failure 
26. I feel rested 
27. I am "calm, cool, and collected" 
28. I feel that difficulties are piling up so that I cannot overcome them 
29, I worry too much over something that really doesn't matter 
3 1 .  I have disturbing thoughts 
32. I lack self-confidence 
34. I make decisions easily 
35. I feel inadequate 
36. I am content 
37. Some unimportant thought runs through my mind and bothers me 
38. I take disappointments so keenly that I can't put them out of my mind 
__ 39. I am a steady person 
__ 40. I get in a state of tension or turmoil as I think over my recent concerns and 
__ 30. Iamhappy 





Below is a list of symptoms that people experience. Please rate each item by writing 
the number in each slot that best describes how you felt during the task you just completed. 
0 = None 
1 =Mild 
2 = Moderate 
3 = Severe 


















Frustrated with things 
10. Worried about myself 
1 1. Worried about attack 
12. Dizzy 
13. Itchy lungs 
14. Nauseated 
15. No energy 
16. Tingly in spots 
17. Scared 
18. Short tempered 
19. Racindpounding heart 
20. Sweating 
21. Hot flashes or chills 
22. Fear of going crazy or 
23. Hearing difficulties (ringing, 
24. Desire to escape or run out 





28. Afraid of dying 
29. Itchy skin 
30. Panicky 
3 1. Short of breath 
32. Chest filling up 
33. Chest congestion 





39. Rapid breathmg 
40. Chest tightening 
4 1. Frightened 
42. Weak 
43. Hard to breathe 
44. Trembling or shaking 
45. Chest paiddiscomfort 
46. Feeling that things aren’t real 
47. Visual difficulties (blurred, 
48. Difficulty concentrating 
49. Difficulty keeping calm 




Visual Analog Panic Scale 
Please rate the similarity of the sensations you experienced during the task to 
those of a panic attack. 
7 1 _ _ _ _ _ _ _ _ _ _ _ _ _  2 _ _ _ _ _ _ _ _ _ _ _ _ _  3 _ _ _ _ _ _ _ _ _ _ _ _ _  4 _ _ _ _ _ _ _ _ _ _ _ _ _  5 _ _ _ _ _ _ _ _ _ _ _ _ _  6 _ _ _ _ _ _ _ _ _ _ _ _ _ _  
Not at all Moderately Extremely 
similar similar similar 
APPENDIX P 
Visual Analog Stress Scale 
Please rate the level of stress you felt during the task. 
1 _ _ _ _ _ _ _ _ _ _ _ _ _  2 _ _ _ _ _ _ _ _ _ _ _ _ _  3 _ _ _ _ _ _ _ _ _ _ _ _ _  4 _ _ _ _ _ _ _ _ _ _ _ _ _  5 _ _ _ _ _ _ _ _ _ _ _ _ _  6 ________-_____ 7 
Not at all Moderately Extremely 
stressed stressed stressed 
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APPENDIX Q 
Visual Analog Asthma Scale 
Please rate the similarity of the sensations you experienced during the task to 
those of an asthma attack. 
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APPENDIX R 
Visual Analog Control Scale 
Please rate how much you believed you had control over the sensations you 
experienced during the task. 
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